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ABSTRACT 
 
Background: Critically ill patients face physical, psychological, and health-related quality of 
life (HRQOL) problems. Factors relating to the intensive care unit (ICU) stay of a critically ill 
patient may affect a patient’s HRQOL after discharge from hospital and may include the 
development of acute respiratory distress syndrome (ARDS) and sepsis, prolonged length of 
mechanical ventilation (MV) and prolonged periods of immobility. Organ dysfunction and 
multiple organ failure (MOF) influence a patient’s QOL after hospital discharge. The 
presence of chronic diseases such as chronic obstructive pulmonary disease (COPD), 
diabetes mellitus (DM), and obesity may also contribute to the development of and severity 
of critical illness. Survivors of critical illness may be confronted with major problems during 
their recovery from critical illness. Limited South African data is available regarding the QOL 
of survivors of critical illness and limited research evidence is available to support 
rehabilitation services for this population after hospital discharge.The population of South 
Africa is a complex society and therefore has its own unique challenges that patients may 
face on a daily basis after a period of critical illness. These challenges may result in patients 
experiencing functional problems and a reduced HRQOL after critical illness. The aim of this 
study was to determine the functional ability and HRQOL of survivors of critical illness when 
assessed in the first six months after discharge from hospitals in South Gauteng.  
 
Methods: A prospective, observational, and longitudinal study was conducted using 
patients, who met the inclusion criteria for the study, in the ICU’s of a private hospital in 
Johannesburg. The acute physiology and chronic health evaluation II (APACHE II) and 
simplified acute physiology score II (SAPS II) were calculated and recorded for enrolled 
participants, as well as duration of MV, ICU length of stay (LOS) and hospital LOS. The 
physical function in ICU test scored (PFIT-s) was performed at the time of discharge from 
ICU and repeated at discharge from hospital. At one and six months after discharge from 
hospital, participants’ peripheral muscle strength was measured using a handheld 
dynamometer (HHD), exercise endurance was assessed using the six minute walking test  
(6MWT), and participants completed the short form 36 (SF-36) questionnaire, EuroQol 
Group 5 dimension (EQ-5D) questionnaire, patient health questionnaire (PHQ-9) and recent 
physical activity questionnaire (RPAQ). 
 
Results and Discussion: Twenty-four participants were enrolled into the study. The mean 
age was 51 (± 13.8) years, the majority were male (n=19, 79.2%), and most participants 
were employed (n=20, 83.3%) prior to the onset of critical illness. Half of the participants in 
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this study presented with pre-existing disease prior to critical illness (n=12; 50%). Majority of 
participants underwent surgical interventions (n=19, 79.2%) which led to ICU admission and 
half of participants (n=12, 50%) reported having pre-morbid disease. All participants in the 
current study received physiotherapy treatment for the duration of their hospital stay. A 
significant change between mean PFIT-s interval scores (p=0.02) at ICU discharge and 
hospital discharge was found with a 0.4 points (± 0.7) change in interval scores. This change 
was not clinically significant, suggesting that not all the rehabilitation needs of these 
participants, who were recovering from critical illness, were met before their discharge from 
hospital. The increase in median 6MWT distance achieved was 65 meters, this being of 
clinical significance. There was no significant change in mean 6MWT distance achieved (53 
meters ± 74.9).The limited mean distances that participants in this study were able to 
achieve during the 6MWT suggests that their endurance is impaired, which may impact their 
ability to perform activities of daily living. A marginally significant relationship was found 
between 6MWT distance at one month follow-up and SF-36 mental component score (MCS) 
at six months (p=0.05).  
 
Significant mean changes in peripheral muscle strength over six months after discharge 
were observed for right-sided (dominant side in all participants) elbow flexion (17.3 ±15.7, 
p=0.00), elbow extension (32.6 ± 37, p=0.02), hip abduction (53.4 ± 52.3, p=0.01), knee 
extension (59.9 ± 40.3, p=0.00), knee flexion (42.4 ± 31.3, p=0.00) and ankle dorsiflexion 
(29.9 ± 36.9, p=0.02), left-sided hip abduction (36.4 ± 45.2, p=0.02), knee flexion (40 ± 43.3, 
p=0.01), and ankle dorsiflexion (43.3 ±  48.1, p=0.03). The fact that majority of participants in 
this study lived alone may account for the improvements in muscle strength observed as 
they would be dependent on themselves for performing daily activities.The median PHQ-9 
score showed an improvement of 2 points between one month and six months follow-up.  A 
significant change in mean SF-36 physical component score (PCS) of 8.8 points (± 7.6, 
p=0.00) was observed over the six months period. This relates to improvements in the 
physical domain of HRQOL over the first six months after discharge from hospital following 
critical illness. The significant improvement in HRQOL related to PCS in the current study 
may be due to the fact that most participants lived alone and were self-dependent for daily 
activities even though they had some form of support from family and friends, and some of 
them had also returned to work by six months following discharge. Participants in the current 
study had several co-morbidities which may also have contributed to the lower observed 
mean PCS scores at six months. Significant changes in mean SF-36 domain scores were 
observed over six months for the role physical (RP) (p=0.00), bodily pain (BP) (p=0.05), 
general health (GH) (p=0.00), vitality (VT) (p=0.01) and the social functional (SF) (p=0.00). A 
significant mean change of 14.6 points (± 9.7) in EQ-5D visual analogue scale (VAS) scores 
vi 
 
was observed over six months after discharge. Participants’ abilities to mobilise, care for 
themselves and participate in usual activities (measured using the EQ-5D) improved over 
time as they continued to recover from critical illness. Large reduction in level of pain and 
discomfort experienced at six months as measured with the EQ-5D questionnaire may be 
due to wound healing that took place as the majority of participants underwent surgery. A 
significant relationship was found between the SF-36 PCS at one month follow-up and 
severity of illness (SAPS II) scores.Very weak and weak relationships were found between 
the SF-36 PCS and APACHE II scores (r=0.036) and SAPS II scores (r= 0.31) and moderate 
strength relationships were found between SF-36 PCS and PHQ-9 scores (r= -0.49) and 
6MWT distance (r= 0.54) at six months follow-up. None of these relationships were 
statistically significant. Moderate strength negative relationships which were statistically 
significant, were identified between the SF-36 MCS and ICU LOS (r= -0.56; p=0.04) and 
hospital LOS (r= -0.56; p=0.04) at six month follow-up. A strong negative relationship was 
found between the SF-36 MCS at six months follow-up and duration of MV which was 
statistically significant (r= -0.7; p= 0.01). A strong negative relationship was found between 
SF-36 MCS scores and PHQ-9 scores at six months after discharge from hospital which was 
statistically significant (r= -0.72; p= 0.01). The main reasons reported by participants for not 
returning to work were pensioner status and physical weakness; however, at six months 
more than half of participants had returned to employment. The presence of depressive 
disorders did not directly influence return to work. The relatively good return to work rate 
observed may be attributed to the significant increases in muscle strength and PCS 
observed as well as the reduction in problems reported in relation to mobility, self-care, pain 
or discomfort and participation in usual activities over the first six months following 
discharge. Length of MV, SF-36 MCS and SF-36 PCS scores had no statistically significant 
relationship with exercise endurance at six months after hospital discharge. Limitations to 
this study include the small sample size and high drop-out rates.  
 
Conclusion: Survivors of critical illness in Gauteng province suffered from limitations in 
functional abilities at ICU discharge and improvements observed at hospital discharge were 
not clinically significant. Even though peripheral muscle strength improved significantly for 
participants in the six months following discharge, they still  presented with limitations in 
exercise endurance. Significant improvements were observed in QOL related to physical 
functioning but little improvements were observed for QOL related to mental health. Some 
participants presented with symptoms of depression. More than half of participants returned 
to employment by six months following discharge. Findings from this study suggest that 
survivors of critical illness don’t recover fully on their own after an episode of acute illness. 
These results should be used to motivate for implementation of structured rehabilitation 
vii 
 
programmes, including counselling, to aid the physical, emotional and mental recovery of 
survivors of critical illness in the long term after hospital discharge.   
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CHAPTER 1 
1. INTRODUCTION 
 
1.1  BACKGROUND 
Patients admitted to intensive care units (ICU’s) due to critical illness may face 
reduced quality of life (QOL) after discharge from hospital. There are many 
definitions of health related QOL (HRQOL) available in the literature; however, there 
is not one universally accepted definition. A commonly used definition for health is 
that provided by the World Health Organisation (WHO, 1948). They define health as 
“A state of complete physical, mental, and social well-being and not merely the 
absence of disease or infirmity” (WHO, 1948, p.1). One of the basic rights of every 
human being is to be able to enjoy the highest level of health attainable (WHO, 
1948). The WHO QOL Group defines QOL as being the perception of a person of his 
or her own position in life in the specific context of the value and culture systems in 
which he or she lives. This is relative the individual’s goals, expectations, standards, 
and concerns (WHO, 1995).  Mendlowicz and Stein (2000) describe QOL as being a 
person’s perception of the quality of his or her own life. They further describe QOL to 
be multi-dimensional as it involves a person’s social life, health status, and ability to 
function well during activities of daily living as well as activities at work (Mendlowicz 
and Stein, 2000). They concluded in their review of epidemiological and clinical 
studies investigating QOL that a more thorough understanding of the impact of QOL 
is needed (Mendlowicz and Stein, 2000).    
 
Critically ill patients admitted to ICU face physical, psychological, and HRQOL 
problems (Rattray, 2013). Survivors of critical illness may suffer from health problems 
of a physical and psychological nature for an extended period of time after discharge. 
These health problems consequently impact negatively on a patient’s social life 
(Ramsay, et al., 2012). According to Rattray (2013), physical difficulties may include 
muscle wasting, muscle weakness, fatigue, lethargy, ICU-acquired weakness (ICU-
AW) covering both critical illness myopathy (CIM) and critical illness polyneuropathy 
(CIP). Recently there has been a shift in approaches in the assessment of the quality 
of care in ICU’s with more emphasis being placed on a patient’s functional abilities 
and QOL instead of mortality rates (Boots, et al., 2013). Psychological problems may 
include anxiety, depression, post-traumatic stress, delirium and cognitive dysfunction 
(Rattray, 2013). All these difficulties may influence HRQOL negatively. This reflects 
in the HRQOL of survivors of critical illness being consistently poorer than that of the 
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general population norms when using standardized measures of HRQOL such as the 
Short Form-36 (SF-36) Health Survey and the EuroQol Group 5 Dimension (EQ-5D) 
questionnaires (Rattray, 2013). Survivors of critical illness may also be faced with 
problems when they need to return to their occupation.  
 
Factors relating to the ICU stay of a critically ill patient may affect such a patient’s 
HRQOL after discharge from hospital. Such factors may include development of 
acute respiratory distress syndrome (ARDS) and sepsis, prolonged duration of 
mechanical ventilation (MV) and prolonged periods of immobility. Organ dysfunction 
or failure developed during a patient’s ICU stay may have consequences on the 
HRQOL of such a patient after hospital discharge (Ivaskevicius, et al., 2011). When 
the abovementioned factors are present during the ICU stay of a patient, a significant 
reduction in HRQOL is seen (O’Neill, et al., 2014).  
 
Many patients with critical illness in ICU’s may be treated with prolonged MV. 
Prolonged MV and prolonged periods of immobility in bed have a major influence on 
the body including the disruption of endocrine homeostasis, circulatory shock, 
respiratory failure, catabolism of muscles with subsequent muscle weakness (Van 
Aswegen, et al., 2011). Consequently, a reduction in muscle mass may have a 
negative impact on a patient’s HRQOL after critical illness (Van Aswegen, et al., 
2011).  
 
Other factors present prior to admission to ICU and not directly related to the ICU 
stay of a patient such as the presence of chronic diseases may also contribute to the 
development of and severity of critical illness. Chronic diseases contribute 60 to 75 
percent of all deaths worldwide and may result in discrepancies in health outcomes 
between different social groups (WHO, 2005). An important chronic disease 
worldwide is chronic obstructive pulmonary disease (COPD). 
 
Chronic obstructive pulmonary disease is fourth of the top 10 leading causes of death 
worldwide. It resulted in approximately 5.8 percent of all global deaths in 2011 as 
reported by the WHO. Patients suffering from COPD have been shown to have 
reduced HRQOL as measured using the EQ-5D (Jo, et al., 2014; Wu, et al, 2015).  
Coventry and Hind (2007) report that patients with COPD present with increased 
psychosocial morbidity and this consequently impacts negatively on the HRQOL of 
these patients.  
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Patients with COPD present with airflow limitation with irreversible respiratory 
disease. This has a large impact on their physical abilities, social functioning and 
their sense of well-being (Wu, et al., 2015). Wu et al. (2015) reported that almost 40 
percent of COPD participants in their study had problems with mobility, their usual 
daily activities, pain and discomfort, as assessed using the EQ-5D questionnaire. 
Twenty percent of their participants also reported problems with self-care activities. 
The degree of difficulty experienced by these participants was significantly 
associated with the severity of COPD (Wu, et al., 2015). Not only patients with COPD 
suffer from reductions in HRQOL, but patients with other chronic diseases also feel 
the burden of their disease.   
 
Patients with diabetes mellitus (DM) also show increased psychosocial morbidity and 
resultant reduction in HRQOL (Coventry and Hind, 2007). They are reported to have 
a lower HRQOL as compared to the general population as reflected in lower SF-36 
scores of the physical functioning (PF), role limitations due to emotional problems 
(RE), and global HRQOL domains compared to scores for the general population 
(Ak, et al., 2015). These patients also have a higher incidence of anxiety and 
depression when compared to the general population, consequently having a 
detrimental effect on their HRQOL (Bahar, 2006). When DM occurs in combination 
with other chronic diseases, patients show a further reduction in HRQOL (Johnson, 
1996). The HRQOL of patients with DM type two is influenced by low quality sleep, 
mild depression, and mild anxiety which may ultimately result in a reduced HRQOL 
for these patients (Ak, et al., 2015).  
 
Patients with cardiac disease may also experience reduced HRQOL. Limited 
literature is available regarding the HRQOL of patients undergoing coronary artery 
bypass graft (CABG) surgery pre- and post-operatively (Oberai, 2014). Reductions in 
HRQOL have been reported by some researchers who have shown that there is an 
association between the reduction in HRQOL and the severity of cardiac disease and 
mental distress (Peric, et al., 2006; Stafford, et al., 2007; Faller, et al., 2009; Faller, et 
al., 2011). There are no available South African studies investigating the HRQOL of 
patients with cardiac disease following a period of critical illness.      
 
It is therefore clear that in the absence of ICU admission and critical illness, patients 
with chronic diseases such as COPD, DM and cardiac disease experience reductions 
in QOL (Lopes, et al., 2005; Mallon, et al., 2005; Alves, et al., 2009; Ringburg, et al., 
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2011; Ak, et al., 2015). It is however also important to consider the effects of critical 
illness on the HRQOL of such patients admitted to the ICU.   
After a period of critical illness, a patient returns to his or her daily life and this may 
require that they return to work. The available literature regarding the effect of return 
to work on patients’ HRQOL is conflicting. Some studies suggest a positive effect of 
actively working on HRQOL (Cox, et al., 1992; Chan, et al., 1994). Others suggest 
that there is no association between actively working and HRQOL (Talbot and 
Nülmen, 2000). There is limited literature regarding the financial impact of a period of 
critical illness on a patient and his or her immediate family (Griffiths, et al., 2013). 
Critical illness has been shown to have a negative effect on a patient’s socio-
economic status (Griffiths, et al., 2013). 
 
As with COPD and DM, those patients admitted to ICU with pneumonia, respiratory 
failure, organ dysfunction, surgical interventions, penetrating and blunt trauma to the 
trunk who undergo surgical intervention as a result of the injuries sustained, and 
patients admitted for elective and non-elective cardiac surgeries (for example mitral 
valve replacements, aortic valve replacements, and CABG) may also suffer from 
reduced HRQOL (Dowdy, et al., 2005; Orwelius, et al., 2010; Van Aswegen, et al., 
2010; Van Aswegen, et al., 2011; Goixart, et al., 2013; Scheneiderman, et al., 2013; 
De Jongh, et al., 2014; Di Battista, et al., 2014). This may be related to the 
detrimental effects of critical illness and its negative influences on the HRQOL of 
critically ill patients.  
 
As survivors of critical illness may be confronted with major problems during their 
recovery and rehabilitation from critical illness, the outcomes of intensive care cannot 
be assessed only by patient’s survival rates, but should be expanded to include the 
return to an acceptable HRQOL (Rattray, 2013). Furthermore, limited literature is 
available to support rehabilitation services after hospital discharge (O’Neill, et al., 
2014). Clarity is needed on where the focus of rehabilitation after hospital discharge 
should be (O’Neill, et al., 2014).   
 
1.2 STATEMENT OF PROBLEM AND JUSTIFICATION FOR RESEARCH 
In view of the information shared in section 1.1 (mostly from international reports) it 
would be reasonable to assume that patients admitted to ICU in hospitals in South 
Africa may be faced with similar physical, psychological or social difficulties after 
discharge from these units and from hospital as reported in the abovementioned 
studies. Delay in return to occupation may also be a reality for ICU survivors in South 
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Africa.  The survival rate of critically ill patients has improved in recent years and this 
requires the assessment of the HRQOL of the increased number of survivors of 
critical illness (Rubenfeld, et al., 1999; Angus and Carlet, 2003). It is important to 
understand the HRQOL of patients recovering from critical illness as they face 
increased risk of mortality after discharge. This is required to ultimately assess the 
effect of specific interventions during a period of critical illness on these patients 
(Dowdy, et al.,2005).Even with the achievement in intensive care outcomes, 
survivors of critical illness face an increased risk of mortality for a few years after 
discharge from hospital (Wright, et al., 2003; Williams, et al., 2005; Williams, et al., 
2008).   
 
Limited literature is available regarding the HRQOL of survivors of critical illness 
within the South African population. A study conducted by Van Aswegen et al. (2011) 
investigated the HRQOL of survivors of penetrating trunk trauma in Johannesburg. 
This was the first study of its kind in South Africa. Almost 60 percent of all cases of 
trauma admitted to South African hospitals are admitted with penetrating trunk 
injuries(Van Aswegen, et al., 2011). Van Aswegen et al. (2011) reported that 
participants who survived critical illness showed significant initial reductions in 
HRQOL; however, this improved in the first six months after discharge. They also 
reported that those patients requiring MV for prolonged periods of time experienced 
more impairment in the PF domain of HRQOL compared to the mental health (MH) 
domain at six months after discharge from hospital (Van Aswegen, et al., 2011). A 
cross-sectional study conducted in Johannesburg by Schneiderman et al. (2013), 
investigating the HRQOL of survivors of trauma six months after discharge, showed 
that these patients experienced reductions in the emotional and physical domains of 
HRQOL at six months after discharge from hospital.  
 
Another South African study by Karachi et al. (2011), conducted in the Western Cape 
province, investigated the survival and HRQOL of 46 patients at 12 months following 
discharge from an adult surgical ICU. They found that severity of illness as measured 
using Acute Physiology and Chronic Health Evaluation II (APACHE II) scores were 
correlated to long-term patient survival and the physical functioning domain of 
HRQOL. Health related quality of life was also found to be slightly lower than that of 
comparable international ICU populations (Karachi, et al., 2011). As their study 
focused on the surgical ICU patient population, further research is required to 
investigate the HRQOL of survivors of critical illness in other ICU subgroups such as 
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the medical, trauma (blunt trauma to the thorax)  and cardiac patient populations in 
South Africa.  
Certain limitations have been reported in these South African studies investigating 
the HRQOL of survivors of critical illness. Karachi et al. (2011) reported difficulties in 
generalising their results to the surgical ICU patient population due to a small sample 
size. Van Aswegen et al. (2010) reported from their prospective observational study a 
small sample size and a high dropout rate of 46 percent in their short term MV study 
group. They speculated that a possible reason for the high drop out in this group was 
that these patients felt well enough to deem follow-up assessment as unnecessary. 
Two international studies by Cuthbertson et al. (2005) and Michaels et al. (2000) also 
reported a high dropout rate in the trauma patient population. Small sample sizes and 
high dropout rates in HRQOL studies are thus well-documented in the literature and 
needs to be addressed in future studies.  
 
Other reported problems in HRQOL studies are that of missing data and language 
barriers. Schneiderman et al. (2013) reported missing data during their cross-
sectional study(level three evidence) of the HRQOL of survivors of trauma as the 
APACHE II scores for all participants were not obtained on admission. They also 
reported that some of their participants struggled to comprehend the English 
language used in the SF-36 version one questionnaire. The issue of missing data in 
HRQOL studies was confirmed by a systematic review conducted by Dowdy et al. 
(2005) investigating HRQOL of adult survivors of critical illness. They reported 
inconsistencies in baseline data reporting and reporting methods. Future HRQOL 
research should emphasize the punctual and accurate collection of baseline data as 
this is lacking in the current literature.  
 
The shortfalls in the current available literature on HRQOL after critical illness are 
therefore the following; limited South African data; small sample sizes; high dropout 
rates; missing baseline data; comprehension of the language used in certain HRQOL 
questionnaires. 
 
Survivors of critical illness in South Africa may have other important factors 
influencing their recovery from critical illness after discharge from hospital. These 
factors may include socioeconomic status, poverty, residential environment, work 
situation, and cultural factors.  All of these factors may affect a patient’s willingness to 
and opportunities to obtain rehabilitative services after critical illness. The population 
of South Africa is a complex society and therefore has its own unique challenges that 
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patients may face on a daily basis after a period of critical illness. These challenges 
may result in patients experiencing functional problems and a reduced HRQOL after 
critical illness. Due to the unique challenges faced by South African survivors of 
critical illness, results from international studies may not always be applicable to the 
South African patient population. More information is thus needed to provide insight 
into the functional abilities and HRQOL of survivors of critical illness in the first six 
months after hospital discharge in South Africa with attention being paid to the 
abovementioned shortfalls in the literature. The current study aimed to determine the 
functional ability and HRQOL of survivors of critical illness when assessed in the first 
six months after discharge from hospitals in South Gauteng.  
 
 
1.3 RESEARCH QUESTIONS 
1.3.1  What are the functional and physical abilities of survivors of critical illness at ICU 
discharge and how do these change at hospital discharge and over the first six 
months after discharge?   
 
1.3.2  What is the HRQOL of survivors of critical illness and how does it change over the 
first six months after discharge from hospital? 
 
1.3.3  Do survivors of critical illness return to employment within the first six months after 
hospital discharge? 
 
1.4 RESEARCH AIMS 
1.4.1 To determine functional ability of survivors of critical illness at the time of ICU 
discharge and at hospital discharge.  
 
1.4.2 To determine physical activity and HRQOL of survivors of critical illness over the first 
six months after hospital discharge.  
 
1.4.3 To determine if survivors of critical illness return to employment within six months 
after hospital discharge. 
 
1.5 RESEARCH OBJECTIVES 
1.5.1 To establish the level of functional ability of survivors of critical illness at discharge 
from ICU and to determine changes in their level of functional ability at hospital 
discharge. 
8 
 
 
1.5.2 To establish the exercise endurance and peripheral muscle strength of survivors of 
critical illness at one month after hospital discharge and to determine changes in their 
exercise endurance and peripheral muscle strength at six months. 
 
1.5.3 To establish the level of depression of survivors of critical illness at one and six 
months after discharge from hospital and to determine changes in level of depression 
at six months. 
 
1.5.4 To establish baseline levels of physical and mental health domains of HRQOL of 
survivors of critical illness at one month after hospital discharge and to determine 
changes in these domains of HRQOL at six months. 
 
1.5.5 To establish the level of physical activity of survivors of critical illness at one and six 
months after discharge and to determine changes in physical activity at six months. 
 
1.5.6 To determine if survivors of critical illness return to employment in the first six months 
after hospital discharge. 
 
1.5.7 To determine if a relationship exists between functional ability and severity of illness 
on ICU admission [APACHE II and Simplified Acute Physiology Score II (SAPS II)], 
duration of MV, ICU length of stay (LOS) and hospital LOS. 
 
1.5.8 To determine if a relationship exists between exercise endurance and severity of 
illness on ICU admission (APACHE II and SAPS II), duration of MV, ICU LOS and 
hospital LOS, HRQOL, level of depression of survivors of critical illness at one and 
six months after discharge 
 
1.5.9 To determine if a relationship exists between HRQOL and severity of illness, duration 
of MV, ICU LOS and hospital  LOS, level of depression and exercise endurance of 
survivors of critical illness at one and six months after discharge. 
 
1.5.10 To determine if a relationship exist between level of depression and return to 
employment in the first six months after hospital discharge. 
 
1.5.11 To determine which factors influence exercise endurance at six months after hospital 
discharge. 
9 
 
 
1.5.12 To determine which factors influence HRQOL at six months after hospital discharge. 
 
1.6 TYPE OF STUDY 
A prospective, observational, longitudinal study was conducted in order to answer the 
research questions and objectives. 
 
1.7 HYPOTHESES 
1.7.1 Alternate Hypothesis 
1.7.1.1 Participants who were admitted to ICU due to critical illness suffer from limitations in 
physical activity and HRQOL at six months after hospital discharge. 
 
1.7.1.2 Participants who survived critical illness do not return to employment in the first six 
months after hospital discharge. 
 
1.7.2 Null Hypothesis 
1.7.2.1 Participants who were admitted to ICU due to critical illness do not suffer from 
limitations in physical activity or HRQOL at six months after hospital discharge. 
 
1.7.2.2 Participants who survived critical illness return to employment in the first six months 
after hospital discharge. 
 
 
1.8 SIGNIFICANCE OF RESEARCH 
 
The current study contributes to the available limited evidence in South Africa relating 
to the functional ability and HRQOL of survivors of critical illness at ICU discharge 
and over the first six months after discharge from hospital. This information, together 
with data from existing studies, provides an indication of where rehabilitation 
interventions should be focused by exposing the possible causes of prolonged 
recovery, reduced functionality and poor HRQOL of patients recovering from critical 
illness. Based on this information, rehabilitation interventions may be developed and 
its effectiveness tested in improving functional ability and HRQOL for survivors of 
critical illness in South Africa in future research. 
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CHAPTER 2  
The following chapter will consist of the review of literature pertaining to worldwide 
and South African burden of chronic diseases of lifestyle, acute respiratory tract 
infections, and trauma; the effect of these on ICU admission rates; the complications 
of and risks associated with diseases of lifestyle; respiratory diseases or infections 
and the role they play in development of respiratory failure; the effects of 
hypovolaemic shock on oxygenation levels; severity of illness scoring systems used 
in ICU; the effects of immobility and critical illness on physical recovery; ICU-AW and 
post-ICU syndrome; changes observed in muscle power and exercise endurance of 
survivors of critical illness after discharge from hospital; the functional and physical 
abilities of survivors of critical illness as reported by other researchers; effects of 
critical illness on MH; and recovery from critical illness in the South African context. 
The outcome measures used to assess the functional ability and HRQOL of survivors 
of critical illness in this study will also be explored. The available literature involves 
studies with levels of evidence two and three.  
 
2. LITERATURE REVIEW 
 
2.1 INTRODUCTION 
Patients are admitted to ICU’s for various reasons which may include respiratory 
failure, dysfunction or disease of one or more organ, multiple injuries or following 
surgery (Benson, et al., 2011; Du, et al., 2013). Patients admitted to ICU are often 
critically ill. These patients are faced with many challenges, both during their ICU 
stay and during recovery after discharge from the ICU. These challenges may 
include immediate life-threatening conditions, organ failure, ICU-AW, and depression 
(Rattray, 2013). Survival rates for patients with critical illness have increased 
(Rubenfeld, et al., 1999; Angus and Carlet, 2003), however, the challenges 
experienced by these individuals are not only limited to the hospital environment. 
Patients may face challenges and potential problems after discharge from hospital 
resulting in difficult and often extended recovery from critical illness (Rattray, 2013). 
These challenges may be physical, social, emotional or cognitive in nature. The 
assessment of the success of intensive care provision should thus include the return 
of a patient to an acceptable level of HRQOL. There has consequently been a shift of 
research focus to the investigation of HRQOL of survivors of critical illness (Wright, et 
al., 2003; Dowdy, et al., 2005; Williams, et al., 2005; Williams, et al., 2008).  
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The following search engines and databases were used to find relevant literature for 
this review: Elton Brysan Stephens Company Host, Cumulative Index to Nursing and 
Allied Health Literature, Public Medical Literature Analysis and Retrieval System 
online, The Cochrane Library, Physiotherapy Evidence Database, and Google 
Scholar. The following key words and combinations of key words were used to 
identify relevant information for the study topics: critical illness and QOL; physical 
function in ICU Test (PFIT); six minute walking test (6MWT); EQ5-D; SF-36; Patient 
Health Questionnaire (PHQ-9); depression; depression after critical illness; PHQ-9 
and critical illness; PHQ-9 and ICU; Pro-inflammatory Cytokine Storm; Systemic 
Inflammatory Response Syndrome (SIRS); SIRS and QOL; APACHE II and SAPS II; 
APACHE II; critical illness; PHQ-9 and ICU; EQ-5D and ICU; EQ-5D Afrikaans;  SF-
36 Afrikaans; validation of the Afrikaans SF-36; validation of the Zulu SF-36; 
validation of the Sotho SF-36; COPD and QOL; DM and QOL; hand-held 
dynamometry (HHD); HHD validity and reliability; Recent Physical Activity 
Questionnaire (RPAQ); WHO and World Bank global burden of disease; cardiac 
disease and QOL; pneumonia and QOL; organ dysfunction and QOL; trauma  and 
QOL; QOL after ICU in South Africa; incidence DM; DM; DM South Africa; COPD 
South Africa; COPD incidence; COPD incidence South Africa; COPD prevalence; 
obesity; obesity prevalence; obesity incidence; obesity incidence South Africa; 
obesity incidence global; pneumonia incidence; pneumonia incidence South Africa; 
bronchitis South Africa; hypovolaemic shock and oxygenation; shock and 
oxygenation; shock; hypovolaemia; respiratory failure; critical illness and respiratory 
failure; respiratory infections; critical illness and return to work; critical illness and 
return to work South Africa;  ICU admission rates; SAPS II and QOL; APACHE II and 
QOL; and ICU admission rates South Africa.   
 
Publications from all years up to and including February 2016 were included in the 
search. English language full text articles and abstracts were selected from the lists 
generated by the search and were reviewed.  
 
2.2  INCIDENCE AND PREVALENCE OF DISEASE 
2.2.1 Diseases of Lifestyle 
Diseases associated with lifestyle account for 60 to 75 percent of all deaths 
worldwide and these diseases are one of the main causes resulting in differences in 
health between different groups in society (Kenealy, et al., 2015). Many patients are 
admitted to the ICU with exacerbations of chronic diseases such as COPD and DM. 
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Chronic obstructive pulmonary disease is defined by Boon, et al. (2006) as the 
presence of airway obstruction which does not change significantly over several 
months and is not fully reversible. According to the WHO, COPD is the fourth leading 
cause of death worldwide and by 2020, it is predicted to be the third (WHO, 2010; 
Biron, et al., 2014). The WHO and World Bank global burden of disease study 
published in 1990, reported that the prevalence of COPD worldwide is 9.33 per 100 
000 people for males and 7.33 per 100 000 people for females (Murray and Lopez, 
1996). In sub-Saharan Africa the prevalence was found to be 4.41 per 100 000 
people for males and 2.49 per 100 000 people for females (Murray and Lopez, 1996). 
The 2010 WHO and World Bank global burden of disease study does not provide 
updated figures on the abovementioned statistics. The 1990 study noted that the 
prevalence of COPD may be higher than the figures mentioned due to the fact that 
COPD is usually only diagnosed when the disease has reached a moderately 
advanced stage and is mostly diagnosed after the age of 45 (Ait-Khalet, et al., 2001). 
The 2014 WHO Non-communicable Diseases Country Profile for South Africa 
reported that chronic respiratory diseases accounted for three percent of all deaths 
across all ages and both genders(WHO, 2014).The most important etiological factor 
in COPD is tobacco smoking. Tobacco smoking accounts for more than 75 percent of 
worldwide cases of COPD (Gross, 1994; Burchfiel, et al., 1995; Kerstjens, et al., 
1997). The WHO Non-communicable Diseases Country Profile for South Africa 
reported that the total percentage of the South African population who smokes was 
18 percent in 2011 (WHO, 2014).It has been reported that the prevalence of COPD 
in Africa is largely related to pollution in the workplace (Ait-Khalet, et al., 2001).  
 
Chronic obstructive pulmonary disease has been reported to be among the top 20 
causes of death in South Africa in 2000 accounting for 113 499 deaths (Bradshaw, et 
al., 2003). The South African Demographic and Health Survey (2003) reported that 
the highest prevalence of self-reported chronic bronchitis and asthma in the Western 
Cape was found in female patients (5.7 percent and 8.9 percent respectively), with 
the second highest found in males (3.4 percent and 5.7 percent respectively) (Ehrlich 
and Jithoo, 2006; DOH, 2007). The Burden of Obstructive Lung Disease study 
conducted in 2007 found the prevalence of mild and moderate COPD to be 19.1 
percent in Cape Town. This study did not report the prevalence of COPD for 
Johannesburg (Bradshaw, et al, 2000).   
 
Chronic obstructive pulmonary disease may result in a patient being admitted to an 
ICU. Patients suffering from acute exacerbations of COPD who are admitted to the 
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ICU with acute hypercapnic respiratory failure often have poor outcomes. These 
patients may require intubation and mechanical ventilation. Patients with COPD 
admitted to ICU have mortality rates as high as six to 24 percent, increasing to 14 to 
57 percent in patients requiring ventilator support. The mortality rate of these patients 
is influenced by factors such as the type of ICU, the presence of co-existing diseases 
and personal characteristics of the patient (Alatas, et al., 2006).  
 
Biron et al. (2014) found that patients with COPD experienced reductions in HRQOL, 
with HRQOL being lower in women affected by the condition as compared to men. 
The progressive deterioration of the respiratory system and the systemic effects of 
COPD result in disability due to dyspnoea, fatigue and reductions in exercise 
tolerance. Consequently, these patients present with reductions in HRQOL 
(Basuthakur, et al., 2015).  
 
One of the most frequently diagnosed chronic metabolic diseases of lifestyle is DM 
type two. Diabetes mellitus is a characterised by raised levels of blood glucose 
associated with abnormal fat, protein and carbohydrate metabolism (Abbas, et al., 
2015). Some risk factors have been identified for the exacerbation of the disease. 
These include poor education status, low income, smoking, obesity, and the female 
gender (Gebel, 2011; Australian Diabetes Council, 2014). Diabetes mellitus type two 
occurs worldwide with 300 million people expected to have the condition by 2025 
(International Diabetes Federation, 2006). There are few epidemiological studies 
related to the prevalence of DM in South Africa. The South African demographic and 
health survey conducted in 1998 (MRC, 1998) investigating the demographics and 
health of the South African population found that the self-reported prevalence of DM 
was 2.4 percent for males and 3.7 percent for females. The Gauteng province 
reported a prevalence of 4.3 and 3.3 percent respectively for females and males 
(MRC, 1998).  In the urban areas the prevalence was found to be 4.4 and 2.9 percent 
for females and males respectively.  A much lower prevalence was found in the rural 
areas of South Africa (2.7 and 1.7 percent for females and males respectively). The 
study had a large sample size of 13827 adults aged 15 years and older (MRC, 
1998).Although valuable, these statistics are however outdated and more up to date 
statistics are now available. Diabetes mellitus is a major financial burden on 
healthcare facilities worldwide (Boon, et al., 2006). Diabetes mellitus accounted for 
1.1 million deaths worldwide in 2004 (1.9 percent of all worldwide deaths) according 
to the 2004 update on the 2010 World Bank Global Burden of Diseases Study. This 
updated report found that DM affects 9.7 million people in Africa in 2004 (WHO, 
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2008).  The 2010 World Bank Global Burden of Disease Study reported that globally, 
DM is the fourteenth leading cause of disability-adjusted life years (DALY’s) and 
twenty fourth in sub-Saharan Africa. The same study reported that in South Africa, 
DM is the sixth leading cause of DALY’s.The WHO non-communicable Diseases 
Country Profile for South Africa reported in 2014 that DM accounted for 5.7 percent 
of all deaths in South Africa in 2012, making it the third leading cause of death in 
South Africa in 2012 (WHO, 2014).  It is clear that DM is a major health concern 
globally and in South Africa.  
Diabetes Mellitus may result in a number of different complications as the chronic 
hyperglycaemia associated with DM causes damage to many organ systems in the 
body. Some of these complications include coronary heart disease, myocardial 
infarctions, cerebrovascular accidents, retinopathy, neuropathies, nephropathy and 
arterial occlusive disease (Boehme et al., 2015). These complications may be life-
threatening and may result in patients being admitted to the ICU and they may suffer 
from critical illness. This may consequently result in reduced HRQOL and life 
expectancy.     
 
A major current health concern is the prevalence of obesity worldwide. Obesity is 
characterised by a body mass index (BMI) of more than 30 kilogram per meter 
squared associated with alterations in metabolic functions as a result of increased 
body fat and an accumulation of visceral adipose tissue (Kopelman, et al., 1997). The 
WHO recognises obesity as a chronic disease.  In many countries the prevalence 
rates tripled in the last 30 years (Walls, et al., 2012). Obesity is a real problem in 
developed and developing countries (Filozof, et al., 2001; Puoan, et al., 2002; Rivera, 
et al., 2002). The global incidence of obesity is reported to be 1.3 billion people 
(WHO, 2005). The South African Medical Research Council (MRC) reported in 2007 
that the incidence of obesity or ‘being overweight’ is as high as 29 percent in adult 
males and 56 percent in adult females. Another concerning finding by the MRC is 
that 17 percent of children aged nine years and under in South Africa were found to 
be overweight (MRC, 2007; Stein, 2007). Daily mortality rates in South Africa due to 
obesity show that 60 patients die from diseases related to obesity daily (MRC, 2007; 
Stein, 2007). The WHO Non-communicable Diseases Country Profile for South Africa 
reported in 2014 that the prevalence of obesity was 31.3 percent of the population in 
South Africa in 2012 (WHO, 2014).  
 
This disturbing rise in the incidence of obesity in South Africa, more specifically in the 
women and young children population, may be the result of misconceptions in the 
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beliefs of these people about the health risk of being overweight or obese (Mvo, et 
al., 1999; Ndlovo, et al., 1999). A common misconception is that an increased body 
weight indicates a good health state. Studies reporting on BMI values of different 
ethnic groups in South Africa have been inconsistent in the reporting of their results 
and therefore comparisons of results between these studies becomes difficult. The 
prevalence of obesity was reported by Puoane et al. (2002) to be 31 to 34 percent in 
black woman, 18 to 24 percent in white women, 20 to 22 percent in Indian women, 
and 26 to 28 percent in coloured women. Much lower prevalence rates were reported 
from the same study in some male groups being eight percent in black men, three to 
nine percent in Indian men, and six to nine percent in coloured men. Fifteen to 20 
percent of white men were reported to be obese, representing the highest prevalence 
rate of all groups (Puoane, et al., 2002).   
 
A major factor which may contribute to the development of obesity is poverty. The 
inaccessibility of healthy food for a healthy, balanced diet as a result of poverty may 
lead to obesity as the unhealthy food is consumed on a daily basis because it may be 
more affordable (Bradshaw, et al., 2000). There are many challenges to the 
development and implementation of obesity prevention programmes in South Africa. 
These include poverty as mentioned above, the high incidence of human 
immunodeficiency virus (HIV) and the ability to access a healthy, balanced food 
supply (Puoane, et al., 2002).  
 
A method of assessing whether a patient has obesity is the BMI. Cross-sectional 
studies, however, have shown a relationship between BMI scores and physical 
activity. They reported that BMI scores increase as physical activity is reduced. Thus, 
patients with a higher BMI, were reported to have lower levels of physical activity 
(Cooper, et al., 2000; Ball, et al., 2001; Ewing, et al., 2003; Bernstein, et al., 2004; 
Thompson, et al., 2004).       
 
Pre-existing obesity is factor that may affect the outcomes of critically ill patients in 
the ICU. Pepper et al. (2016) reports that a minimum of 25 percent of all adults 
admitted to the ICU in the United States of America are classified as obese or 
morbidly obese. Obesity is associated with increased risks of co-morbidities such as 
DM, cardiovascular disease, musculoskeletal disorders, cerebrovascular accidents, 
some types of cancer and respiratory and gastrointestinal diseases. These co-
morbidities are all linked to premature death and reduced HRQOL (Chittleborough, et 
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al., 2014). Any of the mentioned co-morbidities to obesity may result in patients being 
admitted to ICU due to critical illness.  
 
2.2.2 Acute Respiratory Tract Infections 
Acute respiratory infections like pneumonia and bronchitis contribute to ICU 
admission rates. Pneumonia is defined by the Merck manual of medical information 
as an infection of the alveoli and the tissues around them (Merck, 2003, p. 237).  
Boon et al. (2006) also describes pneumonia as an acute respiratory illness 
associated with characteristic changes on lung x-rays. It can be lobar, segmental or 
multi-lobar in nature. According to Boon et al. (2006), pneumonia can be classified as 
being community-acquired, occurring in patients with pre-existing lung damage or in 
those who are immune-compromised or nosocomial. These categories of pneumonia 
are also described by Merck (2003).  Pneumonia is a common condition which can 
be successfully treated at home. However, 20 to 40 percent of patients diagnosed 
with pneumonia require admission to hospital (Boon, et al., 2006). Of those patients 
admitted to hospital, five to 10 percent are critically ill and require admission to an 
ICU (Boon, et al., 2006). Each of the mentioned categories of pneumonia shows a 
different presentation in terms of incidence and contribution to mortality rates (Boon, 
et al., 2006). In sub-Saharan Africa, lower respiratory tract infections were found to 
be the third leading cause of years of healthy life lost (World Bank, 2010). 
Community acquired pneumonia is estimated to affect four to five million people 
annually in the United States of America with 25 percent of patients needing hospital 
admission (Schmitt, 2010). It usually occurs by droplet spread infection in the 
community. It contributes five to 12 percent of all lower respiratory tract infections 
(Boon, et al., 2006).  Certain individuals may be more prone to the development of 
community acquired pneumonia than others. Predisposing factors include smoking, 
upper respiratory tract infections, alcohol abuse, corticosteroid therapy, advanced 
age, recent infection with influenza, and the existence of a previous lung disease 
(Boon, et al., 2006). 
 
Nosocomial pneumonia involves the presence of a new episode of pneumonia which 
occurs after two days of hospital admission. This type of pneumonia is more often 
seen in patients with chronic lung conditions admitted to hospital, MV patients, 
patients with general debilitation, and those patients with aspiration pneumonia. 
Nosocomial pneumonia affect annually approximately 250 000 people per year in the 
United States of America and accounts for 15 to 18 percent of all nosocomial 
infections (Schmitt, 2010). No data related specifically to the ICU admission rates as 
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a result of  pneumonia in South Africa could be identified. Patients who present with 
a compromised immune system, aspiration of nasopharyngeal or gastric secretions, 
exposure of the lower respiratory tract to bacteria, or those with bacteraemia are at 
higher risk of development of nosocomial pneumonia. Nosocomial pneumonia is of 
particular importance to critically ill patients as the onset of pneumonia in addition to 
their pre-existing and admission diagnoses may have a major impact on their 
outcomes (Merck, 2003; Boon, et al., 2006). 
 
Patients with compromised immune systems are more prone to the development of 
pneumonia, especially Pneumocystis pneumonia (Merck, 2003).A laboratory-based 
surveillance study conducted at 61 South African hospitals reported that 1537 cases 
of Pneumocystis Jirovecii pneumonia occurred between 2006 and 2010 across these 
hospitals. Eighty-nine percent of these patients were infected with the human 
immunodeficiency virus (Du Plessis, et al., 2016). These patients may receive drugs 
which suppress their immune systems or have diseases which impair their immune 
systems for example HIV. The pathogens resulting in pneumonia in these patients 
are the same as the pathogens involved in community acquired pneumonia and 
nosocomial pneumonia (Boon, et al., 2006).     
 
Pneumonia is a major contributor to death rates worldwide. Hospital mortality rates 
for adult patients are between five and 10 percent (Boon, et al., 2006). Patients who 
are critically ill in ICU as a result of pneumonia have a mortality rate of as high as 50 
percent (Boon, et al., 2006). Those patients treated at home have a mortality rate of 
less than one percent (Boon, et al., 2006). Pneumonia (together with influenza) was 
the second leading cause of death in South Africa in 2013 at 5.1 percent accounting 
for 24 323 deaths (Statistics South Africa, 2014).  According to the WHO, the 
environmental burden of disease of respiratory infections in South Africa is 3.9 
DALY’s per 100 000 people (WHO, 2009). The WHO Non-communicable Diseases 
Country Profile for South Africa reported in 2014 that lower respiratory tract infections 
accounted for 4.2 percent of all deaths in South Africa in 2012, making it the fifth 
leading cause of death in South Africa in 2012 (WHO, 2014). 
 
Bronchitis is another condition which may result in hospital or ICU admission. 
Bronchitis is defined as inflammation of the bronchi which is usually causes by 
infection but may also be as a result of irritation after exposure to gasses or particles 
(Scanlan, et al., 1990; Merck, 2003, p. 236). Acute bronchitis is characterised by an 
irritating unproductive cough with tracheitis. When there is involvement of the 
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bronchi, chest tightness, wheezing and dyspnoea will present. Common 
complications associated with acute bronchitis are the development of 
bronchopneumonia, acute exacerbation of bronchial asthma, or acute exacerbation 
of severe COPD. In patients with severe COPD, acute bronchitis may result in type 
two respiratory failure (Boon, et al., 2006).  
 
Chronic bronchitis is a disease classified under COPD together with emphysema. 
Chronic bronchitis is characterised by the enlargement of mucous-secreting glands 
and an increase in the number of goblet cells in the large airways. This consequently 
results in excessive secretion of airway mucus and a prolonged productive 
cough(Scanlan, et al., 1990; Merck, 2003; Boon, et al., 2006). COPD was discussed 
in section 2.2.1.    
 
2.2.3 Traumatic Injury 
Patients recovering from traumatic injury also experience reduced HRQOL. 
According to the WHO global burden of disease update (2004), 10 percent of all 
deaths worldwide were due to injuries (WHO, 2008). There is a difference between 
the two genders relating to death due to injuries with one in every eight male deaths 
being due to injury and one in every 14 female deaths being due to injuries (WHO, 
2008). Road accidents are the ninth leading cause of death worldwide which resulted 
in one point three million deaths in 2004 (WHO, 2008). The worldwide incidence of in 
injuries sustained in 2004 was 24.3 million from road traffic accidents, 37.3 million 
from falls, and 17.2 million from violence (including penetrating trauma) (WHO, 
2008). These injuries often result in critical illness. The high incidence of violence in 
South Africa leads to many patients being admitted to South African hospitals with 
penetrating trunk trauma. Penetrating trunk injury results from injuries caused by 
firearms or sharp instruments and frequently necessitate surgical intervention (Van 
Aswegen, et al., 2011). Penetrating trauma accounts for nearly 60 percent of all 
trauma cases in South African hospitals (Van Aswegen, et al., 2010). A cross-
sectional study conducted by Bergen et al. (2014) investigating psychological 
complaints and HRQOL in severely injured trauma patients concluded that 
psychological problems are underestimated and plays a major role in the reduced 
HRQOL experienced by these trauma survivors. It is suggested in the literature that 
psychological problems may have a greater impact on HRQOL compared to somatic 
dysfunction or disability (De Jongh, et al., 2014). The WHO Non-communicable 
Diseases Country Profile for South Africa reported in 2014 that road injuries 
accounted for two percent of all deaths in South Africa in 2012, making it the tenth 
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leading cause of death in South Africa in 2012 (WHO, 2014). They also reported that 
traumatic injuries account for eight percent of all deaths in South Africa across all 
ages and genders (WHO, 2014).   
 
2.2.4 Cardiac Disease 
According to the WHO, the environmental burden of disease of cardiovascular 
disease in South Africa was 3.9 DALY’s per 100 000 people (WHO, 2009).  In the 
South African population, hypertension is more prevalent in the black population than 
in any other race group (Seedat, 1998). One of the important factors in the 
development of hypertension in black African women is obesity (Seedat, 1998; Van 
Rooyen, et al., 2000).  A major cause of worldwide mortality is coronary artery 
disease; however, patients’ lives can be prolonged due to the developments in CABG 
surgery (Oberai, 2014).  Another important cardiac condition related to coronary 
artery disease is heart failure. The incidence of heart failure increases with age and 
is more prevalent in males as compared to females. Two of the most important 
contributors to the development of heart failure are hypertension and coronary artery 
disease (Ho, et al., 1993).  
 
In South Africa, 195 people died per day between 1997 and 2004 due to 
cardiovascular disease-related conditions, 33 from myocardial infarctions and 37 
from heart failure (Bradshaw, unpublished). More than half of the cases of 
cardiovascular disease occur before these patients reach the age of 65 years 
(Pestana, et al., 1996; Bradshaw, et al., 2003). The highest death rate due to 
cardiovascular disease in South Africa is found in the Indian population (Norman, et 
al., 2006).The WHO Non-communicable Diseases Country Profile for South Africa 
reported in 2014 that ischaemic heart disease and hypertensive heart disease 
accounted for 4.8 and 2.7 percent of all deaths in South Africa in 2012, making it the 
fourth and seventh leading causes of death in South Africa respectively in 2012 
(WHO, 2014). The cardiac diseases described above are life-threatening and 
patients are often admitted to ICU for close monitoring. Such patients may contract 
infections in the ICU setting or develop organ dysfunction due to poor organ 
perfusion as a result of cardiac disease and therefore present with critical illness. 
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2.3 COMPLICATIONS AND RISKS ASSOCIATED WITH DISEASES OF LIFESTYLE 
 
The diseases of lifestyle discussed earlier may be associated with particular 
complications and risks. This section will highlight the prominent complications and 
risks associated with COPD, DM, and obesity.  
 
2.3.1 Chronic Obstructive Pulmonary Disease 
In COPD, the progression of respiratory system deterioration and the systemic 
effects of COPD result in disability due to dyspnoea, fatigue and reductions in 
exercise tolerance. The early respiratory system manifestations of COPD include 
coughing and breathlessness, with the latter being the symptom resulting in a patient 
seeking medical assistance. In the later stages of the disease, oedema and morning 
headaches may be present and this is indicative of hypercapnia (Boon, et al., 2006). 
The musculoskeletal and systemic signs of COPD are mostly seen in the later stages 
of the disease and include muscular weakness due to cellular changes in skeletal 
muscles and reduced mobility, an increase in the blood-markers for inflammation, 
peripheral oedema due to impairment in salt and water excretion by the kidneys, 
weight loss due to changes in fat metabolism and impaired nutritional status, and an 
increase in the prevalence of osteoporosis. Patients with poor prognosis include 
those who develop pulmonary hypertension in the late stage of the disease (Boon, et 
al., 2006). Consequently, these patients present with a reduction in HRQOL 
(Basuthakur, et al., 2015). Of particular concern in patients suffering from COPD is 
the occurrence of acute exacerbations. Acute exacerbation involves a worsening in 
symptoms with deterioration of lung function and poorer health status. Bacteria, 
viruses or changes in the quality of the air breathed may result in acute 
exacerbations of COPD. Exacerbations become more frequent as the disease 
progresses. Severe acute exacerbations may result in respiratory failure and possible 
death (Boon, et al., 2006).During these acute exacerbations of COPD, patients may 
be admitted to the ICU for management of respiratory failure and may become 
critically ill if their response to therapy received is suboptimal. Respiratory failure is 
discussed further in section 2.4.  
 
2.3.2 Diabetes Mellitus 
The chronic hyperglycaemia associated with DM type two results in damage to many 
organ systems and consequently affects the patient negatively. The negative 
influences on the patient stems from the vascular complications both on a 
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microscopic and macroscopic level, including coronary heart disease, myocardial 
infarction, cerebrovascular accidents, retinopathy, nephropathy, neuropathy, and 
arterial occlusive disease. Diabetes mellitus is also associated with the development 
of other co-morbidities such as hypertension, dyslipidaemia, obesity and depression 
(Abbas, et al., 2015). Many of these co-morbidities associated with DM type 2 are 
however treatable. The mentioned vascular complications of and co-morbidities 
associated with DM may result in a patient being critically ill and admitted to the ICU. 
Patients suffering from DM are also susceptible to complications like lower extremity 
infections, urinary tract infections and fungal infections. This is due to the weakened 
immune system in patients with DM (Mann, 2010; Weintrob and Sexton, 2015). 
Diabetes mellitus type two may therefore result in a reduced lifespan with functional 
limitations in activities of daily living. This may ultimately reduce such a patient’s QOL 
(Rendell, et al., 1993; Zimmet, et al., 2001; Liebl, et al., 2002; Narayan, et al., 2003; 
Sarwar, et al., 2010; Danaei, et al., 2011; Hu, 2011; O’Reilly, et al., 2011; Seshasai, 
et al., 2011; Chen, et al., 2012; Schunk, et al., 2012; Boehme, et al., 2015). Another 
significant finding is that by Ak et al. (2015) who found that the majority of patients 
with DM type two experienced low quality sleep, mild depression, and mild anxiety. 
Due to the psychological and physical difficulties seen in patients with DM, there is 
progression of the disease and this result in a reduced HRQOL in these patients. 
Poor control of blood glucose levels in women suffering from DM type 2 has been 
found to be correlated with poorer HRQOL (Weintrob and Sexton, 2015). 
 
2.3.3 Obesity 
Obesity has been correlated with an increased risk of young mortality and also with 
the development of conditions which affects HRQOL negatively (Lafortune, et al., 
2009). Certain diseases may develop as a result of obesity including cardiovascular 
diseases, cerebrovascular accidents, musculoskeletal disorders, certain neoplasms, 
gastrointestinal conditions, osteoarthritis and mental disorders (WHO, 2000; WHO, 
2003; Guh, et al, 2009), all of which could be life-threatening and result in ICU 
admission and critical illness.    
 
As reported by the Australian Diabetes, Obesity and Lifestyle Study, a relationship 
exists between the reduction in physical activity levels and obesity (Cameron, et al., 
2003). This was confirmed by Pan et al. (2011) who reported that the incidence of 
obesity was higher in adults who were inactive. There is very limited literature related 
to the correlation between physical inactivity and the development of obesity. It is 
unclear whether the development of obesity is a result of physical inactivity or vice 
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versa. Peterson et al. (2003) found in a longitudinal study that there was no evidence 
to show that reduced physical activity may lead to obesity. 
 
2.4 CAUSATIVE FACTORS FOR ADMISSION TO INTENSIVE CARE 
2.4.1 Respiratory Failure  
Respiratory failure refers to the failure of pulmonary gas exchange to maintain the 
normal levels of oxygen and carbon dioxide in arterial blood. Two types of respiratory 
failure are identified: type one and type two (Boon, et al., 2006).  
 
Type one respiratory failure is characterised by hypoxia with normal carbon dioxide 
levels in the blood (also known as failure of oxygenation). This is seen in diseases 
where there is local ventilation impairment in the lungs. Arterial blood gas testing in 
type one respiratory failure will show a partial pressure of oxygen in arterial blood of 
less than 60 mmHg and a normal partial pressure of carbon dioxide in arterial blood 
or a partial pressure of carbon dioxide in arterial blood of less than 50 mmHg (Boon, 
et al., 2006). Type one respiratory failure can be acute or chronic in nature. Acute 
causes include acute asthma, pulmonary oedema, pneumonia (Carillo, et al., 2012) 
collapse of a lung lobe, pneumothorax, pulmonary embolus, and ARDS. Chronic type 
one respiratory failure may be caused by emphysema, lung fibrosis, lymphangitis, 
carcinomatosa, and brain stem injuries or lesions (Boon, et al., 2006).  
 
In contrast, type two respiratory failure is characterised by hypoxia in combination 
with hypercapnia (also known as failure of ventilation). Type two respiratory failure is 
seen in situations where there is a generalised ventilation-perfusion mismatch in the 
lungs or diseases where total ventilation is reduced. Type two respiratory failure can 
also be acute or chronic in nature. Acute type two respiratory failure may be caused 
by acute exacerbations of COPD, acute severe asthma, obstructions of the upper 
airway, acute neuropathies, acute paralysis, narcotic drugs, primary alveolar 
hypoventilation, and chest wall injuries through trauma. Chronic causes include 
COPD, sleep apnoea, kyphoscoliosis, myopathies, muscular dystrophies, and 
ankylosing spondylitis (Boon, et al., 2006). People who develop acute or acute 
chronic respiratory failure may require admission to ICU for management which may 
include endotracheal intubation and MV (Pryor and Prasad, 2008). 
 
People suffering with COPD are at particular risk of developing hypercapnic 
respiratory failure (Behera and Sidhu, 2000) as they present with a diminished 
respiratory drive especially in the later stages of the disease. They present with a 
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loss of elastic tissues in the lungs with inflammation and fibrosis in the airway wall 
resulting in premature closure of the airways (Pryor and Prasad, 2008). This results 
in trapping of gas in the airways and dynamic hyperinflation. This in turn results in 
alterations in the compliance of the lungs and chest wall. When patients with COPD 
suffer from an acute exacerbation of disease and subsequent respiratory failure, non-
invasive ventilation (NIV) is used successfully in most cases to support the patient 
until the acute exacerbation has been resolved (Lightowler, et al., 2003). As there are 
many complications of endotracheal intubation (Keith and Pierson, 1996), NIV is 
preferred. It allows the patient to speak, eat, and mobilize, and also lessens the need 
for sedation (Pryor and Prasad, 2008). As NIV does not necessarily need to be 
administered in the ICU but may also be used in the general hospital ward setting, it 
assists in reducing the rates of ICU admissions. Endotracheal intubation in acute 
exacerbations of COPD, unfortunately, may not always be prevented, resulting in 
ICU admission of these patients with a period of MV and immobilisation (Behera and 
Sidhu, 2000; Pryor and Prasad, 2008). 
 
2.4.2 Shock 
An important and dangerous condition often associated with patients admitted to the 
ICU is that of circulatory shock. This condition is often referred to as circulatory 
failure. In circulatory shock, cardiac output is low and this consequently reduces the 
delivery of oxygen to the tissues. The reduction in cardiac output could be a result of 
major haemorrhage, left heart failure, major pulmonary embolus, exacerbation of 
COPD, or septic shock. In critically ill patients, the state of circulatory failure is seen 
in association with hypotension. Hypotension, however, is a late sign of circulatory 
shock and thus shock may be present in the absence of hypotension and the patient 
may present with a normal blood pressure initially. It is thus important to identify the 
presence of circulatory shock as early as possible as it may result in inadequate 
regional tissue perfusion and a consequent lack of cellular oxygenation. This will 
result in cell death and subsequent multiple organ failure (MOF) (Baskett, 1990; 
Rivers, et al., 2001; Brealy, et al., 2002; Boon, et al., 2006; Regueira, et al., 2012).  
 
There are six different types of shock namely hypovolaemic, septic, cardiogenic, 
obstructive, neurogenic, and anaphylactic. Two types of particular importance to the 
critically ill patient are that of hypovolaemic shock and septic shock (Boon, et al., 
2006). Hypovolaemic shock occurs when the perfusion of tissues is relatively 
inadequate due to the loss of blood or plasma, typically after injury to the vascular 
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system. This could result from penetrating trauma to the trunk. There are four 
different classes of hypovolaemic shock. Class one involving blood losses of up to 
750 ml, class two up to a loss of 1.5 litres of blood, class three with a blood loss of up 
to two litres, and grade four with a blood loss of 2.5 to three litres (Baskett, 1990).  
 
Septic shock involves overwhelming inflammation. During the process of sepsis there 
is an excessive production of pro-inflammatory cytokines with resultant hypotension, 
hypovolaemia, reduced tissue perfusion and oedema. Damage to vascular 
endothelium and resultant increase in capillary permeability stem from the 
uncontrolled activation of neutrophils that cause the release of proteases and oxygen 
free radicals in blood vessels (Boon, et al., 2006). The consequences of septic shock 
involve cardiovascular system dysfunction, ARDS, disseminated intravascular 
coagulation, MOF, and possible death (Boon, et al., 2006).  It has been reported that 
patients who suffered septic shock in ICU had reduced physical activity on the 
physical component score (PCS) of the SF-36 at one year after septic shock 
(Poulson, et al., 2009).  Systemic inflammatory response syndrome and MOF are 
discussed in more detail in section 2.7.  
 
2.5 SEVERITY OF ILLNESS SCORING SYSTEMS USED IN ICU 
Patients admitted to ICU are assessed for severity of illness and predicted mortality. 
Two commonly used scoring systems are APACHE II and SAPS II (Le Gall, et al., 
2005). When interpreting the scores of these two systems, higher scores predict 
greater risk of mortality (Du, et al., 2013). The APACHE II scoring system is one of 
the most widely used scoring system in ICU. It is an overall severity scoring system 
and is useful in predicting hospital mortality, hospital LOS, and assists in clinical 
reasoning and decision making (Balreldin, et al., 2011). It also allows for the 
comparison of ICU outcomes and for monitoring of the quality of care in ICU. The 
SAPS II was developed in 1994 to provide the probability of hospital mortality for ICU 
patients over 18 years of age (Balreldin, et al., 2011). The APACHE II and SAPS II 
scoring systems can aid therapeutic decision making by determining disease severity 
(Balreldin, et al., 2011).  
 
Cardosa and Chiavoni (2013) evaluated the APACHE II scoring system by assessing 
its performance in predicting the mortality rate of 355 patients discharged from the 
ICU. They found that it is useful in identifying those patients who have higher 
likeliness of dying after discharge from ICU. Karachi et al. (2011) found a strong 
correlation between APACHE II scores on ICU admission and PF as related to 
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HRQOL in adult surgical patients at 12 months after hospital discharge. Long term 
survival after critical illness was also found to be significantly correlated to APACHE 
II scores (Karachi, et al., 2011). Schneiderman et al. (2013) found a relationship 
between APACHE II scores on ICU admission and the degree of problems 
experienced with usual daily activities as measured with the EQ-5D in trauma 
survivors at six months after hospital discharge. Goixart et al. (2013) however did not 
find a significant correlation between APACHE II scores on ICU admission and 
HRQOL (SF-36 and EQ-5D scores) of trauma survivors at six and 12 months after 
ICU admission. The design of the study by Goixart et al. (2013) was a prospective 
observational study. Van Aswegen et al. (2010) found no significant correlation 
between APACHE II scores and muscle strength in a prospective observational study 
involving adult survivors of penetrating trunk trauma and MV. Both the research of 
Goixart et al. (2013) and Van Aswegen et al. (2010) are considered level three 
evidence as it involves observational study designs with controls. 
 
During a long-term mortality and HRQOL follow-up study of patients who suffered 
septic shock, the group of participants who survived critical illness had lower SAPS II 
scores and a longer hospital LOS, with a reduction in HRQOL at six months after 
critical illness (Nesseler, et al., 2013). It has also been reported from a prospective 
cohort study by Flaatten and Kvale (2003) that there was no significant difference in 
the SAPS II scores of patients with increased SF-36 scores as compared to those 
with decreased SF-36 scores at two years after medical and surgical ICU discharge.   
Higher SAPS II scores in medical patients were also associated with higher ICU 
mortality after ICU admission (Roch, et al., 2011).  
 
2.6 EFFECTS OF IMMOBILITY AND CRITICAL ILLNESS ON PHYSICAL RECOVERY 
One of the main treatments for acute trauma and acute and chronic illnesses is 
immobilisation and bedrest (Dittmer and Teasell, 1993a). It is a good choice to 
ensure protection and recovery in the acute phase of injury or illness, but if 
immobilisation and bedrest is prolonged, it has many negative effects on the human 
body. The complications of immobilisation can be very severe, complicating the acute 
injury or illness. These complications can be so severe that they may threaten the life 
of the patient more than the original injury or disease (Dittmer and Teasell, 1993a). 
The complications of immobilisation may include muscle weakness, muscle atrophy, 
contractures, osteoporosis due to disuse, and cardiovascular complications 
(tachycardia, reduced cardiac reserve, orthostatic hypotension, and venous 
thromboembolism), respiratory complications (such as decreased ventilation, 
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atelectasis, pneumonia), endocrine complications, renal complications, 
gastrointestinal complications, pressure sores, central nervous system complications 
and problems with balance and coordination(Dittmer and Teasell, 1993a; Dittmer and 
Teasell, 1993b).Certain patient populations are more likely to develop complications 
of immobilisation such as chronically ill patients, disabled patients, and older adults 
(Dittmer and Teasell, 1993a; Dittmer and Teasell, 1993b).Patients in ICU with critical 
illness are prone to development of the mentioned complications of bedrest as they 
are also often treated with prolonged bedrest and immobility (due to various reasons 
related to their clinical presentation, diagnoses and injuries).  
 
The immobility of patients after admission to ICU, results in muscle weakness. 
Muscle weakness is increasingly recognized in ICU patients who have survived the 
initial acute phase of critical illness. This can partly be attributed to immobility and 
bed rest. It has been reported that muscle weakness in patients regaining their 
normal consciousness after more than seven days of being treated with MV, occurs 
in 25 to 60 percent of patients (De Jongh, et al., 2009). This muscle weakness may 
subsequently result in difficulty of weaning such patients from mechanical ventilation. 
Intensive care acquired weakness is discussed in more detail in section 2.6.2. 
 
As a result of the reduced physical activity during a period of immobilisation, patients 
may have problems with the function of the musculoskeletal and cardiovascular 
systems. This will consequently affect such a patient’s ability to achieve functional 
independence in the hospital environment and in the community after discharge from 
hospital (Topp, et al., 2002). 
 
2.6.1 Sepsis and Systemic Inflammatory Response Syndrome  
Systemic inflammatory response syndrome is described as a complex patho-
physiologic response, in the form of systemic inflammation to insults like trauma, 
burns, ketoacidosis or pancreatitis. This definition was adopted by The American 
College of Chest Physicians and the Society of Critical Care Medicine at their sepsis 
definitions consensus conference held in Chicago, Illinois, in August 1991 (Balk, 
2014).  
 
Sepsis is defined as SIRS with infection, is a common life-threatening complication of 
critical illness and may lead to the development of MOF (Baba, et al., 2012; Davies, 
et al., 2014). Patients with sepsis may present with disseminated intravascular 
coagulation which is characterised by development of intravascular microthrombi 
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leading to alterations in organ perfusion, ultimately contributing towards the 
development of multiple organ dysfunction syndrome (Davies, et al., 2014). Sepsis 
can thus lead to hypotension, MOF and death (Davies, et al., 2014).  Sepsis also 
results in damage to the microcirculation in peripheral nerves and muscles and 
contributes to the development of CIM and CIP (Apostolakis, et al., 2014). In the 
clinical setting, it is often difficult to differentiate sepsis from SIRS. This is a barrier to 
the effective treatment of these patients (Battle, et al., 2014). Sepsis develops in 
900 000 people in the United States of America annually with a 33 percent mortality 
rate (Kellum, et al., 2007). A multicentre study by Orwelius et al. (2013) conducted in 
medical and surgical ICU’s investigated the HRQOL of patients admitted with 
community-acquired sepsis, severe sepsis, and septic shock at six months after ICU 
discharge. They concluded that patients admitted to the ICU with sepsis and septic 
shock did not have significantly different levels of HRQOL as compared to ICU 
patients admitted for other diagnoses when assessed using the EQ-5D questionnaire 
at six months after discharge from ICU (Orwelius, et al., 2013).  
 
2.6.2 Post Intensive Care Unit Syndrome and Intensive Care Unit Acquired 
 Weakness 
On admission to an ICU, a critically ill patient may present with any number of 
specific medical or surgical problems, for which treatment and monitoring is needed. 
Some of these problems may result in a patient being MV for a prolonged period of 
time and subsequently having a prolonged ICU LOS (Boots, et al., 2013). 
 
Post-intensive care syndrome refers to the combination of poor physical, functional 
and cognitive outcomes in survivors of critical illness. It negatively affects the 
availability of ICU beds and length of waiting lists for surgeries and the health, 
productivity and return to occupation rates of survivors of critical illness. It also results 
in healthcare services being more expensive (Boots, et al., 2013). A major 
component of the post-intensive care syndrome is ICU-AW (Boots, et al., 2013). 
 
Intensive care unit acquired weakness is a major physical problem presenting as the 
onset and progression of severe muscle wasting and subsequent muscle weakness 
and fatigue (Rattray, 2013). The exact pathology of ICU-AW which results in the 
muscle weakness and fatigue is still unknown, however, it has been reported that it 
involves abnormalities in muscles and nerves with the entire neuromuscular junction 
implicated (Bat and Dos Santos, 2012). As patients with critical illness often 
experience dysfunction or failure of multiple organs in the body (more often the renal, 
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respiratory and cardiovascular systems) these patients are treated using MV, 
vasopressor drugs and haemodialysis, resulting in immobility and reduced PF. With 
focus being placed on the treatment of the life-threatening MOF, neuromuscular 
dysfunction may not be identified at first (Benson, et al., 2011).  Griffiths and Hall 
(2010) report that patients may lose two to four percent of their muscle mass per day 
during a period of critical illness. This was also reported by others (Fan, et al., 2009; 
Herridge, 2009; Hall, et al., 2010). This together with other factors results in the 
development of ICU-AW.  
 
Intensive care unit acquired weakness includes two distinctly different conditions 
namely CIM and CIP. It is suggested by some researchers that CIP and CIM co-exist 
(Khilnani, et al., 2014).  
 
Apostolakis et al. (2014) reported on the ICU-AW in a brief review of the diagnosis, 
risk factors, and management of patients with ICU-AW. Critical illness myopathy 
involves the atrophy, fibrosis and fatty degeneration of muscle fibers (Apostolakis, et 
al., 2014). Critical illness polyneuropathy on the other hand is characterised by the 
degeneration of sensory and motor nerve fibres, affecting mostly the nerves of the 
legs (Apostolakis, et al., 2014). Both CIM and CIP presents as diffuse skeletal 
muscle weakness (Khilnani et al., 2014). Patients suffering from ICU-AW present 
with progressive generalised muscle weakness and muscle atrophy due to functional 
and structural abnormalities in the muscles and nerves as a result of the surge in 
systemic inflammation associated with critical illness. Often the muscle weakness is 
to such an extent that it presents the same as flaccid areflexic quadriparesis 
(Khilnani, et al., 2014). The pathogenesis of ICU-AW seems to involve the entire 
neuromuscular junction as distal axonal neuropathy which affects muscles of the 
limbs and respiratory system is observed (Batt and Dos Santos, 2012). The facial 
nerves are not affected by ICU-AW (Batt and Dos Santos, 2012).  
 
Intensive care unit acquired weakness is more commonly seen in patients with a 
prolonged ICU stay, especially those who reside in ICU for longer than seven days 
(Herridge, 2007; Dryer, et al., 2009). Mechanically ventilated patients in ICU have a 
greater risk of developing ICU-AW, with patients presenting with sepsis, prolonged 
ICU stay, and advanced age also being at higher risk (Denehy, et al., 2014). 
Severely critically ill patients such as those with ARDS and those with sepsis, SIRS, 
or MOF, and longer ICU stay with more than one organ dysfunction, are more at risk 
to develop ICU-AW (Khan, et al., 2004; Hall and Schweickert, 2007; Linos, et al., 
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2007; Dryer, et al., 2009; Herridge, 2009; Truong, et al., 2009). It is reported that the 
combination of immobilisation of a patient during long periods of bed rest, critical 
illness, the body’s inflammatory response, and the circulation of toxins in the blood, 
results in ICU-AW (Fan, et al., 2009; Herridge, 2009; Hall, et al., 2010). The extent of 
disability a patient presents with as a result of ICU-AW is related to pre-morbid 
functional status, the effects of co-morbidities, and the nature and duration of critical 
illness (Batt and Dos Santos, 2012).   
 
As a result of ICU-AW, patients treated with MV may have difficulties in weaning from 
ventilation or may even fail to wean. This is due to the respiratory muscle weakness 
associated with ICU-AW, especially weakness of the diaphragm, intercostal muscles 
and the accessory muscles of respiration (Hall, et al., 2007; Khilnani, et al., 2014). 
Intensive care unit acquired weakness is often identified when weaning from sedation 
and MV is commenced (Hall, et al., 2007) and may be present in 25 to 60 percent of 
MV patients (Chambers, et al., 2009; Griffiths and Hall, 2010).  This results in a 
longer ICU and hospital stay for these critically ill patients (Dryer, et al., 2009).  
 
2.7 ASSESSMENT OF FUNCTIONAL ABILITY IN THE INTENSIVE CARE UNIT 
Assessment of the functional ability of ICU survivors, while in hospital and at 
discharge from hospital, would be important in order to observe whether 
improvement occurred. The PF status of a patient during his/her ICU stay can be 
measured using a variety of tests. Recently three tests have been developed 
specifically for use in the ICU patient population for the assessment of physical 
function. These tests are: the Functional Status Score for the ICU(Thrush, et al., 
2012)), the Chelsea Critical Care Physical Assessment Tool (Corner, et al., 2012), 
and the PFIT (Denehy, et al., 2013; Denehy, et al., 2014). All three of these outcome 
measures have been reported through pilot studies to be safe, feasible, and 
responsive measures to assess the functional abilities of a patient. Only one of these 
three tests has undergone further psychometric validation testing and scale analysis: 
the PFIT (Berney, et al., 2009: Zanni, et al., 2010; Corner, et al., 2013; Denehy, et 
al., 2013; Denehy, et al., 2014).  
 
The PFIT was developed by physiotherapy researchers in Australia to assess the PF 
of ICU survivors during their hospital stay in order to comment objectively on the 
improvements observed (Berney, et al., 2009).  In response to many patients in ICU 
not having the ability to perform the 6MWT, the development of the PFIT test was 
commenced.  As more evidence suggests the effectiveness of early mobilisation in 
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ICU’s for critically ill patients to counter ICU-AW (Bailey, et al., 2007; Morris, et al., 
2008; Schweickert, et al., 2009; Denehy, et al., 2013), an objective measure was 
needed to measure a patient’s functional status during their ICU stay. An objective 
measure is also important to assist with determining the effect on rehabilitation on 
these patients’ abilities. Many tests assessing the functional ability in ICU fail to 
measure the endurance of patients. The PFIT however assesses patient endurance 
for task performance as well as strength and function (Denehy, et al., 2014). The 
PFIT includes five components namely amount of assistance needed to stand up, 
shoulder flexion and knee extension strength, marching on the spot (MOS), and 
upper limb endurance using arm elevation above 90 degrees of shoulder flexion 
range of movement. The upper limb endurance component of the PFIT was removed 
from the scoring by Denehy et al. (2013) after they refined the testing components 
using principle component analysis, resulting in an ordinal score for PFIT scoring.  
 
The PFIT is useful to assess and subsequently prescribe an appropriate exercise 
programme for ICU patients. Safety of the test in ICU is achieved through the 
assessment of a patient’s heart rate, blood pressure, respiratory rate, and blood 
oxygen saturation during the testing procedure (Denehy, et al., 2014). The 
assessment of these vital signs during the test allows for the assessment of a 
patient’s exercise endurance in ICU and therefore an appropriate rehabilitation 
programme can be devised. This serves as an alternative to the sub maximal 
exercise tests commonly used in the acute care setting such as the 6MWT.  Another 
advantage of the PFIT is that it can be used very early on during a patient’s stay in 
ICU to identify strength and functional problems. The PFIT is also beneficial as it can 
be used again at discharge from the ICU and therefore allows for the assessment of 
change in a patient’s functional abilities during their ICU stay. Appropriate 
rehabilitation can then be prescribed at the time of discharge by using data obtained 
from the PFIT (Denehy, et al., 2014).  
 
Unfortunately, the PFIT cannot be used if a patient is unable to follow commands. 
The PFIT is the best choice of assessment for physical abilities early on during a 
critically ill patient’s ICU stay (Denehy, et al., 2014).  
 
It has been observed during a study of 116 participants that those participants with 
high PFIT scores were more likely to be discharged directly home from hospital and 
have higher scores during assessment of HRQOL at three-, six-, and 12-months after 
discharge from hospital (Denehy, et al., 2013). It was also found in the same study 
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that participants with low PFIT scores were more likely to have a longer hospital LOS 
in the acute care setting and be discharged to a rehabilitation centre rather than 
home (Denehy, et al., 2013).This nested cohort study aimed to further develop the 
PFIT to derive the interval score (PFIT-s) and also to determine the validity, 
responsiveness, and predictive utility of the PFIT-s. This study has a level of 
evidence of two. Denehy et al. (2013) suggested that the PFIT test be adopted to 
assess a patient’s PF in the ICU and those being discharged from the ICU. The PFIT 
should however be used in combination with other outcome measures (Denehy, et 
al., 2013). Skinner et al. (2009) reported that the participants in their study showed 
an increase in muscle strength with an increase in the MOS cadence component of 
the PFIT.  Denehy et al. (2014) reported on the use of the PFIT in ICU patients. They 
found that PFIT scores at ICU discharge was strongly correlated with hand grip 
strength measured with a HHD at ICU discharge (r=0.76) (Denehy, et al., 2014). The 
study by Denehy et al. (2014) constitutes level two evidence as it is a high quality 
randomized, controlled trial with narrow confidence intervals (95 percent). This study 
had a large sample size of 51 participants recruited from four different ICU’s in 
Denver. The author could not identify other studies assessing participants with the 
PFIT in the ICU.     
 
2.8 CHANGES IN MUSCLE POWER, EXERCISE ENDURANCE AND FUNCTIONAL 
 ABILITY AFTER DISCHARGE FROM ICU 
 
The presence of CIM and CIP during a period of critical illness results in negative 
effects on skeletal muscle power and may lead to reduction in muscle mass and 
functional difficulties. Intensive care unit acquired weakness places a huge burden on 
critically ill patients as they suffer from distal muscle weakness and sensory 
weakness for some time after discharge from ICU due to the axonopathy evident in 
ICU-AW. Recovery from ICU-AW is variable, with some patients experiencing 
spontaneous recovery in a few weeks (mild cases of ICU-AW) and some experience 
recovery within months (moderate to severe cases of ICU-AW) and some presenting 
with no recovery at all (Khilnani, et al., 2014). Recovery from neuromuscular 
problems like ICU-AW may still be present for up to five years after hospital 
discharge, where the possibility exists for incomplete recovery (Benson, et al., 2011).  
This consequently has a negative effect on a patient’s health status after critical 
illness. Patients with CIP have a worse prognosis than those with CIM (Khilnani, et 
al., 2014). 
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Van Aswegen et al. (2011) found in the retrospective and observational, prospective 
study with level of evidence three of survivors of penetrating trunk trauma that those 
patients who underwent prolonged MV had reduced HRQOL for up to six months 
after hospital discharge. This reduction in HRQOL was especially seen in the PF 
(Van Aswegen, et al., 2011).  Schneiderman et al. (2013) also reported a reduction in 
PF at six months after hospital discharge in survivors of trauma in Johannesburg 
when they had prolonged ICU and hospital LOS.  Van Aswegen et al. (2010) 
reported that patients with penetrating trunk trauma treated with MV for five or more 
days presented with significant limitations in muscle strength, exercise capacity, and 
the PF domain of SF-36 for up to six months after discharge from hospital. A 
significant relation was found between the length of immobility and muscle weakness 
suffered by patients at one and three months after discharge (van Aswegen, et al., 
2010).   
 
Internationally, a landmark study by McHugh et al. (1994) reported that 52 patients 
who were followed -up for one year after surviving critical illness experienced severe 
impairments in HRQOL. These subjects’ HRQOL at one year after discharge from 
hospital was persistently lower than that of healthy population norms. Similar findings 
were reported by Herridge et al. (2003) who showed that their participants reported 
problems mainly in functional abilities and HRQOL as a result of the loss of muscle 
mass, muscle fatigue and muscle weakness following recovery from ARDS. The 
patient sample for this study who presented with ARDS during a period of critical 
illness,  were healthy and young prior to critical illness (median age 45) with minimal 
co-morbidities and full employment prior to hospital admission (Herridge, et al., 
2003). Despite this, the patients still presented with poor outcomes following 
discharge from hospital.        
 
After discharge from hospital, exercise capacity and peripheral muscle strength can 
be assessed by utilising the 6MWT as described by the American Thoracic Society 
(ATS) (2002)(Holland, et al., 2014; Singh, et al., 2014) and HHD respectively (Van 
Aswegen, et al., 2010). The 6MWT is an appropriate test to use for patients after 
discharge from ICU. If a patient recovers to such an extent that they are able to 
perform the 6MWT, it is a good measure to use in an outpatient setting (Denehy, et 
al., 2014). Herridge et al. (2011) reported lower 6MWT distances achieved by 64 
ARDS survivors at one year after onset of ARDS compared to predicted distances for 
6MWT. Eighty percent of predicted 6MWT distance was achieved by only 39 percent 
of patients in their study (Herridge, et al., 2011). Very limited literature is available on 
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the use of the 6MWT in survivors of critical illness (Aitken, et al., 2012). Aitken et al. 
(2012) reported increases in mean 6MWT distances in survivors of critical illness at 
one week (15 metres), eight weeks (13 metres), and at 26 weeks (9 metres) hospital 
discharge. They also reported a relationship between 6MWT distance and SF-36 PF 
score at one (r=0.62), eight (r=0.55) and 26 (r=0.47) weeks after hospital discharge 
(Aitken, et al., 2012). This study by Aitken et al. (2012) was performed as a 
secondary analysis on data of a previous randomized, controlled trial that included 
173 participants. This constitutes level two evidence as the original study was a 
randomized, controlled trial.  
 
Herridge et al. (2003) reported an increase of median 6MWT distance from 281 
metres at three months after ARDS to 396 metres at six months. Van Aswegen et al. 
(2010) showed better results in their short-term MV group that had an improved 
median 6MWT distance from 633 metres at three months after discharge to 680 
metres at six months, and their long-term MV group had an improved median 6MWT 
distance of 586.5 metres at three months to 626 metres at six months. Secombe et 
al. (2013) however reported no significant increase in 6MWT distance from their 
investigation of survivors of critical illness at high risk of future morbidity between ICU 
discharge and six months follow-up.   
 
An essential part of a patient’s physical assessment is that of mobility assessment. 
Muscle strength and joint range of movement form part of a patient’s mobility 
(Jannsen and Le-Ngoc, 2012). An outcome measure to assess a patient’s PF is 
muscle strength assessment. It is important to obtain objective and discrete 
measurements of muscle strength during assessment. This may be obtained using a 
HHD.   
 
Some studies have reported on the use of HHD in survivors of critical illness at ICU 
discharge. Burtin et al. (2009) reported a significant correlation between changes in 
lower limb muscle strength and ambulatory ability in the ICU. Ali et al. (2008) 
examined handgrip strength in critically ill patients using a HHD to diagnose muscle 
weakness in the ICU. Schweickert et al. (2009) and Chiang et al. (2006) reported 
from their randomised controlled trials that there was no significant change in 
handgrip strength in response to physical therapy interventions in ICU when 
measured using a HHD. Other studies have also reported using the HHD in the ICU 
(Hough, et al., 2011: Hermans, et al., 2012; Baldwin, et al., 2013). Baldwin et al. 
(2013) reported from their investigation of HHD the minimally detectable differences 
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in measurements. These were 71 Newton on the left side of the body and 57 Newton 
on the right.  
 
Van Aswegen et al. (2010) used HHD to measure the peripheral muscle strength of 
survivors of critical illness due to penetrating trunk trauma in Johannesburg. They 
found that patients who were MV for short periods of time had significantly greater 
muscle strength in most peripheral muscle groups at one month follow-up after 
discharge when compared to participants who had been MV for longer periods of 
time. They found that the weaknesses recorded between the groups were specific to 
the biceps, triceps, quadriceps and hamstrings muscles, and were persistent at six 
months after discharge. The short term ventilation group had significant weakness of 
the right deltoid and triceps muscles at one month after discharge which resolved at 
three months after discharge. The group who received MV for longer periods of time, 
however, had muscle weakness in all upper limb muscle groups from one to six 
months after discharge (Van Aswegen, et al., 2010). Significant relationships were 
reported by Van Aswegen et al. (2010) between ICU LOS of participants MV for 
longer periods of time and right deltoid, right triceps, and right hamstrings muscle 
strength at one month after discharge and left triceps muscle strength at six months. 
In the same study, hospital LOS of participants mechanically ventilated for longer 
periods of time was significantly correlated with left deltoid, right triceps, left 
hamstrings, and right hamstrings muscle strength at one month follow-up and left 
deltoid, left triceps, right triceps and right hamstrings muscle strength at three months 
after discharge (Van Aswegen, et al., 2010). On the contrary, in their participant 
group receiving short-term MV, no statistically significant relationship wad found 
between peripheral muscle strength and ICU LOS (Van Aswegen, et al., 2010). Van 
Aswegen et al. (2010) also reported no statistically significant relationships between 
peripheral muscle strength and APACHE II scores.        
Baldwin and Bersten (2014) reported that septic patients with critical illness who were 
MV showed reduced muscle strength (measured during their ICU stay) in all 
peripheral muscle groups as measured using a HHD.    
 
This reduction in functional abilities together with certain psychological problems may 
consequently affect a patient’s HRQOL negatively after discharge from hospital.    
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2.9 EFFECTS OF CRITICAL ILLNESS ON MENTAL HEALTH 
2.9.1 Anxiety and Depression 
Psychological problems such as anxiety and depression are experienced by 
survivors of critical illness after discharge from hospital (Rattray, 2013). As is the 
case with physical problems such as ICU-AW, these psychological problems may 
negatively influence a patient’s HRQOL. The gold standard to diagnose 
psychological problems is with a clinically structured diagnostic interview. However, 
self-report measures such as the PHQ-9 which has been standardised with 
established validity and reliability may be helpful in identifying specific symptoms of 
these conditions. It may therefore serve as a screening tool for psychological 
problems (Rattray, 2013).  
 
The PHQ-9 is an example of a standardised screening tool for depression. A 
reduction in HRQOL after critical illness may be the result of patient depression. 
Depression is the third leading cause of disease burden in the world (WHO, 2008). 
Depression is a mental illness and requires identification and appropriate treatment 
as it greatly impacts on a person’s HRQOL. Depression is a common illness and may 
lead to suicide (Chan, et al., 2013). The detection of major depressive disorders may 
lead to early treatment and thus better outcomes, such as HRQOL. By this, the risk 
of a patient committing suicide may be reduced and the patient may function better at 
work and in society in general. 
 
Davydow et al. (2009) reported from their systematic review of depression of ICU 
survivors, a 28 percent point prevalence of depression symptoms in these patients in 
the first year after discharge from hospital. As rehabilitation takes place, patients may 
realize that they may not achieve the same level of function as they had before ICU 
admission. This together with a prolonged recovery period from critical illness may 
make these patients more prone to developing symptoms of depression (Rattray, 
2013). The HRQOL of patients with coronary artery disease and heart failure has 
been correlated with the severity of disease in these patients, the social support 
available to the patient, and patient psychological factors (Brozaitiene, et al., 2015).  
Patients with a longer ICU and hospital LOS and those with a higher severity of 
disease on admission may also be more prone to developing symptoms of 
depression (Rattray, 2013). It is suggested in the literature that psychological 
problems may have a greater impact on HRQOL compared to somatic dysfunction or 
disability (De Jongh, et al., 2014). 
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Severely injured patients also experience reduced HRQOL after such a traumatic 
event. A cross-sectional study conducted by De Jongh et al. (2014) investigating 
psychological complaints and HRQOL in severely injured trauma patients concluded 
that psychological problems are underestimated and play a major role in the reduced 
HRQOL experienced by these trauma survivors (De Jongh, et al., 2014). The author 
could not identify other studies using the PHQ-9 in the ICU patient population.  
 
2.10 THE EFFECT OF CRITICAL ILLNESS ON QUALITY OF LIFE 
Different aspects of HRQOL namely the physical and mental components need 
consideration when investigating HRQOL after critical illness. Various measures of 
HRQOL of survivors of critical illness have been described, but the SF-36 and EQ-5D 
questionnaires have been used and reported on by most researchers (Dowdy, et al., 
2005; Oeyen, et al., 2012; Goixart, et al., 2013; Nesseler, et al., 2013).  
 
The PCS of the SF-36 questionnaire was found to be consistently impaired in 
survivors of ARDS at five years after admission to hospital (Herridge, et al., 2011). 
Herridge et al. (2011) also found that the PF score of the SF-36 was strongly 
correlated with 6MWT distance achieved by their participants. These results were 
reproduced by Aitken et al. (2012). They reported the PF score of the SF-36 
questionnaire to be a strong indicator of 6MWT distance achieved during the early 
recovery stage from critical illness (Aitken, et al., 2012). They reported a relationship 
between PF scores and 6MWT distance at one, eight, and 26 weeks after discharge 
from hospital (Aitken, et al., 2012). Ivaskevivius et al. (2011) found a reduction in PF 
and RP domain scores of the SF-36 in survivors of critical illness (as a result of 
medical conditions) at six months after discharge. 
 
In their investigation of the HRQOL of survivors of trauma, Schneiderman et al. 
(2013) reported that participants scored the lowest scores in the role physical (RP) 
and RE scores of the SF-36 at six months after discharge from hospital. They 
reported that mean PCS scores were higher than mean mental component score 
(MCS) scores at six months after discharge from hospital (Scheniederman, et al., 
2013). An inverse relationship was also found between SF-36 PF scores and ICU 
and hospital LOS at six months after hospital discharge (Schneiderman, et al., 2013). 
They concluded that survivors of trauma in Johannesburg experienced limitations in 
the emotional and physical domains of HRQOL at six months after discharge from 
hospital (Schneiderman, et al., 2013). At six months after penetrating trunk trauma, 
Van Aswegen et al. (2010) found a statistically significant difference between short-
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term MV and long-term MV groups in SF-36 PF, bodily pain (BP), general health 
(GH), and PCS scores, but not in MCS scores.  
 
Van Aswegen et al. (2011) investigated the HRQOL of survivors of penetrating trunk 
trauma in Johannesburg. They found the PCS scores of the SF-36 to be significantly 
reduced at one and three months in the group of participants who were MV for a 
short period of time. The MCS scores of the SF-36 for the same group were also 
significantly reduced at one, three and six months after discharge from hospital. For 
the group of participants receiving long-term MV, the SF-36 PCS and MCS scores 
were also significantly reduced at one, three and six months after discharge from 
hospital (Van Aswegen, et al., 2011). The same study reported that at one month 
after discharge from hospital, the short-term MV group showed significant differences 
compared to healthy controls in the PF, RP, BP, social functional (SF) and vitality 
(VT) domains and PCS scores of the SF-36. This however changed to no statistically 
significant differences in these domains or summary scores between the short-term 
MV group and healthy controls at six months after discharge (Van Aswegen, et al., 
2011). At one month after discharge from hospital, the long-term MV group showed 
significant differences compared to healthy controls in the PF, RP, BP, GH, SF, RE 
and MH domains and PCS scores of the SF-36 (Van Aswegen, et al., 2011). At six 
months the long-term MV group still scored significantly lower in the PF, RP, BP, GH, 
SF domains and PCS scores of the SF-36 compared to the healthy group (Van 
Aswegen, et al., 2011).Granja et al. (2004) and Herridge et al. (2003) reported 
reduced HRQOL in survivors of sepsis at six months after discharge from hospital.   
 
A systematic review of the HRQOL of adult survivors of critical illness by Dowdy et al. 
(2005) reported that survivors of critical illness have lower HRQOL in all domains of 
the SF-36 questionnaire, except for BP, from six months to 14 years after discharge 
from hospital. They  reported that an increase in severity of illness may be associated 
with poorer PF and GH perceptions and that the survivors of critical illness in their 
review did not experience significant improvements in HRQOL at six months after 
discharge. They also added that small improvements in HRQOL are seen up to 36 
months after discharge (Dowdy, et al., 2005).These findings by Dowdy et al. (2005) 
are very valuable as the study involved level one evidence. Niskanen, et al., (1999) 
reported from their cohort study with level of evidence two b that QOL at six months 
after prolonged ICU LOS was found to be the highest for cardiac surgery patients 
and lowest for patients admitted to ICU for trauma and respiratory conditions. The 
results of the study by Niskanen et al. (1999) was obtained from a large sample of 
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ICU patients (n=718), allowing for easier generalization of the results to a general 
ICU population.  
 
Other studies have reported reductions in HRQOL after critical illness as compared 
to pre-admission HRQOL when measured using the SF-36 questionnaire. Pettila et 
al. (2000), Vedio et al. (2000), Flaatten and Kvali (2001), Kaarlola et al. (2003), Graf 
et al. (2003), and Wehler et al. (2003) reported statistically significant reductions in 
HRQOL which were clinically significant (more than five points reduction on the SF-
36).   
 
The EQ-5D is used widely in clinical studies. It is the most used preference-based 
outcome measure, being used in half of studies published (Chen, et al., 2014b). 
Schneiderman et al. (2013) reported from their retrospective cross-sectional study of 
an adult cohort  (level three evidence)that the majority of participants in their study 
reported some problems with their usual activities and with pain or discomfort at six 
months after hospital discharge as measured using the EQ-5D questionnaire. They 
reported a relationship between EQ-5D VAS scores and age at six months after 
discharge from hospital (Schneiderman, et al., 2013).The relatively small sample size 
of the study limits the degree to which the results can be generalized to the ICU 
population. Badia et al. (2001),from their prospective cohort study (level three 
evidence), reported a significant increase in mobility and significant decreases in self-
care and usual activities from baseline to 12 months after ICU discharge in survivors 
of critical illness as measured by the EQ-5D questionnaire. They also reported no 
statistically significant changes in pain or discomfort, anxiety or depression or in the 
EQ-5D VAS over the first 12 months after discharge from ICU (Badia, et al., 2001). 
This study involved 334 ICU patients and assessed the HRQOL of ICU patients 
before and after admission to ICU. The study was published in 2001, however the 
data is slightly outdated as it was collected from1994 to1995 (Badia, et al., 2001). 
This may limit the ability to generalize the results to today’s ICU patient populations. 
Significant relationships have been reported by Granja et al. (2002) and Garcia et al. 
(2003) between APACHE II scores and EQ-5D VAS and EQ-5D usual activities at six 
and 18 months after discharge from hospital respectively. Orwelius et al. (2010) 
reported no increase in EQ-5D scores in survivors of critical illness up to 36 months 
after discharge.  
 
As discussed, certain physical and psychological problems, may affect a patient’s 
HRQOL negatively. Patients admitted to ICU due to critical illness may face reduced 
39 
 
HRQOL after discharge from hospital (Ivaskevicius, et al., 2011; Fan, et al., 2012). It 
was reported by Oeyen et al. (2012) that the PF domain of HRQOL is worst in the 
first three months after discharge from hospital and that it will slowly improve 
thereafter. On the contrary, mental function may not improve and patients may 
struggle with these problems for a prolonged period of time (Oeyen, et al., 2012). It is 
thus important to assess and measure the health perception of patients after critical 
illness. Reduction in HRQOL can be considered a consequence of ICU admission 
and thus these patients can’t be seen as fully recovered from their illness while their 
HRQOL is still reduced. Backman et al. (2010) reported that few studies on HRQOL 
in ICU survivors accounted for and adjusted results for the existence of pre-morbid 
conditions. They found that the major factor contributing to the reduced HRQOL 
found at 36 months after critical illness was the existence of pre-morbid conditions 
and diseases. Their study hada large sample size of 262 ICU participants, but the 
design of their prospective trial did not include randomization (Backman, et al., 2010). 
The study reported improved HRQOL during the three year follow-up period in those 
participants who received their study intervention (ICU-diary), however, the effect of 
their intervention needs to be duplicated in a randomized study as the level of 
evidence for their study is a level three (Backman, et al., 2010).    
 
Certain factors relating to the ICU stay of a critically ill patient may affect his or her 
HRQOL after discharge from hospital (Elliot and Rattray, 2012). Such factors include 
the effects of the disease or illness on admission, organ dysfunction prior to 
admission, pre-morbidities, complications that develop during ICU stay and 
prolonged length of ICU stay (Ivaskevicius, et al., 2011).  Patients who suffered from 
ARDS, severe sepsis, severe trauma or prolonged length of MV show more 
reductions in HRQOL after discharge from hospital (Kapfhammer, et al., 2004; 
Hopkins, et al., 2005; Oeyen, et al., 2012).   
 
2.11  RETURN TO WORK FOLLOWING CRITICAL ILLNESS 
Van Aswegen et al. (2010) reported from their prospective, observational study (level 
three evidence) that there was no difference between their short-term MV and long-
term MV groups in the rate of return to work over the first six months after hospital 
discharge.This study had a good sample size of 42 participants, allowing for easier 
generalizability of the results to other patients suffering from penetrating trunk trauma 
being treated with MV.A multicenter questionnaire-based study conducted by Griffiths 
et al. (2013) showed that patients in the United Kingdom have difficulties with 
employment following a period of critical illness in a general ICU. The main reported 
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reason for the difficulties is the physical disabilities experienced by these patients. 
Many of their participants required additional care after discharge from hospital and 
this care was mostly provided by family members of the patient. This negative impact 
of critical illness on return to employment was seen at six months after discharge 
from hospital (33 percent of participants) and did not show significant improvement at 
12 months post discharge (28 percent of participants) (Griffiths, et al., 2013). Similar 
results were reported by Myhren et al. (2010) in a 12 months follow-up study of 
general ICU patients. Only 50 percent of their study participants had returned to work 
or school at 12 months after discharge from hospital (Myhren, et al., 2010).  
 
2.12 RECOVERY FROM CRITICAL ILLNESS IN THE SOUTH AFRICAN CONTEXT 
In contrast to the wealth of available international literature on recovery of survivors 
of critical illness, limited information is available regarding recovery of survivors of 
critical illness in the South African context. The purpose of this section is to 
specifically highlight the findings of South African studies; however, the international 
literature (as reviewed throughout the other sections of this literature review) may 
also be applicable to the South African context.  
 
As mentioned previously, Karachi et al. (2011) investigated the survival and HRQOL 
of patients at 12 months following discharge from an adult surgical ICU in the 
Western Cape Province. They concluded that the HRQOL scores of their study 
population were lower than that reported for ICU populations internationally. 
Participants presented with limitations in HRQOL mainly in the domains of PF, RP 
and RE domains of the SF-36 questionnaire.  
 
Results from other South African studies namely Schneiderman et al. (2013), Van 
Aswegen et al. (2010) and Van Aswegen et al. (2011) have already been discussed 
above. The current study was conducted in order to add information to the existing 
limited body of evidence on recovery of South African survivors of critical illness but it 
also describes outcomes related to patients’ PF in ICU and their level of depression 
as this has not previously been described in the South African context. 
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2.13 CONCLUSION 
 
From the literature presented in this reading it is evident that there are many 
challenges facing critically ill patients admitted to the ICU, both during their ICU stay 
and during recovery from critical illness. Furthermore, limited literature is available to 
support rehabilitation services after hospital discharge (O’Neill, et al., 2014). More 
research and subsequent evidence is needed to identify those factors in the South 
African patient population that affect patients’ functional abilities and QOL after a 
period of critical illness and to identify relationships between these factors to motivate 
for the establishment of structured rehabilitation services for this patient population. 
 
Chapter three describes the methods used to answer the research questions posed 
in chapter one. 
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CHAPTER 3  
 
3. METHODS 
The methodology discussed in this chapter is based on the findings of the literature 
review discussed in chapter two. The ethical considerations that were taken into 
account during the study are given. The study design, sample population, inclusion 
and exclusion criteria as well as instrumentation and data collection procedure used 
during the study are discussed in detail. An explanation of the pilot study, its aims, 
methodology and its implications on the main study procedure is given. The methods 
for data analysis are also discussed. 
 
3.1 ETHICAL CONSIDERATIONS 
Ethical clearance to perform this study was obtained from the University of the 
Witwatersrand Human Research Ethics (Medical) Committee (Certificate number: 
M130404) (appendix A). Permission to perform the study in hospitals belonging to 
the Netcare group was obtained from the Netcare Research Ethics Committee 
(Certificate number: UNIV-2014-005) (appendix B).  Permission was also obtained 
from the hospital management of Netcare Union (appendix C) and Netcare Mulbarton 
(appendix D) hospitals to access patient’s ICU charts and files and to recruit patients 
for this study. For the purpose of patient follow up after discharge from the acute care 
setting, permission was obtained from the hospital management of the following 
rehabilitation facilities: Netcare Rosebank Rehabilitation centre (appendix E), Life 
Kensington clinic (appendices F and G), Netcare Rehabilitation hospital (appendix H) 
and Life Riverfield lodge (appendices F and G). This study was registered on the 
South African National Clinical Trials Registry and received trial number DOH-27-
0614-4751. 
 
3.1.1 Anonymity of Data 
Each participant was assigned a participant code at the time of recruitment to ensure 
anonymity of data. On all data sheets and appointment cards, only the participant 
code appeared. Each participant’s code could be corresponded to his or her name on 
the list of participant’s only. The participants’ list was kept in a safe location (hard 
copy) by the researcher for the duration of the study. By doing this, confidentiality 
and safe-keeping of participant details were ensured. The participants’ list was 
destroyed by the researcher at the end of the study. 
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3.1.2 Informed Consent 
All participants were provided with an information document about the study and 
questions they had about the study were answered by the researcher in the presence 
of a healthcare practitioner known to the participant prior to requesting written 
informed consent from them for participation. All participants had the right to 
withdraw from the study at any given time without prejudice or any penalty. Such 
participants did not have to provide any reasons for withdrawal from the study. All 
participants had the right to access their own study results if they wished to see it. 
The results of this study will be made publicly available and the researcher will 
attempt to publish the results in peer-reviewed journals. 
 
3.1.3 Participant Referral to Specialised Services 
If it was found that any given participant was suffering from depression after 
completion of the PHQ-9 questionnaire, the participant was referred to a psychiatrist 
for appropriate treatment at the end of the six months follow-up period for this study. 
The need for assessment by a psychiatrist was discussed with the participant prior to 
referral and the participant could choose to either attend the assessment or to refuse 
it.  
 
3.2 STUDY DESIGN 
A prospective, observational and longitudinal study was conducted. 
 
3.3  STUDY SETTING 
3.3.1 Study Locations 
The study sites included the Netcare Union hospital in Alberton and Netcare 
Mulbarton hospital in Mulbarton. Both of these hospitals are in the South Gauteng 
province of South Africa. 
 
Alberton is a town situated in the Ekurhuleni Metropolitan Municipality in Gauteng, 
South Africa. This municipality covers an area of 1975 kilometres squared. This is 
mainly an urbanised municipality, with 99.4 percent of the population living in urban 
settlements (Statistics South Africa, 2011). These settlements range from informal to 
residential suburbs. Ekurhuleni has a population size of 3 178 470. The general 
population of Ekurhuleni consists of 24.3 percent young people (aged zero to 14) and 
71.7 percent working age individuals (age 15 to 64). At the time of the survey, the 
elderly population represented four percent of the total population of Ekurhuleni. The 
unemployment rate was 28.8 percent. Three point six percent of persons aged 20 
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and above had no schooling, 14.6 percent received higher education, and 35.4 
percent completed grade 12. The municipality contained 1 015 465 households of 
which 85 percent had flush toilets with a sewage connection, 57.3 percent had piped 
water inside the dwelling, and 82.2 percent had electricity for lighting (Statistics South 
Africa, 2011).  
 
Mulbarton is a town situated in the City of Johannesburg Local Municipality in 
Gauteng, South Africa. This municipality covers an area of 1645 kilometres squared. 
This is mainly an urbanised municipality. Johannesburg is the largest city in Africa. It 
is also the provincial capital of Gauteng. Gauteng is known to be the wealthiest 
province in South Africa. At the time of the survey, the City of Johannesburg had a 
population size of 4 434 827 (Statistics South Africa, 2011). The general population 
of the City of Johannesburg consisted of 23.2 percent young people (aged zero to14) 
and 72.7 percent working age individuals (age 15 to 64). The elderly population 
represented 4.1 percent of the total population. The unemployment rate was at 25 
percent. Two point nine percent of persons aged 20 and above had no schooling, 
19.2 percent received higher education, and 34.7 percent completed grade 12. The 
municipality contained 1 434 856 households of which 87.1 percent had flush toilets 
with a sewage connection, 64.7 percent had piped water inside the dwelling, and 
90.8 percent had electricity for lighting (Statistics South Africa, 2011).  
 
3.3.2 Duration of Study 
Participant recruitment took place from 1 March 2014 to 31 March 2015 (13 month 
period). All final follow-up assessments were completed by August 2015. 
 
3.4 PARTICIPANTS 
3.4.1 Eligibility Criteria 
3.4.1.1 Inclusion criteria 
Patients 18 years or older of both genders who were admitted to the ICU due to 
respiratory failure (pneumonia, exacerbation of COPD or penetrating or blunt trauma 
to the chest wall), organ dysfunction or postoperatively (exploratory surgery following 
trunk trauma; elective cardiac surgery e.g. CABG surgery or valve replacement) and 
were MV for more than 24 hours were eligible for recruitment.  
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3.4.1.2 Exclusion criteria 
Patients with the following conditions were not considered for participation in this 
study. Those with: 
 Terminal illness  
 Cognitive impairments or history of mental disorders  
 Multiple orthopaedic injuries  
 Unstable cardiac conditions e.g. myocardial infarction if they did not undergo 
CABG surgery, uncontrolled cardiac arrhythmias, aortic stenosis, pulmonary 
infarction, myocarditis, pericarditis, and dissecting aneurysm. 
 
3.4.2 Sample Size Estimation 
 
For this study, the power calculations normally used by statisticians to calculate the 
 estimated sample size for randomized, controlled trials, was not applicable as this 
 was a  longitudinal study without randomization and without specific study groups.    
 
Proposed sample size for this study was therefore calculated as follows: 
 
The number of patients admitted to the Union hospital general ICU and cardiac ICU 
per month was on average 163 patients (estimated from data available over a four 
month period). Of these patients, on average, 13 fitted the inclusion criteria for the 
study per month. Approximately 156 patients were therefore potentially available for 
inclusion in the study over a 12 month recruitment period, depending on their rate of 
survival as a result of critical illness and their willingness to participate in the study. 
Each participant that gave consent for inclusion in the study was followed up for six 
months after discharge. By convention, it was decided to include ten participants for 
each of the three main outcome measures for this study namely PFIT score, 6MWT 
distance, and HRQOL (PCS and MCS of SF-36 and EQ-VAS) (Nunally, et al., 
1978).To allow for withdrawals and participants being lost to follow-up, ten 
participants were added to the estimated sample size, thus making allowance for 
withdrawals or loss to follow of up of 20 percent of the estimated sample size. 
Therefore the estimated sample size was 50 participants. 
 
3.4.3 Sample Selection 
Consecutive patient sampling was done from all patients admitted to the ICU 
(Mulbarton and Union Hospitals) and cardiac ICU (Union Hospital) at the two study 
sites from 1 March 2014 to 31 March 2015 (13 months period). The initial participant 
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recruitment period was 12 months, but was prolonged to 13 months due to low 
recruitment numbers at 12 months. Each patient admitted to the ICU and CICU 
(Union Hospital) during this period was screened to determine whether they met the 
eligibility criteria for this study. Those who met the criteria were available for potential 
recruitment in the study. Recruitment in the study depended on the rate of survival of 
potential participants as a result of critical illness and their willingness to participate in 
the study. 
 
3.5 DATA COLLECTION PROCEDURE 
3.5.1 Pilot Studies (Inter- and Intra-Rater Reliability Studies) 
3.5.1.1 Pilot study one 
3.5.1.1.1 Objectives 
To familiarise the researcher and research assistant with the PFIT; to 
establish the inter-rater reliability of the PFIT, used at ICU discharge and 
hospital discharge to assess participants’ functional ability, between the 
researcher and the research assistant.    
3.5.1.1.2 Procedure 
The researcher and one research assistant (senior physiotherapist) across 
the two study sites were involved in PFIT-s assessment of study participants.  
The number of participants recruited for this pilot study was eight, 
representing 20 percent of the .estimated sample size of 40 participants.  The 
study site was the Netcare Mulbarton hospital. The participants were patients 
discharged from the ICU. The researcher and the research assistant each 
performed the PFIT-s once on the eight participants on separate occasions in 
the hospital ward by the participant’s bedside. The PFIT-s procedure was 
explained to each participant prior to assessment and consent was obtained 
from each participant. Each participant was given a rest period of 30 minutes 
between testing sessions. To calculate the inter-rater reliability, the Pearson 
correlation was determined between the data sets or scores (from each 
assessor) collected for each participant using Microsoft Excel 2010.  
 
The Pearson correlation was calculated as r=1 (p=00) for this pilot study.  
Inter-rater reliability is accepted as sufficient if the Pearson correlations are > 
0.80 (indicating an excellent correlation). The inter-rater reliability was 
therefore excellent for the PFIT-s. These eight participants were not enrolled 
in the main study. Appendix I shows the PFIT-s pilot study results and 
47 
 
Pearson correlation data. No changes regarding PFIT-s assessment needed 
to be made for the main study. 
 
3.5.1.2 Pilot study two 
3.5.1.2.1 Objectives 
To familiarise the researcher with study outcome measures and to establish 
the intra-rater reliability for the 6MWT and HHD measurements that would be 
performed by the researcher on ICU survivors at one and six months after 
hospital discharge. 
3.5.1.2.2 Procedure 
Five participants (healthy volunteers at Union hospital) were involved in pilot 
study two. The researcher performed the 6MWT and HHD measurements 
three times on each participant allowing a 30 minutes rest period between 
test sessions. The 6MWT was administered as per guidelines published by 
the ATS (ATS, 2002). Three measurements were taken to determine the 
correlation between three data sets. Handheld dynamometry was applied 
using the MicroFet2® HHD to measure the strength of the following peripheral 
muscle groups: Triceps Brachii (elbow extension) and Hamstrings (knee 
flexion). The procedure for the measurement of peripheral muscle strength 
using a HHD was adhered to as discussed under ‘main study procedure’ in 
section 3.5.2 below.  
 
Measurements were taken three times on the left and right side of each 
participant. The average muscle strength from the three measurements was 
then calculated for each muscle tested. This process was repeated 30 
minutes later.  
 
To determine the intra-rater reliability, the Pearson correlation was calculated 
between the data sets or scores collected of the five participants using 
Microsoft Excel 2010.  
 
The Pearson correlation for right-sided knee flexion HHD was calculated as 
r=0.88 (p=0.02). The Pearson correlation for right-sided elbow extension HHD 
and the distance covered during the 6MWT assessment was r=0.99 (p=0.00) 
for all other data sets.  Intra-rater reliability is accepted as sufficient if the 
Pearson correlations are > 0.80 (indicating an excellent correlation). The 
intra-rater reliability for right-sided knee flexion and elbow extension HHD and 
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the 6MWT distance was therefore excellent. Appendices J to L summarises 
the 6MWT and HHD pilot studies results and Pearson correlations.  
 
From the results of this pilot study, it was concluded that the intra-rater 
reliability was excellent for the HHD and 6MWT measurements. No changes 
were made to the testing procedure laid out for the main study. 
 
Each participant was also asked to complete the SF-36, EQ-5D, PHQ-9 and 
RPAQ questionnaires in order to establish the amount of time that would be 
needed for the administration of the questionnaires during the main study. It 
took approximately 20 minutes in total for participants to complete the four 
questionnaires. 
 
3.5.2 Main Study 
3.5.2.1 Initial contact 
Patients admitted to the ICU’s of the two mentioned research sites were screened 
daily by the researcher (Union hospital) or research assistant (Mulbarton hospital) for 
eligibility for the study. The researcher or assistant approached patients who fit the 
inclusion criteria and explained the nature of the study on the day prior to discharge 
from the ICU to the ward. Only patients with a Glasgow Coma Scale score of 15 with 
the ability to understand and respond appropriately to simple questions were 
approached. If a patient was unable to do this or had a GCS score of fewer than 15, 
the researcher or research assistant would approach the patient again on the 
following day to see if the status of the patient had changed. If a patient’s level of 
awareness was not sufficient to be able to provide signed, informed consent for the 
study, such a patient was excluded from the study.  
 
 A participant information sheet (see appendix M) was given to the participant fitting 
the eligibility criteria. The contact details (telephone number, mobile number, e-mail 
address) of the researcher, research supervisor, and ethics committee were also 
provided. The researcher or assistant approached the participant the following day to 
answer any questions that the person might have and to obtain  written, informed 
consent (see appendix N) for inclusion in the study. On receipt of written consent the 
researcher or assistant captured information required for the demographic 
questionnaire (see appendix O) during a short interview. The ICU charts of each 
participant were reviewed and the necessary data needed to calculate APACHE II 
and SAPS II scores were collected from the charts. The length of MV and ICU LOS 
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were also recorded. Thereafter, the PFIT-s was performed in the hospital ward by the 
patient’s bedside. The PFIT-s was performed in accordance with the prescribed 
guidelines.  
 
Prior to discharge from the hospital, the researcher or assistant performed the 
second PFIT-s on each participant. The length of hospital stay was also recorded at 
this point. The researcher provided each participant with an appointment date for the 
one month post discharge assessment specifying the date, time, and venue as well 
as the contact details of the researcher. The participants were informed that they 
would be reimbursed for their travel costs at a fixed rate, if requested, and that they 
had to wear comfortable clothing and shoes (due to the nature of the outcome 
measures assessed) when they arrived for the follow-up assessment.  
 
Each participant was sent a mobile text message (one week before the appointment) 
and was phoned (two days before appointment) as a reminder and confirmation of 
their attendance at the follow-up appointment.      
 
3.5.2.2 One month follow-up assessment 
The researcher assessed one participant at the Netcare Rehabilitation hospital in the 
physiotherapy department. The researcher met with all the remaining participants at 
the treatment rooms of Sklaar, Laidler and Associates Physiotherapists in Alberton 
where the researcher is employed. 
 
On arrival, each participant was asked to sit and relax in a chair for 10 minutes prior 
to testing. During this time demographic information were verified with the participant 
(including details on returning to employment). After the 10 minutes rest period, the 
researcher explained the 6MWT to the subject. The subject then performed the 
6MWT according to the ATS procedure and all measurements (blood pressure, heart 
rate, and oxygen saturation) were recorded. The 6MWT was performed a second 
time after a 30 minute rest period with all measurements recorded to account for a 
‘learning effect’ and the best of the two tests was captured for data analysis.  
 
After the 6MWT the participant was asked to complete the SF-36, EQ-5D, PHQ-9 
and RPAQ questionnaires in a self-administered fashion. The researcher inquired 
about the participant’s preferred language for completing the SF-36, EQ-5D, and 
PHQ-9 questionnaires, and provided the questionnaire in that language. The 
researcher seated the patient on a comfortable chair at a desk in an office with 
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sufficient ventilation and lighting. The researcher explained the purpose of each 
questionnaire to the participant and provided instructions on how to complete it 
according to the prescribed guidelines. No attempts were made by the researcher to 
influence the responses of the participant to any of the questions in the 
questionnaires.  
 
After completion of the questionnaires, peripheral muscle strength testing was 
performed by the researcher. The specific muscle groups tested, starting positions 
and dynamometer placements are summarised in appendix P.  All muscle testing 
was performed on both sides of the body and muscle strength values were recorded 
in Newton using the HHD. A practice trial was performed with each participant prior 
to measurements being recorded to ensure they understood the testing procedure 
and experienced the feel of pushing against the dynamometer. The researcher 
explained each movement/muscle group tested to the participant prior to testing. 
During the tests, isometric force was measured using “make” tests. The participant 
was asked to build his/her force gradually over two seconds and then maintain a 
maximal contraction for five seconds. During this seven second procedure, the 
researcher held the dynamometer stationary against the limb segment involved 
(Andrews, et al., 1996).Each muscle was tested three times and the measurements 
recorded. The mean of the three values for each muscle was used for data capturing. 
No rest periods were given between measurements of different joint or limb 
movements (Andrews, et al., 1996). 
 
At the end of the appointment, refreshments were provided to the participant in the 
form of bottled water and a small maize snack. The participants were provided with 
an appointment card for the six months follow-up assessment.  Data was transferred 
from the data collection sheets and questionnaires onto Microsoft Excel 
spreadsheets in preparation for data analysis.   
 
Each participant was sent a mobile text message (one week before the appointment) 
and was phoned (two days before appointment) as a reminder and confirmation of 
their attendance at the six months follow-up appointment.      
 
3.5.2.3 Six months follow-up assessment  
The procedures followed during this  assessment session were exactly the same as 
discussed for one month follow up above. The researcher met with all the remaining 
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participants at the treatment rooms of Sklaar, Laidler and Associates 
Physiotherapists in Alberton. 
 
Throughout all assessment sessions, emergency medical equipment was available 
for use. The researcher and assistant were trained in basic life support and in the use 
of an automated external defibrillator. Sklaar, Laidler and Associates 
Physiotherapists had an agreement with the casualty department of the Netcare 
Union hospital to contact them if an emergency arose. This agreement also applied 
to the study assessments. No emergency situations related to the study participants 
arose during the data collection period.  
At the end of the six month assessment each participant was thanked for his/her 
participation in the study. The participant was given informal feedback as to observed 
changes in their condition  and ensured that the final results of the study would be 
made available to them at the end of the data analysis and interpretation phase of 
the study if they requested this. Those participants who showed the possibility of 
having depression, after screening using the PHQ-9 questionnaire, were given the 
name and contact details of a psychiatrist in Alberton, which they could consult if they 
wished to do so. 
 
For this observational, longitudinal study, all participants were followed-up at 
discharge from hospital, at one month and six months after discharge. At discharge 
from hospital, 30 minutes were spent with each of the 22 participants to complete the 
PFIT and to arrange the details of the follow-up appointments. At one month after 
discharge from hospital, one hour was spent with each of the 15 participants for 
follow-up purposes. At six months after discharge from hospital, one hour was spent 
with each of the 11 participants for follow-up purposes. The total time spend by the 
researcher on follow-up was 37 hours.   
 
3.6 VARIABLES 
3.6.1 Dependent Variables 
Physical activity (6MWT distance) at six months; HRQOL (PCS and MCS of SF-36 
and EQ-VAS) at six months; peripheral muscle power; PFIT-s scores; level of 
depression; return to work. 
3.6.2 Independent Variables  
 Severity of  illness (APACHE II and SAPS II scores); ICU and hospital LOS 
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3.6.3 Confounding Variables  
Smoking status, alcohol consumption, substance abuse, diet and previous physical 
disability. 
 
3.7 OUTCOME MEASURES AND INSTRUMENTATION 
3.7.1 Severity of Injury Scoring Systems 
The APACHE II was calculated for each participant using the QxMD Calculator 
(2010) using each participant’s data on admission to ICU. This is a free smart phone/ 
tablet application developed by QxMD Software. The QxMD is recognized as a 
leading developer of free medical software for mobiles devices. Their software 
content is developed in cooperation with expert physicians from their respective 
fields. The software is available from http://www.QxMD.com. The APACHE II is a 
general mortality prediction model widely used in the ICU (Badreldin, et al., 2011). It 
was released in 1985 and developed to predict the mortality of ICU patients (Knaus, 
et al., 1985; Desai and Lakhani, 2013) It is useful in predicting mortality outcomes, 
LOS, assisting clinical decision making and in monitoring of the services provided in 
the ICU (Bouch and Thompson, 2008) The validity and reliability of the APACHE II 
scoring system is well established (Grmec and Gasparovic, 2001; Chou, et al., 2010; 
Tsai, et al., 2012; Raj, et al., 2014). Cardosa and Chiavona (2013) reported that the 
APACHE II scoring system is useful to stratify patients who are at greater risk of 
mortality after discharge from ICU. Some limitations in the APACHE II scoring system 
have also been reported in the literature. Girbes et al. (2001) conducted a study 
assessing the reliability and accuracy of the APACHE II scoring system in two ICU’s. 
They reported that APACHE II scoring may be flawed as too high scores are entered 
by physicians when scoring the APACHE II.  Scores were reported to be too high 
resulting in the over-estimation of mortality risk.  They concluded that assessment 
using the APACHE II scoring system can show variable scores and that these scores 
can be unreliable to a certain extent (Girbes, et al., 2001).  
 
The SAPS II freely available on-line calculator was used to calculate SAPS II scores 
for each participant. The SAPS II calculator by Clinical Calculator was used. This is a 
free online version available on http://clincalc.com/IcuMortality/SAPSII.aspx. The 
SAPS II is used to calculate the probability of hospital mortality for ICU patients over 
the age of 18 years (Badreldin, et al., 2011). This calculator is based on the SAPS II 
tool developed from a large sample of 12997 medical and surgical patients in North 
America and Europe as reported by Le Gall et al. (1993). The SAPS II includes 17 
variables including 12 physiological variables, age, admission type, and three 
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underlying disease variables (Le Gall, et al., 1993). During the initial development 
and validation of the SAPS II it showed good validity for the large international patient 
sample (Le Gall, et al., 1993). Capuzzo et al. (2000) reported the SAPS II to be valid 
in the surgical ICU population. In a study evaluating different models to predict 30-
day mortality in primary pontine haemorrhage, the SAPS II was found to be fit to 
approximately predict 30-day mortality with very good calibration(p=0.89). A study by 
Kim et al. (2005) investigating the performance of the SAPS II, concluded that the 
SAPS II is an excellent predictor of mortality with excellent calibration. One limitation 
of the SAPS II is that the score is complicated to calculate. The discrimination of the 
SAPS II was reported to be moderate with an aROC (area under receiver operating 
characteristic curve) of 0.76 by Sakr, et al. (2012).Capuzzo et al. (2000) also 
reported that the predictive ability of the SAPS II is affected by the type of ICU 
admission as well as the location of the patient in the hospital prior to ICU admission. 
 
3.7.2 Peripheral Muscle Strength 
Peripheral muscle strength was assessed using a MicroFet2® HHD (Hoggan Health 
Industries, Inc., Draper, Utah). The reliability and validity of using HHD for patients 
who are older, weak or physically impaired has been well established in the literature 
(Kwoh, et al., 1997; Roebroeck, et al., 1998; Wang, et al., 2002 Dunn and Iversen, 
2003; Roy and Doherty 2004; Taylor, et al., 2004). During a reliability study by 
Gontkof et al. (2008), HHD was found to have very high intra-rater reliability with the 
experience of the tester having very little or no significant effect on the intra-rater 
reliability. Arnold et al. (2010) reported from a study, using repeated HHD measures 
of 18 older adult (age 65 to 92 years) male and female participants, that HHD 
showed good inter-rater and intra-rater reliability and validity for the assessment of 
muscle strength at the hip and knee, but not at the ankle. They concluded that a HHD 
can be used effectively in the older adult population (Arnold, et al., 2010).The inter-
rater reliability for the MicroFet HHD was reported to be excellent by Bellew, et al. 
(2003) who investigated the reliability of the MicroFet HHD in measuring hip 
abduction muscle strength (r=0.94). They also found the intra-rater reliability to be 
excellent (r=0.88 – r=94) (Bellew, et al., 2003).          
 
The use of a HHD also has certain limitations. Handheld dynamometry would not be 
an appropriate measurement tool if the assessor has insufficient strength to 
overcome that of the patient being assessed. The dynamometer surface does not 
conform to the body surface being tested as an assessor’s hand would, resulting in 
patients reporting tenderness over the place where the HHD is applied to. Gontkof 
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etal. (2008) reported that problems of stabilising of the HHD were experienced when 
difficult movements were assessed in strong patients. Advantages of using a HHD 
are that it is inexpensive, portable, and requires minimal training for proper use 
(Gontkof, et al., 2008). A HHD provides more objective testing results as compared 
to manual muscle testing (Arnold, et al., 2010; Jannsen, et al., 2012). The HHD 
provides an objective measure of isometric muscle strength at a fixed static joint 
position in kilograms, pounds or Newton (Arnold, et al., 2010; Jannsen, et al., 2012).  
During manual muscle testing, the assessor will rate muscle strength subjectively on 
a zero to five scale. The accuracy of this rating is subject to the education and 
experience of the assessor. Due to the accuracy and reliability of manual muscle 
testing being poor, HHD may be a better option for objective muscle strength 
assessment (Jannsen, et al., 2012). Other researchers have used HHD in the 
assessment of critically ill patients (Van Aswegen, et al., 2010). Appendix P shows 
the testing positions and HHD placement followed in this study.  
 
3.7.3 Exercise Endurance 
Exercise endurance was assessed using the 6MWT. The 6MWT has excellent short 
term reproducibility when administered by the same assessor (ATS, 2002). 
Equipment needed for the 6MWT as per ATS guidelines are: a stopwatch, two small 
cones to mark turnaround points, standard chair, worksheets on a clipboard to record 
measurements, supplemental medical oxygen, sphygmomanometer, telephone and 
automated external defibrillator to be used in the case of emergencies (ATS, 2002). 
A tape measure to measure out a 30 meter walking distance is also needed. The 
6MWT has been used in several studies on the outcomes of survivors of critical 
illness (Herridge, et al., 2003; Van Aswegen, et al., 2010; Aitken, et al., 2012).Test-
retest reliability for the 6MWT has been established in patients with Alzheimer’s 
diseases (r=0.95) (Ries, et al., 2009), the geriatric population (r=0.95) (Steffen, et al., 
2002), patients with osteoarthritis (r=0.94) (Kennedy, et al., 2005), patients who had 
stroke (r=0.99) (Fulk, et al., 2008) and patients who had traumatic brain injuries (Van 
Loo, et al., 2004). The construct validity of the 6MWT has been reported to be 
excellent in patients with COPD mobilizing independently (r=0.65) (Szekely, et al., 
1997).Jones and Rikli (1998) reported that the 6MWT had moderate convergent 
validity from their investigation of the reliability and validity of the 6MWT in older 
adults.   
3.7.4 Health-Related Quality of Life 
Health related quality of life was assessed using the SF-36 and EQ-5D 
questionnaires. The following translations of the SF-36 questionnaire were used 
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(depending on patient preference) in this study: English (South African) (appendix Q), 
Afrikaans, Sesotho and Zulu. Appendices R to T contain the translation certificates of 
the questionnaires. Scores of the SF-36 were calculated using the QualityMetrics 
Health Outcome Scoring Software 4.5. This was provided by Quality Metrics through 
OptumInsight Life Sciences Inc. together with the license to administer the SF-36. 
License number: QM023025 (appendix U). The SF-36 questionnaire has been 
comprehensively validated in the critically ill patient population (Dowdy, et al., 2005; 
Khoudri, et al., 2012) and is reported to be an acceptable, reliable and valid outcome 
measure to assess HRQOL in survivors of critical illness (O’Neill, et al., 2014) and in 
many other disease populations (Németh, 2006; Cox, et al, 2015). 
 
The SF-36 questionnaire is a generic health profile measure of general health status 
which is relevant across age, disease, and treatment groups. It is valuable as it can 
be used across a range of conditions and in different settings (Nemeth, 2006).The 
SF-36 questionnaire utilises 36 items to obtain two summary scores of physical and 
mental health and eight domain scores of HRQOL (Dowdy, et al., 2005). The eight 
domains are: PF, BP, GH, VT, SF, RE and MH. The eight domain scores make up 
the summary scores for SF-36 namely PCS and MCS (Dowdy, et al., 2005; Williams, 
et al., 2015). The SF-36 summary scores (PCS and MCS) allow for ease of 
interpretation of results (Dowdy, et al., 2005). Due to the fact that participant 
responses to the questions posed in the SF-36 are completed using a point scale 
instead of ‘yes’ or ‘no’ answers, it allows for positive and negative health states to be 
identified (Brazier, et al., 1992).   
 
The EQ5D questionnaire is a simple preference-based health profile measure of 
HRQOL of which the reliability and validity has been well established in the ICU 
environment (Flaatten, et al., 2008; Khoundri, et al., 2012).The EQ-5D can be used in 
population health surveys and it can also be used in combination with other 
condition-specific measures. The EQ-5D is a self-administered questionnaire 
(Nemeth, 2006). The EQ5D was available to participants in the following language 
translations (depending on patient preference) during the current study: English 
(South African) (appendix V), Afrikaans, Zulu, Sesotho, Setswana, and Xhosa. 
Permission to use the EQ-5D free of charge was provided by the EuroQol Group 
Foundation (appendix W). The EQ-5D consists of two sections: the first section 
consists of five questions (each with three possible responses) that evaluate various 
dimensions (mobility, self-care, usual activities, pain or discomfort, and depression or 
anxiety) of QOL; the second section consists of a visual analogue scale (VAS) in the 
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form of a vertical line that depicts worst to best possible health state (Chen, et al., 
2014b). Results from the EQ-5D could provide 243 possible health profiles (Flaatten, 
et al., 2008). Some researchers have used and reported on the EQ-5D in the critical 
care population (Dowdy, et al., 2005; Sacanella, et al., 2011; Parson, et al., 2012; 
Goixart, et al., 2013; Schneiderman, et al., 2013). Sacanella et al. (2011) investigated 
the HRQOL and functional status of the elderly medical ICU population after 
discharge from hospital in a prospective study, and reported that the survival of these 
patients was low and their HRQOL did not improve significantly. 
 
Many studies have compared the EQ-5D and the SF-36 questionnaires in different 
patient populations. The two measures differ and the validity and responsiveness 
differ depending on the specific patient population studied (Chen, et al., 2014a).It is 
beneficial to assess a specific study population using both the SF-36 and EQ-5D 
questionnaires as they contain different domains of HRQOL, all of which are 
important to assess. The SF-36 is useful as it provides continuous data sets for each 
domain of HRQOL as well as providing information on the mental and physical 
domains of HRQOL. The EQ-5D questionnaire is useful as it provides categorical 
data for the different domains of HRQOL. The EQ-5D questionnaire VAS section 
provides a self-reported measure of health status. The SF-36 and EQ-5D 
questionnaires differ in the domains under investigation, scoring procedures, and 
type of data obtained. It would therefore be important to include both these 
questionnaires in a study investigating HRQOL as it will ensure that all domains of 
HRQOL are thoroughly investigated. It is important to investigate all domains of 
HRQOL in a mixed ICU population as these patients may differ with regards to the 
domains of HRQOL they find problematic after discharge from hospital.      
 
3.7.5 Presence and Severity of Depression 
The presence and severity of depression symptoms among study participants was 
screened for using the PHQ-9. The PHQ-9 is an easy to use and reliable screening 
tool commonly used for detecting depression. It is a self-administered version of the 
Primary Care Evaluation of Mental Disorders diagnostic instrument for common 
mental disorders (Wu, 2014). It consists of nine self-report questions about 
symptoms of depression. A score of eight to 11 on the PHQ-9 is recommended as 
the cut-off score for depression (Kumei, et al., 2015). The PHQ-9 score indicates the 
presence of mild, moderate, moderately severe, and severe depression. These 
descriptions are represented by PHQ-9 scores of five, ten, 15 and 20 respectively. It 
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is free for usage to online users and is available in more than 35 languages, including 
English.   
 
 A study by Wu (2014) investigated the PHQ-9 questionnaire to determine its validity 
and reliability in patients with chronic disease and found it to be a valid and reliable 
tool. It is easy to administer as it takes approximately ten minutes to complete (Wu, 
2014). The PHQ-9 was also found to be a valid and reliable screening tool for 
depression in the primary care setting (Chan, et al., 2013). No studies were found 
that had assessed the validity and reliability of the PHQ-9 in critically ill patients or in 
those recovering from critical illness after discharge from hospital.  
 
There are no South African translations of the PHQ-9 questionnaire. The PHQ-9 was 
available to participants in English in the current study (appendix X). Appendix X also 
shows the usage and scoring instructions for the PHQ-9. The PHQ-9 has specificity 
and sensitivity of 88 percent for major depressive disorders at a cut-off score of more 
or equal to ten. It has a good internal consistency, indicated by a Cronbach’s α being 
0.89 (Chan, et al., 2013).  
 
3.7.6 Functional Ability 
Functional ability of participants in ICU was assessed using the PFIT-s. The PFIT-s is 
a reliable and responsive measure used in the ICU patient population (Skinner, et al., 
2009).  Appendix Y shows the scoring sheet of the PFIT-s. Denehy et al. (2013) 
reported on the validity, responsiveness, and predictive utility of the PFIT-s’s interval 
scores in the ICU. They concluded that the PFIT-s’s intervals scores are valid, 
responsive, and predictive of key outcomes. The PFIT-s was found to be a safe and 
inexpensive outcome measure to use in the ICU and its use is recommended in the 
ICU patient population (Denehy, et al., 2013). Skinner et al. (2009) examined the 
reliability and responsiveness of the PFIT-s in mechanically ventilated patients with 
tracheotomies in the ICU and found that it was good. They reported no adverse 
effects during testing in the ICU. The conclusion was that the PFIT-s is an outcome 
measure with good reliability and responsiveness and that it can be used to prescribe 
and assess exercise and mobilisation in the ICU (Skinner, et al., 2009).  Denehy et 
al. (2014) reported on the use of the PFIT-s in survivors of critical illness. They 
concluded that the PFIT-s is valid to measure the functional status of critically ill 
patients mechanically ventilated in ICU for more than 96 hours if they are alert and 
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awake, able to follow commands and have enough muscle strength to participate in 
the testing process (Denehy, et al., 2014).  
 
 
3.7.7 Physical Activity 
Physical activity level of participants after discharge from hospital was assessed 
using the RPAQ. The RPAQ has been found to be a valid questionnaire to use to 
rank patients on the basis of time spent on activities of vigorous intensity and also 
total energy expenditure (Besson, et al., 2010). This questionnaire was only available 
in English (appendix Z) and its use is free of charge.   
 
3.8 BIAS 
The only possible bias involved in this study may be that some of the participants 
were known to the researcher as he was one of the treating physiotherapists during 
their time in ICU. These participants were not treated any different during study 
assessments and received their regular physiotherapy treatment. All physiotherapy 
treatment sessions and study assessment sessions were kept completely separate 
with no coaching of any participant. 
 
3.9 FUNDING 
The study was funded by the South African Society of Physiotherapy Research 
Foundation and the University of the Witwatersrand Medical Faculty Research 
Endowment Fund.  
 
Neither the researcher nor research assistant gained financial or other benefits from 
the results of the study. 
 
3.10 STATISTICAL METHODS 
Data were captured and entered on Excel spreadsheets. The Statistical 
Programming for the Social Sciences Statistics Version 23 software package was 
used for data analysis. Descriptive statistics were used to present the data. 
Continuous data such as PFIT-s interval scores, 6MWT distance, peripheral muscle 
strength, APACHE II and SAPS II scores and LOS were summarised as means and 
standard deviations (SD). Categorical data such as gender were summarised as 
numbers and percentages. Paired samples t-tests were used to assess changes in 
continuous data over time. Chi-square tests were used to compare categorical data. 
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 Due to the small sample size (n=24), the Spearman’s rho was used to measure the 
degree of association between variables. A linear regression model was used to 
assess relationships between multiple variables.    
 Relationships were considered to be very strong if the value of r was -1.0 to -0.8 or 
0.8 to 1.0, strong if the value of r was -0.79 to -0.6 or 0.6 to 0.79, moderate if the 
value of r was -0.59to  -0.4 or 0.4 to 0.59, weak if the value of r was -0.39 to -0.2 or 
0.2 to 0.39, or none or very weak if the value of r was -0.19 to 0.0 or 0.0 to 0.19.  
 
During statistical analysis, testing was done at the 0.05 level of significance (p≤ 0.05) 
and confidence intervals (CI) were set at 95%.  
 
Assistance was sought from a statistician at the Faculty of Health Sciences of the 
University of the Witwatersrand and a statistician external to the University. Guidance 
was sought from the study supervisor. The results of the study are discussed in detail 
in chapter four. 
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CHAPTER 4  
 
4. RESULTS 
Intensive care unit patients who survived critical illness in the private health care 
sector of South Gauteng province were included in this study. Results in this chapter 
are reported in the format of the Strengthening the Reporting of Observational 
studies in Epidemiology (STROBE) guidelines for reporting a cohort study. A total of 
166 potential study participants were identified over a 13 month period. After 
recruitment, 24 patients from the two hospitals were enrolled in this study (see Figure 
4.1). 
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4.1 PARTICIPANTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
           
 
 
 Figure 4.1: Flow of Participations throughout the Study 
Total Admissions 
Mulbarton Hospital: n=1896 
Union Hospital: n= 3031 
Total: n=4927 
Excluded 
(not meeting eligibility criteria) 
n= 4760 
Excluded 
Refusal: n= 31 
Unable to obtain consent before 
discharge from hospital: n=49 
Cardiac arrhythmias: n=1 
Participant moving away: n= 4 
Plastic surgery restrictions: n= 1 
Direct discharge from ICU to 
rehabilitation facility: n= 1 
 
 
Potential Inclusions 
(meeting eligibility criteria) 
n= 111 
Included in study 
n=24 
 
Excluded at Hospital 
Discharge 
Withdrawal (n= 2) 
Participants at Hospital 
Discharge 
N=22 
Excluded at One Month 
Follow-up 
Deceased (n=1) 
Moved away (n=1) 
Unable to track (n=3) 
Withdrawal (n= 2) 
Participants at One Month 
Follow-up 
N=15 
Excluded at Six Month 
Follow-up 
Moved away (n=1) 
Withdrawal (n= 2) 
Hospitalized/Surgery (n=1) 
Participants at Six Months 
Follow-up 
N=11 
Participants Completing all 
Follow-up Assessments 
N=11 
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Forty nine patients were excluded from the potential study participant’s list due to the 
inability to trace these patients. The reason for this is that patients who were 
transferred from the ICU to the normal hospital ward were often discharged home 
within one or two days after ICU discharge. Participants required time to read the 
information document for the study and often requested to first discuss their 
participation with their family members before consenting to participate. This process 
delayed the recruitment of participants and these patients were then discharged 
before a decision regarding participation in the study was made; hence they were lost 
to follow-up. The researcher made an effort to visit these participants twice a day to 
inquire whether they had made a decision regarding participation in the study. Some 
participants also reported that they were not feeling well at the time they were 
approached with the information document and requested that the researcher return 
the next day to explain details regarding the study, only to find that the patient had in 
fact been discharged home. A number of participants were discharged home directly 
from the ICU and were not able to perform the PFIT-s at the specific time points in 
the study design. The researcher viewed these participants as “unable to obtain 
consent before discharge from hospital” due to the fact that they were discharged 
from hospital before the researcher could recruit them.  
 
 At the time of discharge from hospital, two participants withdrew. The reason 
provided by both was that they felt they had a long hospital stay and did not want any 
further tests done on them. At one month follow-up, two participants withdrew from 
the study. One stated a lack of time to participate further in the study and one 
reported return to work and resultant time constraints to attend sessions for 
reassessment as the reason for withdrawal. At six months after discharge from 
hospital, a further two participants withdrew from the study. Both provided the reason 
of being very busy at work as the reason for withdrawal.  
 
Data sets for 24 participants were in included in analyses at the time of study 
enrolment. At time of discharge from hospital, data sets for 24 participants were 
included in analysis. At one month follow-up assessment, data sets for 15 
participants were included in analysis. At six months follow-up assessment, data sets 
for 11 participants were included in analysis.Not all participants completed all 
assessments of all outcome measures. The recorded drop-out rate for the study was 
37.5% (n=9) at one month follow-up and 54.2% (n=13) at six months.During data 
analysis, per protocol analysis was performed. 
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At the time of discharge from ICU to the ward, three participants were unable to 
complete the march on spot (MOS) component of the PFIT-s due to weakness. At 
hospital discharge 21(87.5%) participants performed the PFIT-s. One participant 
chose not to perform the test due to weakness, but agreed to continue participation in 
the study. One participant could not complete the MOS component of the PFIT-s due 
to pain. There were three missing data sets.  
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4.2 BASELINE CHARACTERISTICS AND DEMOGRAPHICS OF STUDY 
PARTICIPANTS 
 
Demographic and admission details, mortality and morbidity estimation scores, 
surgical details, length of MV and length of ICU stay were collected for 24 (100%) 
participants at baseline.Table 4.1 summarises the baseline characteristics and 
demographics of the study participants.  
 
Table 4.1: Baseline Characteristics and Demographics of Study Participants 
Characteristic Median 
(n=24) 
Percentiles 
25 
(n=24) 
Percentiles 
50 
(n=24) 
Percentiles 
75 
(n=24) 
Age (years) 51.5 41.3 51.5 60.8 
  
                      N 
Percentage (%) 
(n=24) 
Gender 
 Males 
 Females 
 
19 
5 
 
79.2 
20.8 
Handedness 
 Right 
 Left 
 
24 
0 
 
100 
0 
Living arrangements 
 Living alone 
 Living with others 
 Support available at home 
 
3 
21 
24 
 
12.5 
87.5 
100 
Level of education 
 Grade 9 
 Grade 11 
 Grade 12 
 Diploma 
 Basic degree qualification 
 Honours degree qualification 
 Masters degree qualification 
 
1 
1 
9 
7 
2 
2 
2 
 
4.2 
4.2 
37.5 
29.2 
8.3 
8.3 
8.3 
Type of occupation 
 Unemployed 
 Physical labourer 
 Office worker 
 Pensioner 
 
1 
5 
15 
3 
 
4.2 
20.8 
62.5 
12.5 
Previous disabilities and pre-
morbid diseases: 
 Dyslipidaemia 
 Hypertension 
 Cardiac stenting surgery 
 Cardiac valve replacement 
surgery 
 Diabetes mellitus 
 Chronic renal failure 
 Laparotomy 
 Visual difficulties 
12  
 
3 
1 
1 
1 
1 
1 
1 
1 
1 
50 
 
25 
8.3 
8.3 
8.3 
8.3 
8.3 
8.3 
8.3 
8.3 
65 
 
 Cancer 
 Low back pain 
1 8.3 
 
A variety of pre-morbid diseases and disabilities were reported by study participants, 
with the most common pre-morbid disease being dyslipidemia (n=3). No participants 
reported a smoking history, history of alcohol or substance abuse or a history of 
dietary abnormalities. 
 
Figure 4.2 shows the age distribution and frequencies of study participants. 
 
 
Figure 4.2: Age Distribution and Frequency of Study Participants 
 
 
Table 4.2 summarises the reasons for admission and types of surgery that study 
participants underwent. 
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Table 4.2: Reasons for Admission and Types of Surgery Recorded for 
Study Participants 
Admission type N Percentage (%) 
(n=24) 
Medical admissions 
 Pneumonia 
 Pulmonary Tuberculosis 
 Pleural effusion 
 Pulmonary oedema 
 COPD 
 Septicaemia 
 Chronic renal failure 
8 
2 
1 
1 
1 
1 
1 
1 
33.3 
25 
12.5 
12.5 
12.5 
12.5 
12.5 
12.5 
Trauma admissions 
 Penetrating thorax trauma 
 Blunt trauma to the thorax and abdomen 
7 
1 
6 
29.2 
14.3 
85.7 
Cardiac admissions 
 Congestive cardiac failure 
 Coronary artery bypass graft 
 Mitral valve replacement 
 Aortic valve replacement, mitral valve replacement 
and coronary artery bypass graft 
7 
1 
4 
1 
1 
29.2 
14.3 
57.1 
14.3 
14.3 
Surgical interventions 
 Elective surgical intervention 
 Non-elective surgical intervention 
19 
6 
11 
70.8 
31.5 
57.8 
 
The number of medical (n=8), trauma (n=7) and cardiac (n=7) admissions were 
almost equally distributed in the study sample, with the majority of participants (n=19) 
undergoing surgical interventions. 
 
All participants received physiotherapy treatment during their ICU and hospital ward 
stay. These treatment sessions would generally consist of chest physiotherapy 
treatment, assistance with mobilization and strengthening exercises. 
 
Those participants admitted with medical conditions were unlikely to continue with 
physiotherapy treatment after discharge from hospital unless they still had problems 
with retained pulmonary secretions or physical weakness. If required, treatment 
would generally involve chest physiotherapy treatment and rehabilitation to improve 
muscle strength and exercise endurance. Those participants who were admitted with 
trauma were likely to continue with physiotherapy treatment after discharge from 
hospital and would generally include physical rehabilitation to improve muscle 
strength and exercise tolerance. Those participants who underwent CABG surgery 
would generally also continue with physiotherapy after discharge from hospital. The 
first six weeks after discharge would consist if an unsupervised home exercise 
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programme, after which the participant would continue with a supervised cardiac 
rehabilitation in the physiotherapy outpatient department.  
 
Table 4.3: Mechanical Ventilation Duration, ICU LOS, ward LOS, APACHE II 
Scores, SAPS II Scores, and predicted mortality rates for all 24 
participants. 
Characteristic 
Mean 
(±SD) 
(n=24) 
Median 
(n=24) 
Percentiles 
25 
(n=24) 
Percentiles 
50 
(n=24) 
Percentiles 
75 
(n=24) 
MV duration (days) 
9.1 
(8.4) 
7 2.3 7 15.3 
ICU LOS (days) 
18.3 
(10) 
15.5 10.3 15.5 28 
Hospital LOS after ICU 
discharge (days) 
7.8 
(11.1) 
4.5 2 4.5 8.5 
APACHE II scores 15.3 (8) 12.5 9.3 12.5 21.8 
Predicted mortality rate 
percentage (APACHE 
II) 
23.5 
(16.6) 15.6 10.3 15.6 38.9 
SAPS II scores 
44 
(20.9) 
41.5 27 41.5 64.8 
Predicted mortality rate 
percentage (SAPS II) 
36.3 
(33.5) 
27.6 7.9 27.6 73.5 
 
A higher APACHE II or SAPS II score indicates a higher chance of mortality. The 
relatively high risk of mortality of this group of participants resulted in prolonged 
duration of MV and ICU and hospital stay.  
 
4.3 PARTICIPANTS’ LEVEL OF FUNCTIONAL ABILITY AT DISCHARGE FROM ICU 
AND CHANGES IN THE LEVEL OF FUNCTIONAL ABILITY AT HOSPITAL 
DISCHARGE 
 
Participants’ level of functional ability at discharge from ICU and at hospital discharge 
was measured using the PFIT-s. Table 4.4 summarises the findings. 
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Table 4.4: PFIT-s scores at ICU Discharge and Discharge from Hospital 
PFIT Variable ICU 
discharge 
(n=24) 
Hospital  
Discharge  
(n=21) 
95% 
CI 
p-
Value 
IQR 
Percentiles 25 
(n=24) 
ICU 
Discharge/Hospital 
Discharge 
Percentiles 50 
(n=24) 
ICU 
Discharge/Hospital 
Discharge 
Percentiles 75 
(n=24) 
ICU 
Discharge/Hospital 
Discharge 
PFIT-s Interval 
Score (score out of 
10) 
 Mean (±SD) 
 Median 
 Minimum 
 Maximum 
 
 
 
6.7 (1) 
6.8 
4.9 
7.9 
 
 
 
7.1 (1.2) 
7.1 
4.4 
8.8 
 
 
 
-0.7,  
-
0.06 
 
 
 
0.02* 
 
 
 
6/ 6.4 
 
 
 
6.8/ 7.1 
 
 
 
 
 
 
7.7/ 7.9 
Marching on Spot 
(steps/minute) 
 Mean (±SD) 
 Median 
 Minimum 
 Maximum 
 
 
37.9 
(11.5) 
27.6 
0 
58.6 
 
 
43.8 (16.4) 
38.5 
0 
83.5 
 
 
-
12.4, 
0.5 
 
 
0.07 
 
 
 
30.5/ 37.2 
 
 
 
38.5/ 45.2 
 
 
 
43.6/ 51.8 
Shoulder Flexion 
Endurance 
(repetitions/minute) 
 Mean (±SD) 
 Median 
 Minimum 
 Maximum 
 
 
 
27.9 (8.1) 
25.3 
12.9 
42.2 
 
 
 
29.1 (10.5) 
45.2 
15.1 
47.8 
 
 
 
-3.3, 
1.3 
 
 
 
0.38 
 
 
 
20/ 20 
 
 
 
27.6/ 25.3 
 
 
 
33.8/ 40 
*Indicates significance at level p<0.05. 
 
The changes in PFIT-s variables were determined by a paired samples t-test. The 
change in mean PFIT-s interval score between ICU discharge and hospital discharge 
was 0.4 points (± 0.7) which was statistically significant (p=0.02). The change in 
mean cadence for MOS component of PFIT-s between ICU discharge and hospital 
discharge was 6 steps per minute (± 14.2). This change was not statistically 
significant (p=0.07). The change in mean cadence for shoulder flexion component of 
PFIT-s between ICU discharge and hospital discharge was one repetition/minute (± 
4.9) but again this change was not statistically significant (p=0.38). For the MOS 
component and shoulder flexion endurance component of PFIT-s p>0.05, thus the 
null hypothesis is not rejected. The null hypothesis is rejected for the PFIT-s interval 
score as p<0.05.   
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4.4 EXERCISE ENDURANCE OF SURVIVORS OF CRITICAL ILLNESS AT ONE 
MONTH AFTER HOSPITAL DISCHARGE AND CHANGES IN EXERCISE 
ENDURANCE AT SIX MONTHS 
 
Exercise endurance was measured using the 6MWT over the first six months after 
discharge from hospital. Each participant’s percentage of age-predicted distance 
achieved with the 6MWT was calculated using the following equation: expected 
6MWT distance= 868.8 – (2.99 x age) – [74.7 x gender (male= 0; female=1)] 
(Gibbons et al., 2001). Table 4.5 summarises the findings of the 6MWT. 
 
Table 4.5: Results for 6MWT as Assessed at One and Six Months following 
Discharge 
Variable 
1-
month 
(n=14) 
6-months 
(n=11) 
95% 
CI 
p-Value 
IQR 
Percentiles 25 
(n=24) 
1 Month/6 Months 
Percentiles 50 
(n=24) 
1 Month/6 Months 
Percentiles 75 
(n=24) 
1 Month/6 Months 
6MWT 
distance (m) 
 Mean 
(±SD) 
 Median 
 Minimum 
 Maximum 
 
 
421.5 
(134.5) 
425 
110 
628 
 
 
474.5(110) 
 
490 
300 
630 
 
 
-
104.5, 
2.6 
 
 
0.60 
 
 
 
 
332.5/ 400 
 
 
 
 
425/ 490 
 
 
 
 
517.5/ 570 
Percentage 
of predicted 
distance 
achieved 
(%) 
 Mean 
(±SD) 
 Median 
 Minimum 
 Maximum 
 
 
 
 
 
60.45 
(19.1) 
61.5 
16 
88.4 
 
 
 
 
 
68.8 (16.2) 
 
73.3 
43.7 
88.8 
 
 
 
 
 
-15.4, 
0.1 
 
 
 
 
 
0.53 
 
 
 
 
 
48.6/ 58 
 
 
 
 
 
61.5/ 73.3 
 
 
 
 
 
76/ 83.4 
*m = meters. 
 
Non-statistically significant improvements were observed in 6MWT distance achieved 
(p=0.6) and percentage of predicted distance achieved (p=0.53).  
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4.5. PERIPHERAL MUSCLE STRENGTH AT ONE MONTH AFTER HOSPITAL 
DISCHARGE AND CHANGES IN PERIPHERAL MUSCLE STRENGTH AT SIX 
MONTHS 
 
Peripheral muscle strength was assessed using a HHD at one and six months 
following discharge. Table 4.6 shows the mean changes in peripheral muscle 
strength for participants at the one and six months assessments. 
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Table 4.6: Peripheral Muscle Strength Results at One Month and Six Months 
after Discharge from Hospital 
 Peripheral Muscle Strength (Newton) 
(n=11) 
Muscle group 
(Right) 
Mean at 
one 
month 
(±SD) 
Median 
at one 
month 
Mean at 
six 
months 
(±SD) 
Median 
at six 
months 
Mean 
difference 
(±SD) 
95% CI Significance 
(p) 
Shoulder 
flexors 
(Anterior 
Deltoid) 
 Right 
 Left 
 
 
 
 
91.7(24.5) 
91.7(24.4) 
 
 
 
 
92 
91.7 
 
 
 
 
98 (25.1) 
97.9 (28.6) 
 
 
 
 
94 
92 
 
 
 
 
6.3 (15.4) 
6.2 (19.7) 
 
 
 
 
-16.6, 4 
-19.4, 
7.1 
 
 
 
 
0.20 
0.33 
Elbow flexors 
(Biceps 
Brachii) 
 Right 
 
 Left 
 
 
 
141.5 
(20.4) 
136.4 
(25.9) 
 
 
 
141.3 
 
145.3 
 
 
 
158.8 (13) 
 
141.4 (17) 
 
 
 
164 
 
141.3 
 
 
 
17.3 (15.7) 
 
5 (25.7) 
 
 
 
-27.8, -
6.8 
-22.2, 
12.3 
 
 
 
0.00* 
 
0.54 
Elbow 
extensors 
(Triceps 
Brachii) 
 Right 
 
 Left 
 
 
 
 
 
122.5 
(30.8) 
118.4 
(33.7) 
 
 
 
 
142 
 
126 
 
 
 
 
155.1 
(33.8) 
141.3 
(31.8) 
 
 
 
 
144 
 
142 
 
 
 
 
32.6 (37) 
 
22.9 (34.8) 
 
 
 
 
 
-57.5, -
7.7 
-46.3, 
0.4 
 
 
 
 
0.02* 
 
0.05** 
Hip abductors 
(Gluteus 
Medius) 
 Right 
 
 Left 
 
 
 
143.4 
(43.7) 
157.3 
(38.5) 
 
 
 
206.8 
 
153.3 
 
 
 
196.7 
(31.8) 
193.6 
(32.3) 
 
 
 
193 
 
206.8 
 
 
 
53.4 (52.3) 
 
36.4 (45.2) 
 
 
 
-88.5, -
18.2 
-66.7, -6 
 
 
 
0.01* 
 
0.02* 
Ankle 
dorsiflexors 
(Tibialis 
Anterior) 
 Right 
 
 Left 
 
 
 
 
123.9(29.7) 
 
131.3 
(35.4) 
 
 
 
 
157 
 
125 
 
 
 
 
153.7 
(40.7) 
174.7 
(42.8) 
 
 
 
 
168.1 
 
157 
 
 
 
 
29.9 (36.9) 
 
43.3 (48.1) 
 
 
 
 
-54.7, -
5.1 
-75.7, -
11 
 
 
 
 
0.02* 
 
0.01* 
Knee 
extensors 
(Quadriceps 
Femoris) 
 Right 
 Left 
 
 
 
 
149.7(48.9) 
155 (45.7) 
 
 
 
 
187 
181 
 
 
 
 
209.6 
(46.4) 
183.7 
(43.3) 
 
 
 
 
220 
187 
 
 
 
 
59.9 (40.3) 
28.8 (48.7) 
 
 
 
 
-87, -
32.8 
-61.5, 
3.9 
 
 
 
 
0.00* 
0.08 
Knee flexors 
(Hamstrings) 
 Right 
 
 Left 
 
 
128.5 
(28.2) 
125.8 
(36.4) 
 
 
166.2 
 
119.7 
 
 
170.9 
(21.4) 
165.8(39.5) 
 
 
171.7 
 
166.2 
 
 
42.4 (31.3) 
 
40 (43.3) 
 
 
-63.4, -
21.4 
-69, -
10.9 
 
 
0.00* 
 
0.01* 
*Indicates significance at level p<0.05; **Indicates significance at level p=0.05 
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Statistically significant improvements were observed in right sided elbow flexors 
(p=0.00), elbow extensors (p=0.02), hip abductors (p=0.01), knee extensors (0.00), 
knee flexors (p=0.00) and ankle dorsiflexors (p=0.02) muscle strength.  
Statistically significant improvements were also observed in left sided elbow 
extensors (p=0.05), hip abductors (p=0.02), knee flexors (p=0.01) and ankle 
dorsiflexors (p=0.01) muscle strength.  
 
 
4.6 LEVEL OF DEPRESSION AT ONE AND SIX MONTHS AFTER DISCHARGE 
FROM HOSPITAL 
 
Level of depression was assessed using the PHQ-9 questionnaire. Table 4.7 
summarises the difficulties reported by participants and the severity of depressive 
disorders at follow-up.    
 
Table 4.7: Reported Difficulties and Severity of Depressive Disorders as 
Measured with the PHQ-9 at One and Six Months following 
Discharge 
 
PHQ-9: Reported Difficulties and Severity of Depressive Disorders 
 At one month  
follow-up(n=15) 
At six months  
follow-up(n=11) 
Number of participants who reported 
that they experience difficulties 
n (%) 
11 (73.3) 11 (100) 
Difficulty if problems present  
 Not difficult at all 
 Somewhat Difficult 
 Very Difficult 
 Extremely Difficult 
n (%) 
 
 
8 (53.3) 
2 (13.3) 
1 (6.7) 
0 (0) 
 
 
4 (36.4) 
2 (18.2) 
0 (0) 
0 (0) 
Depression Severity  
 None 
 Mild 
 Moderate 
 Moderately severe 
 Severe 
n (%) 
 
6 (40) 
4 (26.7) 
1 (6.7) 
0 (0) 
1 (6.7) 
 
4 (0) 
2 (18.2) 
0 (0) 
0 (0) 
0 (0) 
 Major Depressive disorder 
 Other Depressive disorder  
n (%) 
1 (6.7) 
1 (6.7) 
0 (0) 
0 (0) 
 
73 
 
The mean PHQ-9 scores was 3.3 (± 2.6) at one month follow-up and 1.8 (± 2.6) at six 
months. The median PHQ-9 score was 3 at one month follow-up and 1 at six months. 
The mean PHQ-9 score showed a positive change of 1.5 points (± 3.7) but was not 
statistically significant (p= 0.22). The null hypothesis was not rejected for these 
measurements as p>0.05. 
 
 
4.7 HEALTH-RELATED QUALITY OF LIFE REPORTED AT ONE MONTH AFTER 
HOSPITAL DISCHARGE AND CHANGES IN HRQOL AT SIX MONTHS 
 
In this study HRQOL was assessed using the SF-36 and EQ-5D questionnaires. 
Results obtained from each questionnaire are reported in the sections below. 
 
 
4.7.1 Quality of Life of Participants as Reported using the SF-36 Questionnaire in the 
First Six Months after Discharge from Hospital 
 
 On average it took participants ten minutes to complete the SF-36 questionnaire. 
 Participants choose either the English (South African), Afrikaans or isiZulu translated 
 versions of the SF-36 questionnaire to complete. Table 4.8 summarises results 
 obtained for the domain scores and summary scores of the SF-36 for participants at 
 one and six months following discharge. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
74 
 
Table 4.8: Mean SF-36 Domain and Summary Scores for Participants Obtained at 
  One and Six Months after Discharge 
 
SF-36 Scores 
Mean at one 
month (±SD) 
(n=15) 
Mean at six 
months (±SD) 
(n=11) 
Mean 
difference 
(±SD) 
95% CI 
Significance 
(p) 
PCS 42.9 (8.8) 51.7 (10.5) 8.8 (7.6) -13.9, -3.7 0.00* 
MCS 49.2 (10.5) 53.3 (7.7) 4 (7.7) -9.2, 1.1 0.11 
PF 63.2 (16.7) 77.3 (20.8) 14.1 (17) -25.5, -2.7 0.21 
RP 46 (26.3) 80.1 (27.1) 33.5 (24.6) -50, -17 0.00* 
BP 59 (22.5) 72.2 (28.1) 13.2 (19.4) -26.2, -0.1 0.05* 
GH 70.1 (18.9) 82 (16.3) 11.9 (10.8) -19.2, -4.6 0.00* 
VT 57.4 (15.5) 77.3 (17.7) 19.9 (21.8) -34.5, -5.2 0.01* 
SF 58 (28.7) 84.1 (19.4) 26.1 (27.6) -44.7, -7.6 0.01* 
RE  72 (29.6) 84.1 (19.5) 12.1 (25.4) -29.2, 4.9 0.14 
MH 76.3 (18.7) 76.8 (17.1) 0.5 (18.6) -13, 12.1 0.94 
*Indicates significance at level p<0.05; *indicates significance at level p=0.05. 
 
4.7.2 Quality of Life of Participants as Reported using the EQ-5D Questionnaire in 
the First Six Months after Hospital Discharge 
 
On average it took participants five minutes to complete the EQ-5D questionnaire. 
Participants choose either the English (South African), Afrikaans or isiZulu translated 
versions of the EQ-5D questionnaire. 
 
The mean EQ-5D VAS score was 72.5 (± 15.9) at one month follow-up and 87.2 (± 
11.1) at six months. A change in mean EQ-5D VAS scores of 14.6 (± 9.7) was 
observed between one month and six months following discharge. This change in 
mean EQ-5D VAS score was statistically significant (p=0.00) with 95% CI of -21.2 
and -8.1. The null hypothesis was therefore rejected as p< 0.05.  
 
The EQ-5D domains evaluate five different aspects of HRQOL.  These are the ability 
to mobilise, to perform self-care and to perform usual activities of daily living 
including work and leisure activities, establishes the presence of pain and anxiety or 
depression. The response frequencies to the categorical questions of the EQ-5D 
health survey is summarised in table 4.9. 
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Table 4.9: Response Frequencies for Categorical Data Obtained for the 
Various Domains of the EQ-5D 
 
 
 
 
 
 
 
 
 
 
 
4.9 PHYSICAL ACTIVITY AT ONE AND SIX MONTHS AFTER DISCHARGE AND 
CHANGES OBSERVED OVER THE SIX MONTH PERIOD 
Participants’ level of physical activity at one and six months after hospital discharge 
was assessed using the RPAQ. Results were obtained for 15 (62.5%) of 24 
participants at one month after discharge and for eleven (45.8%) of 24 participants at 
six months after discharge. The participants’ means of transport at one month follow-
up included motor vehicles (n=11; 73.3%) and walking (n=4; 26.7%). At one month 
follow-up 12 participants (80%) had paid employment and three participants (20%) 
reported no paid employment. Employment varied between sedentary employment 
(n=2; 16.7%), manual work (n=1; 8.3%) or standing occupation (n=9; 75%). At the six 
months follow-up assessment six participants (54.4%) had no paid employment and 
only five (45.5%) reported that they had paid employment. Employment varied 
between sedentary employment (n=2; 40%), manual work (n=1; 20%) or standing 
occupation (n=2; 40%). 
 
Time spent working was measured using the RPAQ questionnaire over the first six 
months after discharge from hospital. Table 4.10 summarises the findings from the 
RPAQ results. 
 
EQ-5D Domains 
At one month follow-up 
(n=15) 
n (%) 
At six months follow-up 
(n=11) 
n (%) 
Mobility 
 No Problem 
 Problem 
 
9 (60%) 
6 (40%) 
 
10 (90.9%) 
1 (9.1%) 
Self-Care 
 No Problem 
 Problem 
 
11 (73.3%) 
4 (26.7%) 
 
10 (90.9%) 
1 (9.1%) 
Usual Activities 
 No Problem 
 Problem 
 
6 (40%) 
9 (60%) 
 
9 (81.8%) 
2 (18.2%) 
Pain/Discomfort 
 No Problem 
 Problem 
 
3 (20%) 
12 (80%) 
 
9 (81.8%) 
2 (18.2%) 
Anxiety/Depression 
 No Problem 
 Problem 
 
10 (66.7%) 
5 (33.3%) 
 
8 (72.7%) 
3 (27.3%) 
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Table 4.10: Changes in Time Spent Working as Reported by Study 
Participants on the RPAQ at One and Six Months after Discharge 
 RPAQ time spent working 
 Mean at one 
month (±SD) 
(n=15) 
Mean at six 
months (±SD) 
(n=11) 
Mean 
 difference  
(±SD) 
95% CI Significance 
(p) 
Time spent at work: 
(hours) 
 Four weeks ago 
 Three weeks ago 
 Two weeks ago 
 One week ago  
 
 
30 (0) 
30 (0) 
19.5 (21.9) 
22 (25.5) 
 
 
40 (0) 
40 (0) 
42.5 (3.5) 
42.5 (3.5) 
 
 
10 (0) 
10 (0) 
23 (25.5) 
20.5 (29) 
 
 
-20.8, 48.8 
-120.8, 158. 
-251.7, 205.7 
-281, 240 
 
 
0.22 
0.33 
0.42 
0.5 
*h = hours. 
 
There was no statistically significant differences in the mean time spent working at 
one week (p=0.5) and two weeks (p=0.42) prior to assessment.  
4.9 RETURN TO EMPLOYMENT IN THE FIRST SIX MONTHS AFTER HOSPITAL 
DISCHARGE  
 
Return to employment was assessed at one and six months after discharge from 
hospital using the demographic information sheet and interview. Information gathered 
from each participant included return to work status, time to return to work, and 
reasons for not returning to work (if applicable). Table 4.11 shows the mean time to 
return to work and participants’ return to work status at one and six months 
respectively. Results are presented for 15 participants at one month follow-up and 
eleven at six months follow-up due to participant drop-out.    
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Table 4.11: Mean Time to Return to Work and Return to Work Status at One 
and Six Months Follow-Up 
  Mean (±SD) Minimum Maximum Median 
Time to return to work at 
one month (days) (n=3)  
35.3 (11.6) 23 46 37 
Time to return to work at 
six months (days) (n=6) 
78.8 (64.3) 30 180 43 
 
N 
(n=15) 
Percentage (%) 
(n=15) 
Returned to work at one 
month 
3 20 
Returned to same work at 
one month 
3 20 
Not returned to work at one 
month 
12 80 
 
N 
(n=11) 
Percentage (%) 
(n= 11) 
Returned to work at six 
months 
6 54.5 
Returned to same work at 
six months 
5 83.3 
Not returned to work at six 
months 
5 45.5 
 
One participant with a job requiring manual labour decided to retire and did not return 
to work. One participant with a job requiring manual labour did not return for follow-up 
and the researcher was unable to track this participant.  Other reported reasons for 
not returning to employment at one and six months follow-up are summarised in table 
4.12.   
During data analysis it was noted that there is conflict between the data presented in 
tables 4.10 and 4.11. The researcher concluded that the reason for this was that the 
participants did not fully understand the question posed by the RPAQ questionnaire 
section on occupation and this led to the conflicting data.   
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Table 4.12: Reasons for not Returning to Work at One and Six Months 
 
One month Six months 
N 
Percentage (%) 
(n=12) 
N 
Percentage (%) 
(n=5) 
Physical weakness 2 16.7 0 0 
Re-admission to hospital 1 8.3 0 0 
Family pressure 1 8.3 0 0 
Personal preference 2 16.7 0 0 
*Family pressure: The family of the participant recommended to the participant not to 
return to work.  
 
4.10 THE RELATIONSHIP BETWEEN FUNCTIONAL ABILITY AND SEVERITY OF 
ILLNESS AND LENGTH OF STAY 
 
To determine if a relationship existed between functional ability (PFIT-s) and severity 
of illness (APACHE II and SAPS II), ICU LOS, duration of MV, and hospital LOS, a 
univariate analysis of variance using general linear model was calculated.  No 
statistically significant relationships were shown to exist between the variables. The 
null hypothesis was not rejected as p> 0.05. The adjusted R squared value was 0.13 
(p=0.22). 
 
4.11 THE RELATIONSHIP BETWEEN EXERCISE ENDURANCE AND SEVERITY OF 
ILLNESS, LENGTH OF STAY, HRQOL, AND LEVEL OF DEPRESSION 
 
To determine if a relationship existed between exercise endurance (measured as 
6MWT distance) and severity of illness (APACHE II and SAPS II), ICU and hospital 
LOS, duration of MV, HRQOL (PCS and MCS and EQ-5D VAS), level of depression 
of survivors of critical illness, a linear regression analysis was calculated.  
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 Table 4.13:    The Relationship Between Exercise Endurance And Severity Of 
  Illness, Length Of Stay, HRQOL, And Level Of Depression 
 
6MWT at six months follow-up. 
Variables p-value  
 
r-value (95 %  CI) 
APACHE II 0.62 0.17 (-8.8 - 13.9) 
SAPS II 0.66 0.15 (-3.7- 5.6) 
ICU LOS 0.37 0.3 (-5.6- 13.8 
Hospital LOS 0.65 0.16 (-4.2- 6.4) 
Duration of MV 0.09 0.53 (-1.4- 15.9) 
SF-36 PCS score at six 
months follow-up 
0.09 0.54 (-0.98- 12.23) 
SF-36 MCS score at six 
months follow-up 
0.31 -0.34 (-15 – 5.3) 
EQ-5D VAS score at six 
months follow up 
0.37 0.3 (-4.2 – 10.1) 
PHQ-9 score at six months 
follow-up 
0.7 0.13 (-26.4- 37.7) 
  *indicates significance at level p=0.05. 
   
  A moderate strength, positive relationship (r= 0.53) was found between duration of 
 MV  and  6MWT distance at six months after discharge from hospital. A 
 moderate  strength, positive relationship (r= 0.54) was found between SF-36 
 PCS  score at  six months after discharge from hospital and 6MWT distance 
 at six months after  discharge from hospital. A weak strength, negative 
 relationship (r= -0.34)  was found between SF-36 MCS score at six months 
 after  discharge  from  hospital and 6MWT distance at six months after 
 discharge from  hospital. All these  relationships were not statistically 
 significant. 
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4.12 THE RELATIONSHIP BETWEEN HRQOL AND SEVERITY OF ILLNESS, LENGTH 
OF STAY, LEVEL OF DEPRESSION AND EXERCISE ENDURANCE 
 
A linear regression analysis was used to determine if a relationship existed between 
the abovementioned variables. These relationships are shown in table 4.14.  
  
Table 4.14:  The Relationship Between HRQOL (SF-36 PCS) And Severity Of Illness, 
 Length Of Stay, Level Of Depression And Exercise Endurance 
HRQOL (SF-36 PCS) at six months follow-up. 
Variables p-value  
 
r-value (95 %  CI) 
APACHE II 0.3 0.36 (-0.5 – 1.6) 
SAPS II 0.35 0.31(-0.24- 0.61) 
ICU LOS 0.89 -0.04 (-1.03- 0.92) 
Hospital LOS 0.23 -0.4 (-0.75- 0.2) 
Duration of MV 0.41 0.28 (-0.58- 1.3) 
PHQ-9 score at six months 
follow-up 
0.13 -0.49 (-4.7- 0.7) 
6MWT Distance at six 
months follow-up 
0.09 0.54 (-0.01-0.11) 
*indicates significance at level p=0.05. 
 
 A weak strength, positive relationship (r= 0.36) was found between SF-36 PCS at six months 
after hospital discharge and APACHE II scores. A weakstrength, positive relationship (r= 
0.31) was found between SF-36 PCS score at six months after discharge from hospital and 
SAPS II scores. A moderate strength, negative relationship(r=  -0.49) was found between 
SF-36 PCS score at six months after discharge from hospital and PHQ-9 scores at six 
months after discharge from hospital. A moderate strength, positive  relationship (r=  
0.54) was found between SF-36 PCS score at six months after discharge from hospital and 
6MWT distance at six months after discharge from hospital. All these relationships were not 
statistically significant. 
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Table 4.15:  The Relationship Between HRQOL (SF-36 MCS) And Severity Of Illness, 
 Length Of Stay, Level Of Depression And Exercise Endurance 
 
HRQOL (SF-36 MCS) at six months follow-up. 
Variables p-value  
 
r-value (95 %  CI) 
APACHE II 0.96 -0.02 (-0.8 - 0.8) 
SAPS II 0.94 -0.03(-0.34- 0.32) 
ICU LOS 0.07 -0.56 (-1.1- 0.6) 
Hospital LOS 0.07 -0.56 (-0.59- 0.03) 
Duration of MV 0.02* -0.69 (-1.2-  -0.14) 
PHQ-9 score at six months 
follow-up 
0.01* -0.72 (-3.73-  -0.6) 
6MWT Distance at six 
months follow-up 
0.31 -0.34 (-0.07- 0.03) 
*indicates significance at level p=0.05. 
 
 A strong negative relationship (r= -0.69) with statistical significance (p=0.02) was found 
between SF-36 MCS score at six months after discharge from hospital and duration of MV. A 
strong, negative relationship (r= -0.72) with statistical significance (p= 0.01) was found 
between SF-36 MCS score at six months after discharge from hospital and PHQ-9 scores at 
six months after discharge from hospital. 
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Table 4.16:  The Relationship Between HRQOL (EQ-5D VAS) And Severity Of Illness, 
 Length Of Stay, Level Of Depression And Exercise Endurance 
 
 
HRQOL (EQ-5D VAS) at six months follow-up. 
Variables p-value  
 
r-value (95 %  CI) 
APACHE II 0.44 0.26 (-0.73 - 1.53) 
SAPS II 0.11 0.5(-0.09- 0.73) 
ICU LOS 0.53 -0.22 (-1.3- 0.71) 
Hospital LOS 0.68 -0.14 (-0.64- 0.44) 
Duration of MV 0.93 -0.03 (-0.99- 1.08) 
PHQ-9 score at six months 
follow-up 
0.7 0.13 (-26.4- 37.7) 
6MWT Distance at six 
months follow-up 
0.78 -0.09 (-3.66 – 2.85) 
 *indicates significance at level p=0.05. 
 
  Only weak correlations were identified, without statistical significance.   
 
4.13 THE RELATIONSHIP BETWEEN LEVEL OF DEPRESSION AND RETURN TO 
EMPLOYMENT IN THE FIRST SIX MONTHS AFTER HOSPITAL DISCHARGE 
 
To calculate the relationship between participants’ level of depression as measured 
using the PHQ-9 questionnaire and return to work frequencies at one and six months 
follow-up, a univariate analysis of variance using general linear model was 
calculated. No statistically significant relationships were identified between PHQ-9 
scores and return to work frequencies, neither at one month follow-up nor at six 
months follow-up. The adjusted R squared value was -0.04 (p=0.49) at one month 
follow-up and 0.12 (p=0.25) at six months.  The null hypothesis was not rejected for 
these measurements as p> 0.05. 
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4.14 FACTORS INFLUENCING EXERCISE ENDURANCE AT SIX MONTHS AFTER 
HOSPITAL DISCHARGE 
 
To determine which factors had an influence on exercise endurance (6MWT 
distance) at six months after hospital discharge, Spearman’s rho was calculated to 
measure the degree of association between variables (APACHE II, SAPS II, duration 
of MV, ICU LOS, and hospital LOS).  No statistically significant associations were 
identified. 
 
To determine the relationship between factors that might influence exercise 
endurance (6MWT distance) at six months after hospital discharge, linear regression 
analyses were conducted. The results are presented in table 4.13. 
 
4.15 FACTORS THAT INFLUENCE HRQOL AT SIX MONTHS AFTER HOSPITAL 
DISCHARGE 
 
To determine which factors had an influence on HRQOL (PCS, MCS and EQ-5D 
VAS) at six months after hospital discharge, Spearman’s rho was calculated. A 
strong negative association was found between SF-36 PCS scores at six months 
follow-up and length of hospital stay (r=-0.69; p=0.02). A strong negative association 
was found between SF-36 MCS scores at six months follow-up and the duration of 
MV (r=-0.69; p=0.02). A moderate positive association was found between SF-36 
MCS scores and PFIT interval scores at ICU discharge (r=0.59; p=0.06). 
 
To determine the relationship between factors that might influence HRQOL (PCS, 
MCS and EQ-5D VAS) at six months after hospital discharge, linear regression 
analyses were calculated. The results are presented in tables 4.14 to 4.16. 
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CHAPTER 5  
 
5. DISCUSSION 
To the best of the researcher’s knowledge, this is one of the few studies in South 
Africa investigating the functional ability and HRQOL of survivors of critical illness. 
The study results showed various statistically significant changes in and relationships 
between variables.  
 
5.1 Physical Function in ICU 
 
5.1.1 Changes in PFIT Scores  
 
A statistically significant change in mean PFIT-s interval scores was found for 
participants in this study when assessed at ICU discharge and hospital discharge. 
There were changes in the medians of all the domains of PFIT-s in the current 
study’s participants. The median interval score increased from 6.8 and 7.1. The 
median MOS component however reduced from 38.5 to 27.6 steps per minute. The 
median shoulder flexion endurance component also reduced from 45.2 to 25.3 
repetitions per minute. This shows that the participants actually had reduced 
functional ability between discharge from ICU and discharge home. This could 
indicate that not all the rehabilitation needs of these participants were met before 
they were discharged home. There is also the possibility that the participants were 
not feeling well on the day of assessment with resulting lower scores with the PFIT-s. 
Denehy et al. (2013) reported that the minimum change that needs to occur in the 
PFIT interval score to reflect a clinically meaningful change, the minimal clinically 
important difference (MCID), is 1.5 points in a mixed ICU population. The change in 
mean PFIT scores observed in the mixed ICU population in the current study was 0.4 
points and the change in the median score was 0.3 points; therefore much less than 
the MCID, indicating that the change in PFIT-s scores observed for participants 
between ICU discharge and hospital discharge was not clinically significant even 
though it was statistically significant. All participants received daily physiotherapy 
treatment (consisting generally of chest physiotherapy treatment, exercise and 
rehabilitation) while they were in the hospital ward and if this was continued for a 
longer period of time (as opposed to them receiving physiotherapy for median time of 
4.5 days between ICU discharge and home discharge), a larger increase in PFIT-s 
scores may have been observed. As the participants in this study had relatively high 
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severity of illness levels on admission to ICU, this may have resulted in these 
patients requiring a longer period of recovery from critical illness in order to have 
MCID in PFIT-s scores. This may result from severe physical weakness after a 
prolonged period of critical illness. The current study however, found that there was 
not a statistically significant relationship between severity of illness and PFIT-s 
scores. Another explanation could be thatas patients recover from critical illness, they 
become more motivated to be discharged home and they may be discharged prior to 
reaching a MCID in their PFIT-s score. 
 
5.1.2 Relationships between PFIT results and other variables 
 
No statistically significant relationships were shown to exist between PFIT-s results 
and severity of illness (APACHE II and SAPS II), ICU LOS, duration of MV, and 
hospital LOS. In contrast, Denehy et al. (2013) reported that their participants with 
low PFIT-s scores were more likely to have a longer hospital LOS versus those with 
high PFIT-s scores. All participants in the current study received physiotherapy 
treatment for the duration of their hospital stay. The less than clinically significant 
improvement in PFIT-s interval scores could therefore suggest that not all the 
rehabilitation needs of these participants, who were recovering from critical illness, 
were met before their discharge from hospital. The PFIT-s is not regularly used in 
clinical practice as an outcome measurement by physiotherapists in Gauteng 
province to assess patients’ responses to rehabilitation while in hospital. Raising 
awareness among physiotherapists about this tool and exploring its usefulness as an 
outcome measure in the South African critical care setting, should be the focus of 
future clinical trials.   
 
5.2 Physical Function after Hospital Discharge 
 
5.2.1 Changes in 6MWT results 
 
The participants in this study showed some improvement in exercise endurance as 
the distance that they walked on the 6MWT improved from one to six months after 
discharge; however this change in distance walked was not statistically significant. 
The mean distance achieved improved from 421.5 (±134.5) to 474.5 (±110) meters 
between one and six months after discharge from hospital. The median distance also 
improved from 425 to 490 meters between one and six months follow-up. The mean 
and median percentage of predicted distance achieved thus also improved from 
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60.45 to 68.8 and from 61.5 to 73.3 percent respectively.  The MCID reported for 
6MWT distance is 54 meters in patients with COPD (Rasekaba, et al., 2009). 
Only one participant in the current study was admitted to ICU due to exacerbation of 
COPD; the majority of participants underwent surgery. There is no MCID data 
available for 6MWT distance in the surgical or critical care populations. Aitken et al. 
(2012) reported increases in mean 6MWT distances in survivors of critical illness at 
one week (15 metres), eight weeks (13 metres), and at 26 weeks (9 metres) after 
hospital discharge. The current study showed much larger increases in mean 6MWT 
distances, although the follow-up time points were different than that of Aitken et al. 
(2012). Other researchers reported on the increase in median 6MWT distance in 
survivors of critical illness. Van Aswegen et al. (2010) reported an improved median 
6MWT distance of 47 metres in their short-term MV group and 39.5 metres in their 
long-term MV group from three months to six months after hospital discharge. This 
differs from the current study’s results as these changes took place over a three 
month period and the changes observed in our participants took place over a five 
month period (from one to six months after discharge from hospital). Herridge et al. 
(2003) reported an increase of 115 metres in median 6MWT distance at six months 
after discharge. This is a much larger increase in 6MWT distance as reported in our 
participants.The increase in 6MWT distance observed in the current study may 
possibly be a result of patients staying at home by themselves and therefore they 
needed to perform tasks at home independently; thus they experienced an increase 
in their exercise tolerance. Some participants also returned to work and this may 
have contributed to the improvement seen in their exercise tolerance.   
 
Study participants achieved between 60.5 percent and 68.8 percent of their mean 
percentage of age predicted 6MWT distance at one month and six months 
respectively.  Herridge et al. (2011) reported that only 39 percent of their participants 
achieved 80 percent of age predicted 6MWT distance at one year following ARDS. 
Herridge et al. (2011) also reported a strong relationship between 6MWT distances 
achieved and the PF score of the SF-36 questionnaire.  
 
5.2.2 Relationships between 6MWT results and other variables 
 
  No statistically significant relationships were shown to exist between 6MWT distance 
 at six months follow-up and APACHE II or SAPS II scores, ICU or hospital LOS, EQ-
 5D VAS or level of depression in the current study. A moderate strength, negative 
 correlation (r= -0.34) was found between SF-36 MCS score and 6MWT distance at 
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 six months after discharge from hospital. This was however statistically insignificant
 (p=0.31). No other studies reported similar findings.  
 
  A moderate strength, positive correlation (r= 0.54) was found between SF-36 PCS 
 score and 6MWT distance at six months after discharge from hospital, but this was 
 also not statistically significant (p=0.09). The limited distances that participants in this 
 study were able to achieve during the 6MWT therefore suggests that their endurance 
 is impaired which may impact their ability to perform activities of daily living. The 
 small increase in 6MWT distance observed in the current study could be due to the 
 fact that almost half (45.5%) of the participants did not return to work at six months 
 after discharge from hospital and thus did less physical work-related activities with 
 less subsequent improvement in exercise tolerance.  Exercise training is associated 
 with numerous physical and mental health benefits (Dahn and Penedo, 2005) and 
 seems to be indicated for this mixed ICU population to enhance their recovery from 
 critical illness (Denehy and Berney, 2006; Morris, 2007; Schweickert, et al., 2009).     
 
  A moderate strength, positive correlation (r= 0.53) was found between duration of MV 
 and 6MWT distance at six months after discharge from hospital, but this was not 
 statistically significant (p=0.09). This has not been reported by other researchers. 
 
5.3 Peripheral Muscle Strength 
 
Statistically significant changes in mean peripheral muscle strength were observed in 
the upper and lower limbs of participants over the six months following discharge 
from hospital. Large improvements in median peripheral muscle strength was 
observed for the right-sided elbow flexors (22.7 Newton), left-sided elbow extensors 
(16 Newton), left-sided hip abductors (53.5 Newton), left-sided ankle dorsiflexors (32 
Newton), right-sided knee extensors (33 Newton), and left-sided knee flexors (46.5 
Newton).   
According to Lang et al. (2008) who studied the use of the HHD in acute stroke 
survivors who were critically ill, the MCID for HHD measurements in patients 
following stroke is 50 Newton for the affected dominant side of the body and 62 
Newton for the non-dominant side. All participants in the current study reported to 
have right-handed dominance. Baldwin et al. (2013) reported from their investigation 
of HHD in alert critically ill patients, the minimally detectable differences in 
measurements. These were 71 Newton on the left side of the body and 57 Newton 
on the right.  No MCID data could be found in the literature for HHD measurements in 
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the critical care population. The increase in peripheral muscle strength observed in 
the current study is much less than that reported by Baldwin et al. (2013) and 
therefore not of clinical significance. The median age of the participants in their study 
was 78 years, thus much older than the median age of the current study’s 
participants (51.5 years). Fifty-nine percent of their participants were male whereas 
the current study had a 79.2 percent male representation.  The difference in the 
results could be attributed to the difference in admission diagnoses between the 
current study and Baldwin et al. (2013).  Although Baldwin et al. (2013) also had a 
mixed ICU patient sample in their study, the current study had more patients with 
trauma (n=7) and cardiac conditions (n=7) as compared to the four cardiac 
admissions and the one trauma admission of Baldwin et al. (2013).  No other studies 
reported on the change in peripheral muscle strength at six months after hospital 
discharge following critical illness, but rather on the relationships between peripheral 
muscle strength and factors like ICU and hospital LOS and severity of illness.  
 
Van Aswegen et al. (2010) reported on ICU LOS of participants mechanically 
ventilated for longer periods of time and right deltoid, right triceps, and right 
hamstrings muscle strength at one month after discharge and left triceps muscle 
strength at six months. In the same study, hospital LOS of participants mechanically 
ventilated for longer periods of time was significantly correlated with left deltoid, right 
triceps, left hamstrings, and right hamstrings muscle strength at one month follow-up 
and left deltoid, left triceps, right triceps and right hamstrings muscle strength at three 
months after discharge (Van Aswegen, et al., 2010). Van Aswegen et al. (2010) did 
not find a significant relationship between peripheral muscle strength and ICU LOS in 
their participants receiving short-term MV (Van Aswegen, et al., 2010). They reported 
no statistically significant relationships between peripheral muscle strength and 
APACHE II scores (Van Aswegen, et al., 2010).  
 
From these results it seems that there may be an association between longer 
duration of MV, severity of illness, and peripheral muscle strength at three and six 
months follow-up. The results from the current study cannot accurately be compared 
with these findings as the study did not aim to identify relationships between ICU 
LOS, severity of illness and peripheral muscle strength.         
 
The fact that majority of participants in this study lived alone may account for the 
improvements in muscle strength observed as they would be dependent on 
themselves for performing daily activities. 
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5.4 Health Related Quality of Life 
 
5.4.1 Changes in HRQOL (SF-36) Scores 
 
Significant changes in mean RP, BP, GH, VT and SF domain scores of the SF-36 as 
well as PCS scores were observed for participants at six months following discharge; 
however MCS scores did not change significantly. Mean MCS scores were slightly 
higher than mean PCS scores at six months. Schneiderman et al. (2013) reported 
higher mean PCS scores compared to mean MCS scores at six months after 
discharge for survivors of trauma. When comparing the current study’s results, the 
opposite was found. Even though their subjects had a slightly longer ICU LOS than 
that reported for the current study, their mean severity of illness scores (APACHE II) 
were significantly lower (12.7 ±10.3) than the APACHE II scores observed in the 
current study. This may explain why the mean PCS scores for Schneiderman et al.’s 
(2013) participants were higher at six months (62.1 ±27.8) compared to the current 
study participants’ scores as they were less severely ill. Participants in the current 
study had several co-morbidities which may also have contributed to the lower 
observed mean PCS scores at six months. Van Aswegen et al. (2011) reported lower 
mean PCS scores than MCS scores at six months after discharge for the survivors of 
penetrating trauma that underwent prolonged MV in their study. Findings from the 
current study are similar to these. Participants in the current study had a prolonged 
duration of MV and ICU stay and are thus comparable to the long-MV group in Van 
Aswegen et al.’s (2011) study.  
 
A large increase from one to six months follow-up was observed in SF-36 PCS 
scores (more than five points), but not for MCS scores (less than five points). This 
relates to improvements in the physical domain of HRQOL over the first six months 
after discharge from hospital following critical illness. In contrast to this, Dowdy et al. 
(2010) concluded that survivors of critical illness did not experience statistically 
significant improvements in HRQOL at six months after discharge. They added that 
small improvement in HRQOL is seen up to 36 months after discharge (Dowdy, et al., 
2010). The statistically significant improvement in HRQOL related to PCS in the 
current study may be due to the fact that most participants lived alone and were self-
dependent for daily activities even though they had some form of support from family 
and friends. Some of them had also returned to work by six months following 
discharge. 
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5.4.2 Relationships between HRQOL (SF-36) and other variables 
  
A positive relationship was found between the PCS of the SF-36 questionnaire at six 
months follow-up and severity of illness (measured with APACHE II and SAPS II) on 
ICU admission. No other studies except for Orwelius et al. (2010) reported such 
findings. Orwelius et al. (2010) found no association between HRQOL up to 36 
months after discharge and severity of illness (measured with APACHE II). A positive 
relationship was also found between SF-36 PCS scores at six months follow-up and 
6MWT distance achieved at six months after discharge from hospital. Participants in 
this study had impaired exercise endurance at six months following discharge as they 
were only able to achieve 68.8% of their predicted distance walked on the 6MWT.  
 
They also had a prolonged duration of MV and hospital LOS. It is a well-known fact 
that the inflammatory processes associated with critical illness lead to muscle protein 
breakdown and muscle weakness (Batt and Dos Santos, 2012; Apostolakis, et al., 
2014). These effects are compounded by prolonged immobility in ICU (Dittmer and 
Teasell, 1993a; Dittmer and Teasell, 1993b). Muscle weakness and impaired 
exercise endurance will impact negatively on HRQOL. These factors may explain the 
association found between PCS, severity of illness and 6MWT distance achieved at 
the six months assessment. These relationships must however be interpreted with 
caution as they were not statistically significant. 
 
Furthermore, the current study found no relationship between the PCS of the SF-36 
questionnaire at six months follow-up and length of MV. There was however a 
moderate strength negative correlation (r= -0.69) of statistical significance (p= 0.02) 
between SF-36 MCS scores at six months after discharge from hospital and length of 
MV. This suggests that participants with longer length of MV had poorer mental 
health scores at six months after discharge from hospital. Van Aswegen et al. (2010) 
found different results with regards to the relationship between SF-36 scores and 
duration of MV. At six months after penetrating trunk trauma, they found a statistically 
significant difference between short-term MV and long-term MV groups in SF-36 PF, 
BP, GH, and PCS scores, but not in MCS scores. They also found an improvement in 
the exercise capacity, muscle strength and QOL at six months after discharge in 
patients treated with long-term MV, but they were still weaker than those treated with 
short-term MV. They concluded that the short-term MV group (also with shorter ICU 
LOS) showed faster improvement in exercise capacity compared to the long-term 
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ventilated group (Van Aswegen, et al., 2010). Ivaskevivius et al. (2011) reported a 
reduction in SF-36 PF and RP domain scores at six months after discharge in the 
survivors of critical illness. Kapfhammer et al. (2004), Hopkins et al. (2005) and 
Oeyen et al. (2012) also reported that patients with prolonged duration of MV showed 
more reductions in HRQOL after discharge from hospital.  
 
A strong statistically significant negative relationship (r= -0.72; p= 0.01) was identified 
between SF-36 MCS scores and PHQ-9 scores at six months after discharge from 
hospital. This suggests that participants with lower levels of depression as measured 
using the PHQ-9, scored higher on the SF-36 MCS, indicating better mental HRQOL. 
 
From the results of the current study it seems that longer hospital stay may have an 
influence on a patient’s HRQOL at six months after discharge from hospital as 
indicated by the relationship (however statistically insignificant; p= 0.07) identified 
between hospital LOS and SF-36 MCS scores at six months after hospital discharge 
(r=-0.56). A possible explanation for this is that patients who stay longer in hospital 
may become more physically weak and de-motivated and this may influence their 
HRQOL after discharge from hospital.  
Results from other researchers suggest that duration of MV may have an influence 
on exercise capacity and muscle strength at six months after discharge. These 
relationships were not observed in the current study. Possible explanations for the 
results obtained could be the small sample size of the current study, possible 
differences in baseline characteristics and ICU admission diagnoses of participants in 
this study, the inclusion of cardiac surgery patients with a short length of MV, as well 
as differences in eligibility criteria.  
 
5.4.3 Changes in HRQOL (EQ-5D) Scores 
 
Significant improvement in EQ-5D VAS scores (14.6 points ± 9.7) were observed for 
participants in the current study between one and six months after discharge. A 
higher score on the VAS indicates a better health state. Pickard et al. (2007) reported 
that the MCID in EQ-5D VAS scores was seven points. This study involved 
participants with cancer. No other data relating to the MCID for the EQ-5D VAS in 
other patient populations could be found.  A clinically significant improvement was 
thus observed in the EQ-5D VAS scores for participants in this study over six months 
after discharge from hospital. The current study found a reduction in problems 
experienced with mobility from 40 percent at one month follow-up to 9.1 percent at 
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six months. Reductions were also found in problems with self-care (from 26.7 to 9.1 
percent) and usual activities (60 to 18.2 percent) from one to six months after 
discharge from hospital. This suggests that participants’ abilities to mobilise, care for 
themselves and participate in usual activities improved over time as they continued to 
recover from critical illness. Badia et al. (2001) reported a significant increase in 
mobility from baseline to 12 months after ICU discharge in survivors of critical illness. 
They did however find significant increases in reported problems with self-care and 
usual activities. They reported no statistically significant changes in pain or 
discomfort, anxiety or depression or in the EQ-5D VAS over the first 12 months after 
discharge from ICU (Badia, et al., 2001). The current study found a large reduction in 
reported problems with pain/discomfort from 80 percent at one month to 18.2 percent 
at six months after discharge. The majority of participants underwent surgery and 
may have experienced less pain over time as wound healing took place which could 
account for the large reduction in level of pain and discomfort experienced at six 
months. Participants reported little improvement in problems experienced in the 
anxiety/depression domain of the EQ-5D which showed a reduction from 33.3 
percent at one month to 27.3 percent at six months after discharge. A possible 
explanation for this finding is that participants may experience more 
anxiety/depression as a result of physical weakness, the inability to perform the 
activities they did before the period of critical illness, and the inability to return to work 
with resultant financial strain on the participant and his or her family. 
 
5.4.4 Relationships between HRQOL (EQ-5D) and other variables 
 
Significant relationships were reported by Granja et al. (2002) and Garcia et al. 
(2003) between APACHE II scores and EQ-5D VAS and EQ-5D usual activities at six 
and 18 months after discharge from hospital respectively. The current study did not 
identify statistically significant relationships between EQ-5D VAS scores and 
APACHE II or SAPS II scores at one or six months follow-up.A possible explanation 
for these results from the current study is that the participants continued with their 
normal physiotherapy treatment during their hospital stay and possibly after 
discharge from hospital. This could subsequently impact the degree that the 
participants have improved after discharge from hospital resulting in a lack of 
relationship between HRQOL and APACHE II and SAPS II scores. A participant who 
received more physiotherapy treatment after hospital discharge may have improved 
more in terms of HRQOL as would a participant not receiving the same intervention. 
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The current study however did not include data on the therapeutic interventions a 
participant received after discharge from hospital.    
 
The current study also did not identify statistically significant relationships between 
EQ-5D VAS scores at six months follow-up and ICU and hospital LOS, duration of 
MV, level of depression at six months follow-up, and 6MWT distance at six months 
follow-up.  
 
5.5 Level of depression 
 
A significant association was found in the current study between mean MCS scores 
of the SF-36 questionnaire and level of depression (measured with PHQ-9) at one 
and six months after discharge.  A clinically significant change in PHQ-9 scores 
would involve a reduction in PHQ-9 score of five points or more (Smarr and Keefer, 
2011). As the current study observed an increase in PHQ-9 scores over six months 
after hospital discharge, the participants seemingly suffered from more symptoms of 
depression. Although there was a reduction in the mean and median PHQ-9 scores 
of 1.5 and 2 points respectively, there was a reduction in the number of participants 
presenting with depressive disorders; however the drop-out rate for the study was 
high and therefore it is not known whether those who didn’t come back for follow up 
suffered with depressive disorders. The increase in mean PHQ-9 scores corresponds 
with the small reduction in problems experienced with depression/anxiety as 
measured using the EQ-5D questionnaire. A possible explanation for this finding is 
that patients may realise that they may not achieve the same level of function as they 
had before ICU admission. This together with a prolonged recovery period from 
critical illness may make these patients more prone to developing symptoms of 
depression (Rattray, 2013). Patients with a longer ICU and hospital stay and those 
with a higher severity of disease on admission may also be more prone to developing 
symptoms of depression (Rattray, 2013). Many participants in this study reported co-
morbidities which may have a chronic influence on HRQOL related to mental health. 
 
5.6 Return to Work 
 
The presence of depressive disorders did not directly influence return to work for 
participants in this study. The median time to return to work at one month after 
discharge from hospital was 37 days and 43 days at six months after discharge from 
hospital. No data relating to the MCID for the RPAQ could be found by the author. In 
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South Africa, Van Aswegen et al. (2010) reported no statistically significant difference 
in return to work rate between their short-term MV and long-term MV groups over the 
first six months after hospital discharge. In the United Kingdom, Griffiths et al. (2013) 
found that patients had difficulties with employment after a period of critical illness; 
mainly due to physical disabilities experienced.  In the current study the main reason 
reported by participants for not returning to work was pensioner status. Only 16.7 
percent of participants had not returned to work by one month follow-up as a result of 
physical weakness. This could be explained by the demographics of the participants. 
The mean age of the participants was 51 (± 13.82) years with the maximum age 
being 76 years. The mean age of participants therefore approached early retirement 
age in South Africa (55 years). Griffiths et al. (2013) reported that employment was 
affected by critical illness at six months after discharge from hospital and that it was 
still affected at 12 months post discharge. Similar results were reported by Myhren et 
al. (2010) where only 50 percent of their study participants returned to work or school 
at 12 months after discharge from hospital (Myhren, et al., 2010). Physical, 
psychological and social problems may affect a patient’s behavior of returning to 
work and consequently have an influence on readiness to return to work (Franche 
and Krause, 2002). The relatively good return to work rate observed in the current 
study may be attributed to the significant increases in muscle strength and PCS 
observed as well as the reduction in problems reported in relation to mobility, self-
care, pain or discomfort and participation in usual activities over the first six months 
following discharge.  
 
5.7 Factors influencing exercise endurance and HRQOL after hospital discharge 
 
The current study found that severity of illness, ICU LOS, and hospital LOS did not 
have an influence on exercise endurance (6MWT distance) at six months after 
hospital discharge. Length of MV, and SF-36 MCS and PCS scores  had no 
statistically significant influences on exercise endurance at six months after hospital 
discharge from hospital. Van Aswegen et al. (2010) reported that morbidity 
(measured using the Sequential Organ Failure Assessment) in ICU was significantly 
correlated with distance walked on the 6MWT at three and six months after discharge 
for those subjects who underwent prolonged MV. As morbidity was not assessed in 
the current study it is not known whether this might have contributed to participants’ 
performance on the 6MWT. The relationships between exercise endurance at six 
months after discharge from hospital and severity of illness, hospital and ICU LOS, 
length of MV, HRQOL and level of depression were discussed under section 5.2.2. 
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The current study found that SAPS II score on admission to ICU had an influence on 
EQ-5D VAS scores at six months after discharge from hospital (r=0.5), however this 
was not statistically significant (p=0.11). Length of MV was found to have an 
influence on the MCS of the SF-36 questionnaire at six months after hospital 
discharge as previously discussed. 
 
The negative association found between duration of MV and SF-36 MCS scores at 
six months confirms that participants’ QOL related to mental function was lower when 
MV duration was prolonged.   
 
Many participants in this study presented with pre-existing disease prior to critical 
illness (n=12; 50%). The reductions in HRQOL observed may partly be due to the 
influence of these pre-existing conditions. The relationship between the study 
variables and pre-existing diseases and the influence of these pre-existing diseases, 
however, was beyond the scope of this study. The existence of pre-existing diseases 
may have been a potential confounding variable in this study and therefore may have 
influenced the outcomes.    
 
 
5.8 LIMITATIONS OF CURRENT STUDY 
 Small sample size. The study failed to meet the projected sample size. As many 
patients were discharged to rehabilitation or step-down centres from the ICU and 
did not spend time in the hospital wards prior to discharge home, these patients 
could not be enrolled in the study. The researcher had to allow time for 
participants to decide whether they wished to participate in the study and many 
patients went home during this time before a decision was made. Some 
participants were confused and could not be included in the study as they could 
not provide written, informed consent. The researcher was unable to include 
many possible participants due to various reasons out of his control. After 
realising the challenge of attaining the required number of participants, the 
number of recruitment sites could not be increased due to funding limitations. The 
small sample size limits the degree to which the results can be extrapolated to a 
larger ICU population. The results obtained from this study were often different to 
the available literature base and could partly be a consequence of the small 
sample size. The objectives of the study which relate to the relationships between 
different variables may therefore not been accurately achieved due to the small 
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number of participants which limits the accuracy of the results. The results 
obtained should therefore be interpreted with caution. 
 
 A significant limitation to the study is that a large number (n=49) of potential 
participants were not included due to the inability to obtain consent prior to 
hospital discharge. Participants who were discharged directly from the ICU to 
rehabilitation facilities or discharged to these facilities from the hospital ward prior 
to the researcher obtaining consent for participation in the study were not 
followed up for inclusion in the study. This can be seen as a limitation as 
recruitment of these participants would have assisted in increasing the sample 
size. Only one participant who had his baseline PFIT-s assessment at Netcare 
Union Hospital was seen for his PFIT-s follow-up assessment at Netcare 
Rehabilitation hospital after he was discharged from Netcare Union hospital. He 
was already enrolled in the study before he was discharged from Netcare Union 
Hospital. There were however no participants who consented to participation in 
the study that were not followed-up as a result of their transfer to a rehabilitation 
facility.   
 
 High drop-out rate of 37.5 percent at one month follow-up and 54.2 percent at six 
months. Van Aswegen et al. (2010) reported high drop-out rates for participants 
in their observational study. Methods employed by the researcher to limit drop-
out rate included collection of participants’ contact details at the time of study 
enrolment which included telephone numbers, mobile phone numbers, email 
addresses and physical addresses. A possibility exists that those participants 
who could not be tracked down after discharge changed their contact details. A 
limitation is that the researcher did not visit a participant’s place of living in the 
case where he could not reach the participant by phone or email. The researcher 
did however attempt numerous times to contact all participants who did not arrive 
for follow-up appointments to re-schedule their appointments.        
 
 Assessment of pre-morbid HRQOL at the time of discharge from ICU by 
participant recall could have provided insight into the change in a participant’s 
HRQOL prior to critical illness and to six months after discharge from hospital. 
 
 Assessment for and diagnosis of ICU-AW was not within the scope of this study. 
This information could however have been valuable in the interpretation of study 
findings. 
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 Use of the RPAQ tool was a limitation to this study as it was not possible to 
obtain a total score for the items in the questionnaire which made interpretation 
and comparison of data problematic.  
 
 Recording of therapeutic interventions received by participants after discharge 
from hospital was not included in the current study. This information could 
however have been valuable in the interpretation of study findings. 
 
 
 Only articleswritten in the English language were included in the literature review 
for this study and not articles writtenin other South African languages. 
 
 The inclusion of elective cardiac surgery patients in the study may not have been 
appropriate as these patients do not neccesarily suffer from critically ill or have 
prolonged length of ICU stay, even if mechanically ventilated after surgery for up 
to 48 hours. 
 
 Overly strict eligibility criteria added to the failure of the study to reach the desired 
sample size.  
 
5.9 RECOMMENDATIONS FOR FUTURE RESEARCH 
 Future studies must have strict controls in place to ensure retention of recruited 
participants. Home follow-up of participants and collection of family members’ 
contact details would assist in follow-up of participants and possibly a lower drop-
out rate. Other strategies to improve participant recruitment could be the 
following: 
 Maintaining weekly or biweekly telephonic contact with participants between 
follow-up assessments.  
 Having a larger number of research assistants to assist in the recruitment 
process and follow-up of participants.  
 Having more study sites initially or increasing these if it is noted that 
participant recruitment numbers are low. 
 Particular attention needs to be paid to study recruitment processes and early 
detection of pitfalls to participant recruitment.  
 Very detailed study planning, particularly dealing with procedures to follow in 
order to track patients for follow-up may also assist to maintain recruited 
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participants in future studies. Therefore more rigorous processes to ensure 
follow-up of discharged participants are recommended.  
 
 Future studies may include the assessment and diagnosis of ICU-AW in order to 
further investigate the differences in HRQOL of survivors of critical illness who 
had ICU-AW and those who did not have ICU-AW. 
 
 Researchers intending to use the RPAQ questionnaire may consider using 
additional questionnaires focusing on physical activities which will provide the 
researcher with continuous data and a total questionnaire score for ease of data 
analysis and presentation of results. 
 
 Future studies would benefit from recording the frequency, duration and type of 
therapeutic interventions a participant receives after discharge from hospital in 
order to assist interpretation of data. 
 
 
 Future studies with larger sample sizes should further investigate the influence of 
variables like pre-morbid conditions and physiotherapy treatment on exercise 
tolerance and HRQOL in survivors of critical illness after discharge from hospital. 
 
 Future studies should also investigate the outcomes of survivors of critical illness 
who had different recovery pathways after discharge from hospital eg. 
rehabilitation centres, step-down facilities, home recovery, or home recovery with 
outpatient-based therapeutic interventions to see if there are any differences in 
HRQOL and functional ability of such participants.   
 
5.10  CLINICAL RECOMMENDATIONS 
 
 Raising awareness among physiotherapists regarding the PFIT-s tool and 
exploring its usefulness as an outcome measure in the South African critical care 
setting, where staff shortages and large patient numbers are real problems faced 
by clinicians, should be the focus of future clinical trials.  
 Patients who suffered critical illness should be followed up by physiotherapists 
after discharge from hospital to assess the amount of change in their physical 
function and HRQOL. Based on these findings, individualized rehabilitation 
programmes should be developed for such patients and its effectiveness tested 
regarding improvement in outcome measures in future trials. 
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 Patients who suffered critical illness and experienced prolonged duration of MV 
and demonstrate a significant reduction in mental aspects of HRQOL and signs 
of depression should be referred for counseling.  
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CHAPTER 6 
 
6. CONCLUSION 
 
The findings from this observational, longitudinal study is based on data from a small 
patient sample (n=24 to n=11). The researcher recommends that the results from this 
study be interpreted with caution. 
 
The results from the current study rejects the null hypothesis stating that participants 
who were admitted to ICU due to critical illness do not suffer from limitations in 
physical activity or HRQOL at six months after hospital discharge. The null 
hypothesis that stated that participants who survived critical illness returned to 
employment in the first six months after hospital discharge is accepted as more than 
half of remaining participants had returned to employment at the six months 
assessment. Survivors of critical illness in this mixed ICU population showed 
reductions in physical abilities at ICU discharge and these did not change 
significantly at the time of hospital discharge. They also showed reductions in 
exercise endurance as improvements in mean distance walked on the 6MWT over 
six months after discharge from hospital were not statistically or clinically significant. 
There was however a clinically significant increase in the median 6MWT distance 
achieved (65 meters) between one and six months after discharge from hospital. At 
six months they were only able to achieve 68 percent of their age predicted 
percentage of 6MWT distance. Clinically and statistically significant changes were 
observed in participants’ peripheral muscle strength over the first six months after 
discharge. Survivors of critical illness had more limitations in HRQOL related to 
aspects of physical health than aspects of MH at six months after discharge but 
statistically and clinically significant improvements in mean SF-36 PCS scores were 
observed during this six month period. Participants showed a statistically and 
clinically significant improvement in mean EQ-5D VAS scores over the first six 
months after discharge form hospital but still experienced problems related to anxiety 
and depression.  
 
Factors identified from the results that influence HRQOL related to mental health 
after discharge from hospital are duration of MV and level of depression at six 
months after discharge from hospital. 
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Findings from this study suggest that some survivors of critical illness may not 
recover fully on their own after an episode of acute illness. These results, together 
with results published by other South African researchers, should be used to 
motivate for implementation of structured rehabilitation programmes, including 
counselling, to aid the physical, emotional and mental recovery of survivors of critical 
illness in the long term after hospital discharge. 
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APPENDIX I 
 INTER-RATER RELIABILITY FOR THE PHYSICAL FUNCTION IN ICU TEST (PFIT) 
 Inter-rater Reliability for The Physical Function in ICU Test (PFIT) 
Participant 1 2 3 4 5 6 7 8 
Assessor A B A B A B A B A B A B A B A B 
Outcome  
Sit to 
stand 
ability 
3 3 3 3 3 3 2 2 3 3 3 3 3 3 3 3 
MOS steps 65 65 73 74 10 10 33 34 25 25 3 3 68 68 54 52 
MOS time 64 64 79 79 30 30 54 54 40 40 10 10 82 82 116 116 
Cadence 60.93 60.93 55.44 56.2 20 20 36.67 37.78 37.5 37.5 18 18 49.76 49.76 27.93 26.89 
Shoulder 
flexion 
strength 
right 
5 5 5 5 5 5 4 4 5 5 5 5 5 5 5 5 
Shoulder 
flexion 
strength 
left 
5 5 5 5 5 5 4 4 5 5 5 5 5 5 5 5 
Knee 
extension 
strength 
right 
5 5 5 5 4 4 5 5 5 5 5 5 5 5 5 5 
Knee 
extension 
left 
5 5 5 5 4 4 5 5 5 5 5 5 5 5 5 5 
Shoulder 
flexion 
reps 
33 33 34 35 7 7 30 30 12 12 11 11 27 27 35 35 
Shoulder 
flexion 
time 
60 60 59 59 24 24 50 50 19 19 22 22 48 48 130 130 
Shoulder 
cadence 
33 33 34.57 35.59 17.5 17.5 36 36 37.89 37.89 30 30 33.75 33.75 16.15 16.15 
PFIT 
Ordinal 
Score 
11 11 11 11 9 9 8 8 10 10 10 10 10 10 10 10 
PFIT 
Interval 
Score 
8.8 8.8 8.8 8.8 7.1 7.1 6.4 6.4 7.9 7.9 7.9 7.9 7.9 7.9 7.9 7.9 
Pearson 
Coefficient 
r=1; p=0.00 
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APPENDIX J 
 INTER AND INTRA RATER RELIABILITY TESTING FOR THE SIX MINUTE WALK 
TEST (6MWT) 
Inter and Intra Rater Reliability Testing For the six minute walk test 
(6MWT) 
 6MWT Result (meter) 
Assessor Participant 
testing 
session 
1 2 3 4 5 
A 1 635 450 380 380 580 
A 2 644 470 400 370 585 
A 3 640 460 410 370 590 
 
 Pearson Coefficient 
Assessor A  
Session 1 with 2 r=0.99; p=0.00 
Session 2 with 3 r=0.99; p=0.00 
Session 1 with 3 r=0.99; p=0.00 
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APPENDIX K 
 HANDHELD DYNAMOMETRY INTER RATER AND INTRA RATER RELIABILITY 
TESTING 
Handheld Dynamometry Inter Rater and Intra Rater Reliability Testing 
HHD Reading – Elbow Extension (kilogram) 
Assessor Testing session 1 Right 2 Right 3 Right 4 Right 5 Right 1 Left 2 Left 3 Left 4 Left 5 Left 
A 
1 99 94 148.1 71.6 93 100 71.7 161 76.5 158 
1 92 91 151.7 76.9 92 98 70.2 163.7 72.5 152 
1 91 91 152.1 74.5 94 105 69.8 161.9 67.6 156 
Mean 94 92 150.6 74.3 93 101 70.6 162.2 72.2 155.3 
2 92 90 148.1 73 93 96 73 161.7 74.5 154 
2 91 88 149.1 74.4 91 100 72 162.8 72 155 
2 94 87 150.1 73.6 95 104 70 163.7 70.2 156 
Mean 92.3 88.3 149.1 73.7 93 100 71.7 162.7 72.2 155 
Pearson Coefficient  r=0.99; p=0.00 r=0.99; p=0.00 
 
 
  
Handheld Dynamometry Inter Rater and Intra Rater Reliability Testing 
HHD Reading – Knee flexion (kilogram) 
Assessor Testing session 1 Right 2 Right 3 Right 4 Right 5 Right 1 Left 2 Left 3 Left 4 Left 5 Left 
A 
1 119 144 161 122.3 161 122 106.7 173 137 158 
1 120 157 165 132.1 135 154 118.1 181.5 120.1 145 
1 122 147 163 134.3 146 125 109.8 177.5 145.4 156 
Mean 120.3 149.3 163 129.6 147.3 133.7 111.5 177.3 134.1 153 
2 125.4 145 155 131 144.5 116.1 105.8 183 137.4 154 
2 116.1 166.8 158 128 125 133.9 112.5 168 130.8 137 
2 124.5 160.1 158 132 132.5 129.4 108.5 169 132.1 147 
Mean 122 157.3 157 130.3 134 126.5 108.9 173.3 133.4 146 
Pearson Coefficient  r=0.88; p=0.02 r=0.99; p=0.00 
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APPENDIX L 
 HANDHELD DYNAMOMETRY INTER RATER AND INTRA RATER RELIABILITY 
TESTING 
 
Handheld Dynamometry Inter Rater and Intra Rater Reliability Testing 
HHD Reading – Knee flexion(kilogram) 
Assessor Testing session 1 Right 2 Right 3 Right 4 Right 5 Right 1 Left 2 Left 3 Left 4 Left 5 Left 
A 
1 119 144 161 122.3 161 122 106.7 173 137 158 
1 120 157 165 132.1 135 154 118.1 181.5 120.1 145 
1 122 147 163 134.3 146 125 109.8 177.5 145.4 156 
Mean 120.3 149.3 163 129.6 
147.3 
 
113.7 111.5 177.3 134.2 153 
2 125.4 145 155 131 144.5 116.1 105.8 183 137.4 154 
2 116.1 166.8 158 128 125 133.9 112.5 168 130.8 137 
2 124.5 160.1 158 132 132.5 129.4 108.5 169 132.1 147 
Mean 122 157.3 157 130.3 134 126.5 108.9 173.3 133.4 146 
Pearson Coefficient  p=0.88 p=0.99 
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APPENDIX M 
 INFORMATION DOCUMENT 
 
INFORMATION DOCUMENT 
The functional ability and health related quality of life of survivors of critical illness after 
hospital discharge 
 
Dear patient 
 
I, Johannes van Aartsen, am doing research on the functional ability and health related 
quality of life of survivors of critical illness after hospital discharge. Research is only the 
process to learn the answer to a question. In this study I want to learn the functional ability of 
survivors of critical illness at the time of ICU discharge and hospital discharge, and the 
physical ability and health related quality of life of survivors of critical illness over the first 12 
months after hospital discharge.  
 
I am inviting you to take part in this research study. The study will be an observational study.  
 
Your participation in the study would involve you performing the following tests/assessments: 
 
 The physical function ICU test (PFIT) to assess your level of physical function when you 
are discharged from the ICU and before you are discharged from the hospital. This test 
will be done twice at your bed in the hospital ward.  
 
 One month after discharge from the hospital you will be asked to come back to see me 
for assessment of your recovery. Exercise tolerance will then be assessed using the 6 
minute walking test. During this test you will be asked to walk for 6 minutes at your own 
comfortable pace and the distance you walked will be measured. Before and after this 
test, your blood pressure and heart rate will be measured. 
 
 Your muscle strength will be assessed with a handheld dynamometer which will give you 
resistance against your muscle contractions. 
 
 Your physical activity level will be determined as you fill in the RPAQ questionnaire.  
 
 Your health related quality of life will be determined as you fill in the EQ-5D and SF-36 
questionnaires.  
 
 To determine if you may suffer from depression you will be asked to fill in the PHQ-9 
questionnaire. 
 
You will be asked to return to see me at six and twelve months after hospital discharge. All 
of the abovementioned tests will again be performed on you.  
All tests except for the PFIT will be done at the following venue, depending on the hospital 
you were at: 
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 Netcare Union Hospital: Section 5 
 Netcare Mulbarton Hospital: ICU 
 Chris Hani Baragwanath Hospital: Physiotherapy Department 
 
To determine the severity of your illness and the estimation of morbidity when you were 
admitted to the ICU, I will use the information in your hospital file and/or ICU charts to 
calculate your APACHE II and SAPS II scores.  
 
 There will be 87 participants in this study, all from South Gauteng.  
 
The entire testing session will take approximately 1 hour to complete.  
 
The only risks involved in participating in this study would be possible tiredness and 
shortness of breath while doing the 6 minute walking test. I will ensure that emergency 
equipment is at hand in the case of a medical emergency. You will also be allowed to rest if 
need be. You will also be screened to determine if it would be safe for you to complete the 6 
minute walking test.  
 
The possible benefit of your participation in this study is that you can track your own 
progress after hospital discharge by having standardised tests administered. You will also 
contribute to the data available in South Africa and this may help health care services to 
improve.  
 
You will still be allowed to continue with the treatments of your choice as prescribed by your 
doctor, physiotherapist and/or other health care professional. 
 
 You will be given pertinent information on the study while you are involved in it and after the 
results of the study are available.  
 
Your participation in this study is voluntary. If you refuse to participate it will not involve any 
penalty or loss of benefits which you are otherwise entitled to. You may discontinue your 
participation in the study at any time without penalty or loss of benefits to which you are 
otherwise entitled to. You do not need to provide any reasons if you want to terminate your 
participation. 
 
You will be reimbursed for your travel expenses to attend assessment sessions. 
 
All efforts will be made to keep personal information confidential. Absolute confidentiality 
cannot be guaranteed. Personal information will be disclosed if required by law. 
 
Organizations that may inspect and/or copy your research records for quality assurance and 
data analysis include groups such as the Human Research Ethics Committee of the 
University of the Witwatersrand. 
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If results of the study are published, it may lead to individual or cohort identification. 
 
For further information or reporting of study related adverse events, please contact me: 
 
Johannes van Aartsen 
Mobile: 079 388 2432 
Tel: (011) 976-1754 
E-mail: hannespt@gmail.com 
Post: PO. BOX 8523 
Edleen 
1625 
 
To report any complaints or problems, please contact the Human Research Ethics 
Committee administrator or chair: 
 
Prof Cleyton-Jones 
Tel: (011) 717- 2301 
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APPENDIX N 
 CONSENT FORM 
 
CONSENT FORM 
I have read and understood the information details of the study titled “The functional ability 
and health related quality of life of survivors of critical illness after hospital discharge.” 
 
The nature, demands, risks, and benefits of the project have been explained to me.  I 
knowingly participate in the study and understand that I may withdraw my consent and 
discontinue participation at any time without penalty or loss of benefit to myself. 
 
If circumstances develop during the course of the study that will deem the study continuation 
to be unsafe for me, my participation will be terminated by the investigator without regards to 
the participant’s consent. 
 
The only additional costs I will encounter during the course of the study will be travel costs.  
If significant new findings are developed during the course of the research which may relate 
to my willingness to continue participation in the study, these findings will be provided to me. 
I had the opportunity to ask questions regarding the research study and my participation in it. 
My questions were answered fully and appropriately by the researchers.   
 
The consent is given on the basis that my name will not be publicly divulged. 
 
Subject’s signature: ________________________________ Date: ________________ 
 
I certify that I have explained to the above individual the nature and purpose, the potential 
benefits, and possible risks associated with participation in this research study, have 
answered any questions that have been raised, and have witnessed the above signature. 
 
Signature of investigator: ____________________________ Date: ________________ 
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APPENDIX O 
 DEMOGRAPHIC INFORMATION 
 
DEMOGRAPHIC INFORMATION 
Participant name:___________________________________________________________ 
Participant code:____________________________________________________________ 
Age:______________________________________________________________________ 
Gender: __________________________________________________________________ 
Diagnosis:_________________________________________________________________
_________________________________________________________________________ 
Previous disability or pre-morbid conditions:______________________________________ 
Do you live alone or with others?_______________________________________________ 
If with others, will the people you live with provide you with support after hospital discharge?  
_________________________________________________________________________ 
If you live on your own, would you have any friends or family to provide you with support at 
home?___________________________________________________________________ 
Physical address:___________________________________________________________ 
Telephone number:__________________________________________________________ 
Mobile number:_____________________________________________________________ 
E-mail address:_____________________________________________________________ 
Highest level of education achieved: ____________________________________________ 
Pre-morbid occupational situation:______________________________________________ 
 
At 1, 6, and 12 months after discharge: 
Are you back to work yet?:  yes/no______________________________________________ 
If yes, what date did you return to work? _________________________________________ 
Are you doing the same job at work you did before? Yes/no.__________________________ 
 
If no, what type of work are you doing now?_______________________________________ 
 
If you have not returned to work, what are the reasons for this?_______________________ 
_________________________________________________________________________ 
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APPENDIX P 
 MUSCLE GROUPS AND TESTING POSITIONS FOR HHD 
 
Muscle action 
tested 
*Patient position 
*Joint position 
Dynamometer 
placement 
Stabilization region 
Shoulder Flexion *Supine 
*Shoulder flexed to 
90° and elbow 
extended 
Slightly proximal to 
Humeral epicondyles 
Axillary region 
Elbow Flexion *Supine 
*Elbow flexed to 90° 
with the forearm 
supinated. 
Slightly proximal to 
styloid process of the 
radius.  
Superior surface of 
the arm or shoulder. 
Elbow Extension *Supine 
*Elbow flexed to 90° 
with the forearm in 
neutral. 
Slightly proximal to 
the ulnar styloid 
process. 
Anterior surface of 
the arm or shoulder 
Hip Abduction *Supine 
*Both legs in neutral. 
At the point of the 
lateral femoral 
condyles. 
Stabilization of the 
opposite leg in a 
neutral position. 
Knee flexion *Sitting at the edge 
of the bed 
*Knees and hips 
flexed to 90°. 
Participant’s hands 
resting on hi/her lap. 
Slightly proximal to 
the malleoli on the 
posterior aspect of 
the lower leg. 
An assistant 
stabilizes at the 
shoulders. 
Knee extension *Sitting at the edge 
of the bed 
*Knees and hips 
flexed to 90°. 
Participant’s hands 
resting on hi/her lap. 
Slightly proximal to 
the malleoli on the 
anterior aspect of the 
lower leg. 
An assistant 
stabilizes at the 
shoulders. 
Ankle dorsiflexion *Supine 
*The hip, knee and 
ankle at 0°. 
Slightly proximal to 
the 
metatarsophalangeal 
joints of the foot.  
Knee to be kept in 
full extension. 
The leg is supported 
on the bed while the 
foot is off the bed.  
 
  
142 
 
APPENDIX Q 
 HEALTH AND WELL-BEING QUESTIONNAIRE 
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APPENDIX R 
 DOCUMENT OF CERTIFICATION FOR THE REVISION OF TEXT STRINGS FOR THE 
AFRIKAANS (SOUTH AFRICA) SF-12V2 AND SF36v2 SELF ADMINISTERED FORM 
(STANDARD & ACUTE) PAPER-PENCIL 
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APPENDIX S 
 DOCUMENT OF CERTIFICATION FOR THE REVISION OF TEXT STRINGS FOR THE 
ENGLISH (SOUTH AFRICA) SF-12v2 AND SF36v2 SELF ADMINISTERED FORM 
(STANDARD & ACUTE) PAPER PENCIL 
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APPENDIX T 
 CONFIRMATION OF TRANSLATION OF THE SF-36v2 HEALTH SURVEY INTO 
ISIZULU 
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APPENDIX U 
 NON-COMMERCIAL LICENSE AGREEMENT 
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APPENDIX V 
 EQ-5D-3L HEALTH QUESTIONNAIRE 
 
 
 
 
 
 
 
 
 
 
 
 
 
Health Questionnaire 
 
 
English version for South Africa 
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By placing a tick in one box in each group below, please indicate which 
statements best describe your own state of health TODAY. 
 
 
Mobility 
I have no problems in walking about      
I have some problems in walking about      
I am confined to bed         
 
Self-Care 
I have no problems with self-care       
I have some problems washing or dressing myself    
I am unable to wash or dress myself      
 
Usual Activities (e.g. work, study, housework, family or 
leisure activities) 
I have no problems with performing my usual activities   
I have some problems with performing my usual activities   
I am unable to perform my usual activities     
 
Pain/Discomfort 
I have no pain or discomfort        
I have moderate pain or discomfort      
I have extreme pain or discomfort       
 
Anxiety/Depression 
I am not anxious or depressed       
I am moderately anxious or depressed      
I am extremely anxious or depressed      
159 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
To help people say how good or bad their state of health is, we 
have drawn a scale (rather like a thermometer) on which the best 
state you can imagine is marked 100 and the worst state you can 
imagine is marked 0. 
 
We would like you to indicate on this scale, in your opinion, how 
good or bad your own health is today. Please do this by drawing 
a line from the box below to whichever point on the scale 
indicates how good or bad your state of health is today. 
 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
Worst  
imaginable 
state of health 
0 
Best 
imaginable 
state of health 
Your own 
state of health 
today 
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APPENDIX W 
 EQ-5D REGISTRATION 
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APPENDIX X 
 PATIENT HEALTH QUESTIONNAIRE (PHQ-9) 
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APPENDIX Y 
 PFIT RECORDING SHEET 
 
Subject No: __________________ 
Date:____/_____/20___ 
Time Point (please circle): Recruitment  Other (specify) 
 
ICU Discharge 
 
PFIT RECORDING SHEET 
 
1. Heart rate  
    (beats per minute) 
 
Pre:_____________ 
 
Post: ___________ 
2. SpO2 (%) 
 
 
Pre:_____________ 
 
Post: ___________ 
3. Sit to stand 
    Assistance (circle) 
 
0           1             2 
 
4. MOS 
4.1 RPE (pre) 
 
 
4.2 Able? (circle) 
 
4.3 Steps (number) 
 
4.4 Time (seconds) 
 
4.5. RPE (post) 
 
 
_____________ 
 
Yes               No 
 
 
__________________ 
 
__________________ 
 
__________________ 
5. Strength 
5.1 Shoulder flexion 
 
5.2 Knee extension 
 
Left Right 
 
___________ 
 
_____________ 
 
___________ 
 
_____________ 
6. Shoulder flexion 
6.1  RPE (pre) 
 
6.2 Reps (number) 
 
6.3 Seconds 
 
6.4 RPE (post) 
 
___________ 
 
_____________ 
 
___________ 
 
_____________ 
 
___________ 
 
____________ 
 
___________ 
 
____________ 
 
Reason for test non-completion: 
Patient deceased   Patient lost to follow-up  
Patient refused   Patient confusion   
Other: __________________________________________________ 
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APPENDIX Z 
 RECENT PHYSICAL ACTIVITY QUESTIONNAIRE 
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APPENDIX AA 
 TURN-IT-IN REPORT 
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